"Rank","Title","Status","Study Results","Conditions","Interventions","Sponsor/Collaborators","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Start Date","Completion Date","Locations","URL"
1,"Effect of Some Drugs on Liver Fibrosis","Recruiting","No Results Available","Liver Fibroses","Drug: Candesartan|Drug: Ramipril","Sherief Abd-Elsalam|Tanta University","Phase 3","45","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","October 1, 2018","November 2027","Sherief Abd-Elsalam, Tanta, Egypt","https://ClinicalTrials.gov/show/NCT03770936"
2,"Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection","Completed","No Results Available","Liver Fibrosis","Drug: Warfarin","Imperial College London","Phase 2","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","August 2005","October 2006","St Mary's Hospital NHS Trust, London, United Kingdom","https://ClinicalTrials.gov/show/NCT00180674"
3,"Pirfenidone and Advanced Liver Fibrosis.","Recruiting","No Results Available","Liver Fibrosis|Chronic Liver Disease","Drug: Pirfenidone|Other: Standard of care","Grupo Mexicano para el Estudios de las Enfermedades Hepaticas","Phase 2","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","August 1, 2019","December 31, 2020","Liver Clinic 1, Mexico City, Mexico","https://ClinicalTrials.gov/show/NCT04099407"
4,"Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV","Completed","No Results Available","Liver Fibrosis","Drug: Silybin 94 mg + vitamin E 90 mg + phospholipids 194 mg complex|Drug: Placebo","University of Catania","Phase 3","64","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 2010","December 2012","Cannizzaro Hospital, Catania, Sicily, Italy","https://ClinicalTrials.gov/show/NCT01935817"
5,"Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED)","Completed","Has Results","Liver Fibrosis|Hepatitis C Virus","Procedure: MRE","Merck Sharp & Dohme Corp.","Phase 1","10","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","August 2009","January 2010",,"https://ClinicalTrials.gov/show/NCT00896233"
6,"Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)","Terminated","Has Results","Liver Fibrosis Due to NASH","Biological: Placebo|Biological: SIM","Gilead Sciences","Phase 2","222","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 5, 2012","December 29, 2016","Mayo Clinic Hospital, Phoenix, Arizona, United States|Southern California Liver Centers, Coronado, California, United States|University of California, San Diego (UCSD), San Diego, California, United States|University of California San Francisco (UCSF), San Francisco, California, United States|University of Colorado, Aurora, Colorado, United States|Miami Veterans Administration Healthcare System, Miami, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Northwestern University, Chicago, Illinois, United States|Indianapolis Gastroenterology Research Foundation, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|University of Louisville, Louisville, Kentucky, United States|Tulane University, New Orleans, Louisiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Lahey Clinic, Burlington, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Minnnesota Gastroenterology, PA, Saint Paul, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Saint Louis University Hospital, Saint Louis, Missouri, United States|State University Of New York, Buffalo, New York, United States|Weill Cornell Medical College, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|Duke University, Durham, North Carolina, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|St. Luke's Episcopal Hospital, Houston, Texas, United States|Alamo Clinical Research Associates, San Antonio, Texas, United States|University of Utah, Salt Lake City, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Liver Institute of Virginia, Newport News, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Bucheon St. Marys Hospital, Richmond, Virginia, United States|Virginia Commonwealth University Health System, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|Hôpital Erasme, Brussels, Belgium|Université Catholique de Louvain, Bruxelles, Belgium|UZ Ghent, Gent, Belgium|University of Calgary, Calgary, Alberta, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|London Health Science Center, London, Ontario, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Hopital Beaujon, Clichy, France|Hospital Saint-Antoine, Paris, France|Groupe Hospitalier Pitié- Salpétrière, Paris, France|CHU Strasbourg Hôpital Civil, Strasbourg, France|Medizinische Hochschule Hannover, Hannover, Germany|Gastroenterologisch-Hepatologisches Zentrum Kiel, Kiel, Germany|EUGASTRO GmbH, Leipzig, Germany|Azienda Ospedaliero-Universitaria di Modena Policlinico, Modena, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy|Fundacion De Investigacion, San Juan, Puerto Rico|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario Puerta de Hierro, Majadahonda, Spain|Hospital Donostia, San Sebastian, Spain|John Radcliffe Hospital, Headington, United Kingdom|The Royal London Hospital, London, United Kingdom|Royal Free Hospital, Pond Street, London, United Kingdom|King's College Hospital NHS Foundation Trust No. 1 Account, London, United Kingdom|Nottingham University Hospitals Queens Medica, Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT01672866"
7,"Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis","Completed","Has Results","Liver Fibrosis|Hepatitis C|HIV|HIV/HCV Co-infection","Biological: Simtuzumab","Gilead Sciences|National Institute of Allergy and Infectious Diseases (NIAID)","Phase 2","18","Industry|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","October 4, 2012","October 17, 2014","NIH Department of Laboratory Medicine, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01707472"
8,"A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection","Terminated","No Results Available","Liver Fibrosis Due to Chronic Hepatitis B Infection","Drug: FG-3019|Drug: Placebo|Drug: Entecavir","FibroGen","Phase 2","114","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 2010","June 2015","Queen Mary Hospital, Pokfulam, Hong Kong Island, Hong Kong|Ruttonjee Hospital, Wanchai, Hong Kong Island, Hong Kong|Prince of Wales Hospital, Shatin, Kowloon, Hong Kong|Princess Margaret Hospital, Kowloon, Hong Kong|Tuen Mun Hospital, New Territories, Hong Kong|Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong|Siriraj Hospital, Siriaj, Bangkok Noi, Thailand|Maharaj Nakorn Chiang Mai Hospital, Amphur Muang, Chiang Mai, Thailand|Songklanagarind Hospital, Amphur Hatyai, Songkla, Thailand","https://ClinicalTrials.gov/show/NCT01217632"
9,"Effect of Candesartan in Alcoholic Liver Fibrosis","Completed","No Results Available","Alcoholic Liver Disease","Drug: candesartan for hepatic fibrosis","Yonsei University","Phase 1|Phase 2","85","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 2005","March 2009","Yonsei University Wonju College of Medicine Wonju Christian Hospital, Wonju, Kangwon-do, Korea, Republic of","https://ClinicalTrials.gov/show/NCT00990639"
10,"A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C","Completed","No Results Available","Hepatic Cirrhosis|Liver Fibrosis","Drug: BMS-986263|Other: Placebo","Bristol-Myers Squibb","Phase 2","61","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 14, 2018","May 28, 2019","The Texas Liver Institute, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT03420768"
11,"Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis","Completed","No Results Available","Liver Fibrosis|Liver Cirrhosis","Drug: oltipraz|Drug: placebo","HK inno.N Corporation","Phase 2","81","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment","February 2006","February 2007","The Catholic University of Korea Holy Family Hospital, Sosa-Dong, Wonmi-Gu, Kyungki-Do, Korea, Republic of|The Catholic University of Korea Seoul St. Mary's Hospital, Banpo-Dong, Seocho-Gu, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT00956098"
12,"Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis","Completed","No Results Available","Liver Fibrosis","Biological: Simtuzumab","Gilead Sciences","Phase 2","20","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","November 2011","August 2013","Weill Cornell Medical College: NewYork-Presbyterian Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01452308"
13,"Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)","Completed","No Results Available","Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)","Drug: ND-L02-s0201 Injection","Bristol-Myers Squibb|Nitto Denko Corporation","Phase 1","25","Industry","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","October 2014","May 2016","Texas Liver Institute, Austin, Texas, United States|Tokuda Hospital, Sofia, Bulgaria","https://ClinicalTrials.gov/show/NCT02227459"
14,"Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)","Completed","Has Results","Chronic Hepatitis C|Liver Fibrosis","Biological: peginterferon alfa-2b (SCH 54031)","Merck Sharp & Dohme Corp.","Phase 3","540","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","October 2002","October 2009",,"https://ClinicalTrials.gov/show/NCT00049842"
15,"Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone","Completed","No Results Available","Liver Fibrosis","Biological: Cell injection","Royan Institute","Phase 1","3","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","June 2010","July 2013","Royan Institute, Tehran, Iran, Islamic Republic of","https://ClinicalTrials.gov/show/NCT01454336"
16,"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis","Active, not recruiting","No Results Available","Liver Fibrosis|Nonalcoholic Fatty Liver Disease (NAFLD)|Nonalcoholic Steatohepatitis","Drug: BMS-986036|Other: Placebo","Bristol-Myers Squibb","Phase 2","160","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 7, 2018","December 20, 2021","North Alabama GI Research Center, Madison, Alabama, United States|Arizona Liver Health, Chandler, Arizona, United States|Saint Josephs Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic - Arizona, Phoenix, Arizona, United States|The Institute for Liver Health - Tuscon, Tucson, Arizona, United States|Southern California Research Center, Coronado, California, United States|Kindred Medical Institute for Clinical Trials, Corona, California, United States|University of California San Diego, La Jolla, California, United States|Ruane Clinical Research Group, Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|GastroIntestinal Biosciences, Los Angeles, California, United States|Catalina Research Institute, Montclair, California, United States|Kaiser Permanente, Oakland, California, United States|Diverse Research Solutions, Oxnard, California, United States|California Liver Research Institute, Pasadena, California, United States|Huntington Medical Research Institutes - HMRI Liver Center, Pasadena, California, United States|Stanford Center for Clinical Research, Redwood City, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Southern California Liver Centers - San Clemente, San Clemente, California, United States|Medical Associates Research Group, San Diego, California, United States|California Pacific Medical Center, San Francisco, California, United States|Bridgeport Hospital, Bridgeport, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Clinical Research of South Florida - Coral Gables, Coral Gables, Florida, United States|Top Medical Research, Cutler Bay, Florida, United States|University of Florida Hepatology Research at CTRB, Gainesville, Florida, United States|Clinical Research of Homestead, Homestead, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|University of Miami Hospital and Clinics, Miami, Florida, United States|A+ Research, Miami, Florida, United States|IMIC Research, Miami, Florida, United States|Sensible Healthcare, Ocoee, Florida, United States|Synexus Clinical Research - Orlando, Orlando, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|GI Specialists of Georgia, Marietta, Georgia, United States|Tandem Clinical Research, Marrero, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|Mercy Medical Center - McAuley Plaza, Baltimore, Maryland, United States|Digestive Disease Associates, Catonsville, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|NECCR PrimaCare Research, Fall River, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Clinical Research Professionals, Chesterfield, Missouri, United States|Saint Lukes Hospital - Kansas City, Kansas City, Missouri, United States|Saint Louis University, Saint Louis, Missouri, United States|University at Buffalo, Buffalo, New York, United States|Northwell Health, Manhasset, New York, United States|Mount Sinai Hospital, New York, New York, United States|New York University, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Carolinas Medical Center - Transplant Center, Charlotte, North Carolina, United States|Northeast GI Research Division, Concord, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center - Center for Liver Disease, Pittsburgh, Pennsylvania, United States|Gastro One, Germantown, Tennessee, United States|Associates in Gastroenterology, Hermitage, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States|Liver Center of Texas, Dallas, Texas, United States|Texas Digestive Disease Consultants - Dallas, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Texas Digestive Disease Consultants - Southlake, Fort Worth, Texas, United States|Spring Gastroenterology, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Pinnacle Clinical Research - San Antonio, Rollingwood, Texas, United States|The Texas Liver Institute, San Antonio, Texas, United States|Clinical Trials of Texas, San Antonio, Texas, United States|Pinnacle Clinical Research - San Antonio, San Antonio, Texas, United States|University of Vermont Medical Center, Burlington, Vermont, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Gastroenterology Associates, PC, Manassas, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|The Gastroenterology Group, Reston, Virginia, United States|Bon Secours Liver Institute of Richmond, Richmond, Virginia, United States|Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Kurume University Hospital, Kurume, Fukuoka, Japan|Yokohama City University Hospital, Yokohama-shi, Kanagawa, Japan|Nara Medical University Hospital, Kashihara, Nara, Japan|Toranomon Hospital, Minato, Tokyo, Japan|Keio University Hospital, Shinjuku-ku, Tokyo, Japan|Fukushima Medical University Hospital, Fukushima, Japan","https://ClinicalTrials.gov/show/NCT03486899"
17,"A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients","Withdrawn","No Results Available","Liver Fibrosis|HEPATITIS B CHRONIC|Hepatocellular Carcinoma","Drug: DCB-BO1202|Drug: Placebo|Drug: DCB-BO1202+Placebo","A2 Healthcare Taiwan Corporation|GoldenMed BioTechnology","Phase 2","0","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 2020","December 2021","National Taiwan University Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT02289300"
18,"The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis","Completed","No Results Available","Non Alcoholic Fatty Liver","Dietary Supplement: Resveratrol|Other: placebo","Dr Azita Hekmatdoost|National Nutrition and Food Technology Institute","Phase 2|Phase 3","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 2012","March 2013",,"https://ClinicalTrials.gov/show/NCT02030977"
19,"The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease","Completed","No Results Available","Non Alcoholic Steatohepatitis","Dietary Supplement: Flaxseed|Other: control","National Nutrition and Food Technology Institute","Phase 2|Phase 3","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","March 2014","January 2015",,"https://ClinicalTrials.gov/show/NCT02395900"
20,"Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis","Completed","No Results Available","Liver Fibrosis|Cirrhosis","Drug: interferon gamma-1b","InterMune","Phase 2","502","Industry","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 2001","November 2003",,"https://ClinicalTrials.gov/show/NCT00043303"
21,"The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis","Completed","No Results Available","Non Alcoholic Steatohepatitis","Dietary Supplement: synbiotic|Other: placebo","National Nutrition and Food Technology Institute","Phase 2|Phase 3","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 2012","January 2013",,"https://ClinicalTrials.gov/show/NCT01791959"
22,"Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.","Completed","No Results Available","Hepatitis C, Chronic|Liver Fibrosis","Biological: Peginterferon alfa-2b|Drug: Ribavirin|Drug: Ribavirin-Placebo","French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|Merck Sharp & Dohme Corp.|Rennes University Hospital","Phase 2|Phase 3","372","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 2006","March 2013","CHU Brugmann, Bruxelles, Belgium|Hôpital Bracops, Bruxelles, Belgium|Hôpital Erasme, Bruxelles, Belgium|Hôpital de Jolimont, La Louvière, Belgium|CHU Sart Tilman, Liège, Belgium|Service d'Hépatogastroentérologie et d'endoscopie digestive - CH du Pays d'Aix, Aix en Provence, France|Hôpital Nord, Amiens, France|Service d'Hépatogastroentérologie - Hôpital Nord, Amiens, France|Service d'Hépatologie - Gastroentérologie - Cancérologie digestive - CHU Angers, Angers, France|Centre Hospitalier Victor Dupouy, Argenteuil, France|Service d'Hépatogastroentérologie - Hôpital Avicenne, Bobigny, France|Service d' Hépatogastroentérologie - Hôpital Jean Verdier, Bondy, France|Service d'Hépatogastroentérologie et d'Assistance nutritive - Hôpital Haut-Lévêque, Bordeaux Pessac, France|CH Pierre OUDOT, Bourgoin-Jallieu, France|Service d'Hépatogastroentérologie - Hôpital de la Cavale Blanche, Brest, France|Service d'Hépatologie - Gastroentérologie - Nutrition -Hôpital de la Côte de Nacre, Caen, France|Centre Hospitalier, Châteauroux, France|Service d'Hépatogastroentérologie - CHU d'ESTAING, Clermont-Ferrand, France|Service d'Hépatogastroentérologie - Hôpital Beaujon, Clichy, France|Service d'Hépatogastroentérologie - CH Sud Francilien, Corbeil-Essonnes, France|Service d'Hépatogastroentérologie - Hôpital du Bocage, Dijon, France|Hôpital Nord, Grenoble, France|Service d'Hépatogastroentérologie - CH La Roche sur Yon, La Roche sur Yon, France|Service des Maladies du Foie et de l'appareil Digestif - Hôpital de Bicêtre, Le Kremlin-Bicêtre, France|Département d'Hépatogastroentérologie - CH Le Mans, Le Mans, France|Service d'Hépatogastroentérologie - CHRU - Hôpital Claude Huriez, Lille, France|Service d'Hépatogastroentérologie - Hotel de la Croix Rousse, Lyon, France|Service d'Hépatogastroentérologie - Hôpital Saint Joseph, Marseille, France|Service d'Hépatogastroentérologie - CH Montauban, Montauban, France|Service d'Hépatogastroentérologie - CH Montélimar, Montelimar, France|Service d'Hépatogastroentérologie - Hôpital Saint Eloi, Montpellier, France|Service d'Hépatogastroentérologie - Hôtel Dieu, Nantes, France|Hôpital de l'Archet, Nice, France|Service d'Hépatogastroentérologie - Hôpital de la Source, Orléans, France|Service d'Hépatogastroentérologie - Hôpital La Pitié Salpétrière, Paris, France|Service d'Hépatogastroentérologie - Hôpital Tenon, Paris, France|Service d'Hépatogastroentérologie - Hôpital Pontchaillou, Rennes, France|Service d'Hépatogastroentérologie - CHU Rouen, Rouen, France|Centre Hospitalier, Saint Quentin, France|Service d'Hépatogastroentérologie, Clinique médicale B - Hôpital Civil, Strasbourg, France|Hôpital Purpan, Toulouse, France|Service d'Hépatogastroentérologie - Hôpital Purpan, Toulouse, France|Service d'Hépatogastroentérologie - Hôpital Trousseau, Tours, France|Service d'Hépatogastroentérologie - Hôpital Brabois, Vandoeuvre les Nancy, France|Hôpita Paul Brousse, Villejuif, France","https://ClinicalTrials.gov/show/NCT00323804"
23,"Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM)","Active, not recruiting","No Results Available","Non-alcoholic Steatohepatitis (NASH)","Drug: Tropifexor (LJN452)|Drug: Cenicriviroc (CVC)","Novartis Pharmaceuticals|Allergan|Novartis","Phase 2","194","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 11, 2018","September 29, 2020","Novartis Investigative Site, Madison, Alabama, United States|Novartis Investigative Site, Chandler, Arizona, United States|Novartis Investigative Site, North Little Rock, Arkansas, United States|Novartis Investigative Site, Coronado, California, United States|Novartis Investigative Site, Fresno, California, United States|Novartis Investigative Site, La Jolla, California, United States|Novartis Investigative Site, Los Angeles, California, United States|Novartis Investigative Site, Los Angeles, California, United States|Novartis Investigative Site, Pasadena, California, United States|Novartis Investigative Site, Rialto, California, United States|Novartis Investigative Site, Boca Raton, Florida, United States|Novartis Investigative Site, Lakewood Ranch, Florida, United States|Novartis Investigative Site, Palmetto Bay, Florida, United States|Novartis Investigative Site, Athens, Georgia, United States|Novartis Investigative Site, Atlanta, Georgia, United States|Novartis Investigative Site, Atlanta, Georgia, United States|Novartis Investigative Site, Marietta, Georgia, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Indianapolis, Indiana, United States|Novartis Investigative Site, New Albany, Indiana, United States|Novartis Investigative Site, Marrero, Louisiana, United States|Novartis Investigative Site, Metairie, Louisiana, United States|Novartis Investigative Site, Shreveport, Louisiana, United States|Novartis Investigative Site, Asheville, North Carolina, United States|Novartis Investigative Site, Concord, North Carolina, United States|Novartis Investigative Site, Durham, North Carolina, United States|Novartis Investigative Site, Morehead City, North Carolina, United States|Novartis Investigative Site, Winston-Salem, North Carolina, United States|Novartis Investigative Site, Providence, Rhode Island, United States|Novartis Investigative Site, Chattanooga, Tennessee, United States|Novartis Investigative Site, Germantown, Tennessee, United States|Novartis Investigative Site, Hermitage, Tennessee, United States|Novartis Investigative Site, Dallas, Texas, United States|Novartis Investigative Site, San Antonio, Texas, United States|Novartis Investigative Site, Murray, Utah, United States|Novartis Investigative Site, Richmond, Virginia, United States|Novartis Investigative Site, Richmond, Virginia, United States|Novartis Investigative Site, Seattle, Washington, United States|Novartis Investigative Site, Caba, Buenos Aires, Argentina|Novartis Investigative Site, Caba, Buenos Aires, Argentina|Novartis Investigative Site, Caba, Buenos Aires, Argentina|Novartis Investigative Site, Florencio Varela, Buenos Aires, Argentina|Novartis Investigative Site, Rosario, Santa Fe, Argentina|Novartis Investigative Site, Buenos Aires, Argentina|Novartis Investigative Site, Bruxelles, Belgium|Novartis Investigative Site, Edegem, Belgium|Novartis Investigative Site, Leuven, Belgium|Novartis Investigative Site, Vancouver, British Columbia, Canada|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Chicoutimi, Quebec, Canada|Novartis Investigative Site, Montreal, Quebec, Canada|Novartis Investigative Site, Praha 4, Czech Republic, Czechia|Novartis Investigative Site, Prague, Czechia|Novartis Investigative Site, Prague, Czechia|Novartis Investigative Site, Cairo, Egypt|Novartis Investigative Site, Menoufiya, Egypt|Novartis Investigative Site, Tallinn, Estonia|Novartis Investigative Site, Tartu, Estonia|Novartis Investigative Site, Paris Cedex 13, France|Novartis Investigative Site, Pessac Cedex, France|Novartis Investigative Site, Rennes, France|Novartis Investigative Site, Strasbourg, France|Novartis Investigative Site, Mainz, Germany|Novartis Investigative Site, Wuerzburg, Germany|Novartis Investigative Site, Hong Kong, Hong Kong|Novartis Investigative Site, New Delhi, Delhi, India|Novartis Investigative Site, Ludhiana, Punjab, India|Novartis Investigative Site, Ramat Gan, Israel|Novartis Investigative Site, Tel Aviv, Israel|Novartis Investigative Site, Modena, Itlay, Italy|Novartis Investigative Site, Palermo, PA, Italy|Novartis Investigative Site, Roma, RM, Italy|Novartis Investigative Site, Verona, VR, Italy|Novartis Investigative Site, Milan, Italy|Novartis Investigative Site, Riga, Latvia|Novartis Investigative Site, Riga, Latvia|Novartis Investigative Site, Guimaraes, Portugal|Novartis Investigative Site, Lisboa, Portugal|Novartis Investigative Site, Vila Real, Portugal|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Stavropol, Russian Federation|Novartis Investigative Site, Singapore, Singapore|Novartis Investigative Site, Singapore, Singapore|Novartis Investigative Site, Santander, Cantabria, Spain|Novartis Investigative Site, Barcelona, Cataluna, Spain|Novartis Investigative Site, Barcelona, Cataluna, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, Spain|Novartis Investigative Site, Bern, Switzerland|Novartis Investigative Site, Lugano, Switzerland|Novartis Investigative Site, Ankara, Turkey|Novartis Investigative Site, Izmir, Turkey|Novartis Investigative Site, Pendik / Istanbul, Turkey|Novartis Investigative Site, High Heaton, Newcastle Upon Tyne, United Kingdom|Novartis Investigative Site, Aberdeen, United Kingdom|Novartis Investigative Site, Torquay, United Kingdom","https://ClinicalTrials.gov/show/NCT03517540"
24,"Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C","Terminated","No Results Available","Hepatitis C, Chronic|Liver Fibrosis","Drug: pentoxyphilline|Drug: tocopherol","French National Agency for Research on AIDS and Viral Hepatitis","Phase 3","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment","February 2002","December 2006","Service d'hepatologie Hopital Necker, Paris, France","https://ClinicalTrials.gov/show/NCT00119119"
25,"A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV","Completed","Has Results","Liver Fibrosis|Hepatic Fibrosis|Liver Cirrhosis|Hepatic Cirrhosis","Drug: IDN-6556|Drug: Placebo","Conatus Pharmaceuticals Inc.","Phase 2","64","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 2014","March 9, 2018","Southern California Research Center, Coronado, California, United States|Scripps Clinic, La Jolla, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|UCLA Pfleger Liver Institute, Los Angeles, California, United States|Georgetown University Hospital, Washington, District of Columbia, United States|Johns Hopkins Sibley Memorial Hospital, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|University of Miami, Miami, Florida, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago Medicine, Chicago, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University of Louisville, Louisville, Kentucky, United States|Tulane Health Science Center, New Orleans, Louisiana, United States|Ochsner Clinic, New Orleans, Louisiana, United States|John Hopkins Hospital, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Henery Ford Health System, Detroit, Michigan, United States|Saint Louis University, Saint Louis, Missouri, United States|Rutgers New Jersey Medical School, Newark, New Jersey, United States|Columbia University Medical Center, New York, New York, United States|University of Cincinnati Physicians Company, Cincinnati, Ohio, United States|University of Pennsylvania Milton Hershey Hospital, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States|Baylor All Saints Medical Center, Fort Worth, Texas, United States|Liver Associates of Texas, PA, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|VAMC/Baylor College of Medicine, Houston, Texas, United States|University of Utah, Salt Lake City, Utah, United States|Bon Secours Mary Immaculate Hospital, Newport News, Virginia, United States|Bon Secours St. Mary's Hospital of Richmond, Richmond, Virginia, United States|McGuire DVAMC, Richmond, Virginia, United States|University of Washington Harborview Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02138253"
26,"Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH","Terminated","Has Results","Liver Fibrosis Due to NASH","Biological: Placebo|Biological: SIM","Gilead Sciences","Phase 2","259","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 29, 2012","January 3, 2017","Mayo Clinic Hospital, Phoenix, Arizona, United States|Southern California Liver Centers, Coronado, California, United States|University of California, San Diego (UCSD), San Diego, California, United States|University of California San Francisco (UCSF), San Francisco, California, United States|University of Colorado, Denver, Aurora, Colorado, United States|University of Miami, Miami, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Northwestern University, Chicago, Illinois, United States|Indiana University School of Medicine, Division of Gastroenterology/Hepatology, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|University of Louisville, Louisville, Kentucky, United States|Tulane University, New Orleans, Louisiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Lahey Clinic, Burlington, Massachusetts, United States|University of Mississippi Medical Center, Jackson, Michigan, United States|Minnnesota Gastroenterology, PA, Saint Paul, Minnesota, United States|Saint Louis University Hospital, Saint Louis, Missouri, United States|State University Of New York at Buffalo, Buffalo, New York, United States|North Shore University Health System, Manhasset, New York, United States|New York University, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Methodist University Hospital, Memphis, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|St. Luke Episcopal Hospital, Houston, Texas, United States|Alamo Clinical Research Associates, San Antonio, Texas, United States|Intermountain Transplant Center, Murray, Utah, United States|University of Virginia Health Center, Charlottesville, Virginia, United States|Liver Institute of Virginia, Newport News, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Bucheon St. Marys Hospital, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|University of Manitoba, Winnipeg, Manitoba, Canada|Dalhousie University, Halifax, Nova Scotia, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Hôpital de la Croix Rousse, Lyon, France|Hospital Saint-Antoine, Paris, France|CHU Pitié-Salpêtrière, Paris, France|Fonds de Recherche Honoraires, Strasbourg, France|Gastroenterologisch-Hepatologisches Zentrum Kiel, Kiel, Germany|Eugastro Gmbh, Leipzig, Germany|Istituto Clinico Humanitas, Rozzano, Milano, Italy|Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy|Fundacion De Investigacion, San Juan, Puerto Rico|Hospital Vall D´Hebron, Barcelona, Cataluna, Spain|Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain|Royal Free Hospital, Pond Street, London, United Kingdom|King's College Hospital NHS Trust, London, United Kingdom|Nottingham University Hospitals Queen's Medical Centre, Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT01672879"
27,"Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis","Recruiting","No Results Available","Non-alcoholic Fatty Liver Disease|Liver Cirrhosis","Drug: CC-90001|Drug: Placebo","Celgene","Phase 2","300","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 14, 2019","July 19, 2023","Saint Joseph's Hosptial and Medical Center - Barrow Neurological Institute, Phoenix, Arizona, United States|Mayo Clinic Phoenix, Phoenix, Arizona, United States|UC San Diego School of Medicine, La Jolla, California, United States|Cedars-Sinai Comprehensive Transplant Center, Los Angeles, California, United States|California Liver Research Institute, Pasadena, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|University of California Davis Medical Center, Sacramento, California, United States|University of Colorado, School of Medicine - Hepatology Clinic - Anschutz, Aurora, Colorado, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|South Denver Gastroenterology, Englewood, Colorado, United States|Yale Cancer Center, New Haven, Connecticut, United States|University of Miami Schiff Center for Liver Diseases, Miami, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Gastrointestinal Specialists of Georgia, PC, Marietta, Georgia, United States|Rush University Medical Center - University Cardiovascular Surgeons, Chicago, Illinois, United States|University of Chicago Medicine, Chicago, Illinois, United States|WestGlen Gastrointestinal Consultants, P.A., Shawnee Mission, Kansas, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|The Institute for Digestive Health & Liver Disease at Mercy Medical Center, Baltimore, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Boston University Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconness Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Saint Louis University School of Medicine, Saint Louis, Missouri, United States|University of Nebraska, Omaha, Nebraska, United States|Concorde Medical Group, New York, New York, United States|New York Presbyterian Hospital - Weill-Cornell, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|UNC Hospitals GI Medicine Clinic, Chapel Hill, North Carolina, United States|Duke University School of Medicine, Durham, North Carolina, United States|Carolinas HealthCare System Digestive Health, Huntersville, North Carolina, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|University of Pittsburgh Medical Center - Center for Liver Diseases, Pittsburgh, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|ClinSearch LLC, Chattanooga, Tennessee, United States|Gastro One, Germantown, Tennessee, United States|Texas Clinical Research Institute LLC, Arlington, Texas, United States|Liver Institute at Methodist Dallas, Dallas, Texas, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Brooke Army Medical Center Francis Street Medical Center, Fort Sam Houston, Texas, United States|Baylor College of Medicine - Baylor Heart Clinic, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Digestive Health Associates of Texas (DHAT), Rockwell, Texas, United States|American Research Corporation, San Antonio, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Vermont Medical Center Gastro, Burlington, Vermont, United States|Bon Secours Liver Institute of Hampton Roads, Newport News, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Bon Secours Liver Institute of Richmond, Richmond, Virginia, United States|McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States|Swedish Medical Center, Seattle, Washington, United States|University of Washington Harborview Medical Center, Seattle, Washington, United States|University of Sydney - Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada|University of Alberta, Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada|South Edmonton Gastroenterology, Edmonton, Alberta, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|Dalhousie University, Halifax, Nova Scotia, Canada|Toronto Center for Liver Disease - Francis Family Liver Clinic, Toronto, Ontario, Canada|McGill University Health Center, Royal Victoria Hospital, Montreal, Quebec, Canada|CHU d'Angers, Angers, France|Assistance Publique - Hopitaux de Paris - Hopital Beaujon, Clichy cedex, France|Hopital de la Croix-Rousse, Lyon, France|Assistance Publique - Hopitaux de Paris - Hopital Universitaire Pitie Salpetriere, Paris CEDEX 13, France|Assistance Publique - Hopitaux de Paris - Hopital Cochin, Paris, France|Hopital Haut Leveque, Pessac Cedex, France|Centre Hospitalier Universitaire de Rennes - Hopital de Pontchaillou, Rennes cedex 09, France|Hopital Hautepierre, Strasbourg, France|Universitaetsklinikum der RWTH Aachen, Aachen, Germany|Charite -Universitätsmedizin Berlin, Berlin, Germany|Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany|Universitaetsklinikum Muenster, Muenster, Germany|Hamamatsu University Hospital, Hamamatsu, Japan|Nara Medical University Hospital, Kashihara, Japan|Shin-Yurigaoka General Hospital, Kawasaki, Japan|Kurume University Hospital, Kurume, Fukuoka, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto-City, Japan|Japanese Red Cross Musashino Hospital, Musashino, Japan|Aichi Medical University Hospital, Nagakute, Japan|Ogaki Municipal Hospital, Ogaki, Japan|Osaka University Hospital OUH, Osaka-Fu, Japan|Saga University Hospital, Saga, Japan|Belland General Hospital, Sakai-shi, Japan|Saiseikai Suita Hospital, Suita, Japan|Yokohama City University Hospital, Yokohama, Kanagawa, Japan|Soon Chun Hyang University Hospital Bucheon, Bucheon-si, Korea, Republic of|Hanyang University Seoul Hospital, Seoul, Korea, Republic of|Korea University Hospital at Guro, Seoul, Korea, Republic of|Boramae Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju-si, Korea, Republic of|Szpital Specjalistyczny w Chorzowie, Chorzow, Poland|Katowice (DRS)Synexus Polska Sp. z o.o. Oddzial w Katowicach, Katowice, Poland|Samodzielny Publiczny Centralny Szpital Kliniczny Im Prof. Kornela Gibinskiego, Katowice, Poland|Krakow Medical Center LLC, Krakow, Poland|Lodz (DRS)Synexus Polska Sp. Z o.o. Oddzial w Lodzi, Lodz, Poland|Wojewodzki Specjalistyczny Szpital im. dr Wladyslawa Bieganskiego, Lodz, Poland|ID Clinic, Myslowice, Poland|Synexus SCM Sp. z o.o. Oddz. Warszawa, Warszawa, Poland|Hospital Val d'Hebron, Barcelona, Spain|University Hospital of Girona Dr. Josep Trueta, Girona, Spain|Parc Tauli Hospital Universitari, Sabadell (Barcelona), Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Virgen del Rocio, Sevilla, Spain|University of Birmingham Institute of Biomedical Research, Birmingham, United Kingdom|Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital, Cambridge, United Kingdom|North Tees (DRS) Synexus North Teesside Clinical Research Centre, Hardwick, United Kingdom|Synexus Hexham Clinical Research Centre, Hexham (DRS), Hexham, United Kingdom|Kings College Hospital, London, United Kingdom|Chelsea and Westminster Hospital NHS Foundation Trust - Chelsea and Westminster Hospital (CWH), London, United Kingdom","https://ClinicalTrials.gov/show/NCT04048876"
28,"Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection","Completed","No Results Available","HIV|Hepatitis C|Liver Fibrosis","Drug: Raltegravir|Drug: Ritonavir-boosted protease inhibitor","McGill University Health Centre/Research Institute of the McGill University Health Centre|Merck Sharp & Dohme Corp.|CIHR Canadian HIV Trials Network","Phase 2","9","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","December 2011","September 2016","Providence Health Care- St. Paul's Hospital, Vancouver, British Columbia, Canada|University Health Network - Toronto General Hospital Division, Toronto, Ontario, Canada|Montreal Chest Institute, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01231685"
29,"First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis","Completed","No Results Available","Fibrosis","Drug: BLD-2660","Blade Therapeutics","Phase 1","88","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 11, 2018","October 4, 2019","Nucleus Network, Melbourne, Victoria, Australia","https://ClinicalTrials.gov/show/NCT03559166"
30,"A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body","Completed","No Results Available","Liver Fibrosis/NASH","Drug: BMS-986171|Other: Placebo","Bristol-Myers Squibb","Phase 1","275","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","October 31, 2015","November 5, 2016","Profil Institute For Clinical Research, Inc., Chula Vista, California, United States|Wcct Global, Llc, Cypress, California, United States","https://ClinicalTrials.gov/show/NCT02538874"
31,"Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis","Completed","No Results Available","Nonalcoholic Steatohepatitis","Drug: GR-MD-02|Drug: Placebo","Galectin Therapeutics Inc.","Phase 2","30","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 2015","September 27, 2016","Brooke Army Medical Center, Fort Sam Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02421094"
32,"Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin Compared to Each Monotherapy, in Adult Patients With NASH and Liver Fibrosis.","Recruiting","No Results Available","Non Alcoholic Steatohepatitis (NASH)","Drug: Tropifexor|Drug: Licogliflozin","Novartis Pharmaceuticals|Novartis","Phase 2","210","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 30, 2019","April 12, 2022","Novartis Investigative Site, Dothan, Alabama, United States|Novartis Investigative Site, Los Angeles, California, United States|Novartis Investigative Site, Pasadena, California, United States|Novartis Investigative Site, San Diego, California, United States|Novartis Investigative Site, San Diego, California, United States|Novartis Investigative Site, Van Nuys, California, United States|Novartis Investigative Site, Ventura, California, United States|Novartis Investigative Site, Doral, Florida, United States|Novartis Investigative Site, Miami, Florida, United States|Novartis Investigative Site, Miami, Florida, United States|Novartis Investigative Site, Palm Harbor, Florida, United States|Novartis Investigative Site, South Miami, Florida, United States|Novartis Investigative Site, Marietta, Georgia, United States|Novartis Investigative Site, South Bend, Indiana, United States|Novartis Investigative Site, Bastrop, Louisiana, United States|Novartis Investigative Site, Chesterfield, Michigan, United States|Novartis Investigative Site, Wyoming, Michigan, United States|Novartis Investigative Site, Jackson, Mississippi, United States|Novartis Investigative Site, Chesterfield, Missouri, United States|Novartis Investigative Site, Albuquerque, New Mexico, United States|Novartis Investigative Site, Lenoir, North Carolina, United States|Novartis Investigative Site, Morehead City, North Carolina, United States|Novartis Investigative Site, Cincinnati, Ohio, United States|Novartis Investigative Site, Tulsa, Oklahoma, United States|Novartis Investigative Site, Bethlehem, Pennsylvania, United States|Novartis Investigative Site, Greenville, South Carolina, United States|Novartis Investigative Site, Greenwood, South Carolina, United States|Novartis Investigative Site, Summerville, South Carolina, United States|Novartis Investigative Site, Hermitage, Tennessee, United States|Novartis Investigative Site, Arlington, Texas, United States|Novartis Investigative Site, Austin, Texas, United States|Novartis Investigative Site, Dallas, Texas, United States|Novartis Investigative Site, Dallas, Texas, United States|Novartis Investigative Site, Plano, Texas, United States|Novartis Investigative Site, San Antonio, Texas, United States|Novartis Investigative Site, San Antonio, Texas, United States|Novartis Investigative Site, Sugar Land, Texas, United States|Novartis Investigative Site, Murray, Utah, United States|Novartis Investigative Site, Richmond, Virginia, United States|Novartis Investigative Site, Mechelen, Belgium|Novartis Investigative Site, Sofia, Bulgaria|Novartis Investigative Site, Vancouver, British Columbia, Canada|Novartis Investigative Site, Tallinn, Estonia|Novartis Investigative Site, Tallinn, Estonia|Novartis Investigative Site, Dresden, Germany|Novartis Investigative Site, Mainz, Germany|Novartis Investigative Site, Takamatsu city, Kagawa, Japan|Novartis Investigative Site, Saga-city, Saga, Japan|Novartis Investigative Site, Izumo-city, Shimane, Japan|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Samara, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Barcelona, Cataluna, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Tainan, Taiwan|Novartis Investigative Site, Aberdeen, United Kingdom|Novartis Investigative Site, London, United Kingdom","https://ClinicalTrials.gov/show/NCT04065841"
33,"Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis","Completed","No Results Available","Hypertension, Portal","Drug: GR-MD-02|Drug: Placebo","Galectin Therapeutics Inc.|Brooke Army Medical Center, Stephen A. Harrison, MD|Indiana University","Phase 2","162","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 2015","October 2017","Cedars Sinai Medical Center, Los Angeles, California, United States|University of California Davis Medical Center, Sacramento, California, United States|University of California San Diego Medical Center, San Diego, California, United States|University of Colorado Denver, Aurora, Colorado, United States|University of Florida, Gainesville, Florida, United States|Florida Digestive Health Specialist, Lakewood Ranch, Florida, United States|University of Miami, Miami, Florida, United States|IMIC, Palmetto Bay, Florida, United States|Tampa General Medical Group, Tampa, Florida, United States|Piedmont Hospital, Atlanta, Georgia, United States|Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Minnesota Gastroenterology PA, Saint Paul, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Kansas City VA Medical Center, Kansas City, Missouri, United States|Saint Louis University, Saint Louis, Missouri, United States|North Shore University Hospital, Manhasset, New York, United States|Columbia University Medical Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Digestive Health Specialists, Winston-Salem, North Carolina, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Clinical Research Institute LLC, Arlington, Texas, United States|Texas Digestive Research Center, Dallas, Texas, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|St Luke's Episcopal Hospital, Houston, Texas, United States|Pinnacle Clinical Research, PLLC, Live Oak, Texas, United States|Texas Liver Institute, San Antonio, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|Mary Immaculate Hospital, Newport News, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Bon Secours St. Mary's Hospital of Richmond, Richmond, Virginia, United States|Mcguire Veterans Affairs Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Swedish Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02462967"
34,"Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis","Completed","Has Results","Nonalcoholic Steatohepatitis","Drug: Cenicriviroc|Drug: Placebo","Tobira Therapeutics, Inc.","Phase 2","289","Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 18, 2014","June 22, 2017","Dothan, Alabama, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Rialto, California, United States|San Diego, California, United States|San Diego, California, United States|San Francisco, California, United States|Littleton, Colorado, United States|Miami, Florida, United States|Tampa, Florida, United States|Chicago, Illinois, United States|Louisville, Kentucky, United States|New Orleans, Louisiana, United States|Baltimore, Maryland, United States|Baltimore, Maryland, United States|Chevy Chase, Maryland, United States|Lutherville, Maryland, United States|Boston, Massachusetts, United States|Worcester, Massachusetts, United States|Ann Arbor, Michigan, United States|Saint Paul, Minnesota, United States|Flowood, Mississippi, United States|Jackson, Mississippi, United States|Tupelo, Mississippi, United States|Buffalo, New York, United States|New York, New York, United States|Durham, North Carolina, United States|Raleigh, North Carolina, United States|Winston-Salem, North Carolina, United States|Cincinnati, Ohio, United States|Chattanooga, Tennessee, United States|Germantown, Tennessee, United States|Houston, Texas, United States|Houston, Texas, United States|Live Oak, Texas, United States|San Antonio, Texas, United States|San Antonio, Texas, United States|Salt Lake City, Utah, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Garran, Australian Capital Territory, Australia|Herston, Queensland, Australia|Adelaide, South Australia, Australia|Bedford Park, South Australia, Australia|Clayton, Victoria, Australia|Heidelberg, Victoria, Australia|Melbourne, Victoria, Australia|Perth, Western Australia, Australia|Brussels, Belgium|Brussels, Belgium|Edegem, Belgium|Leuven, Belgium|Angers, France|Lyon cedex 04, France|Montpellier Cedex 5, France|Paris, France|Paris, France|Pessac Cedex, France|Toulouse, France|Vandoeuvre-les Nancy, France|Villejuif, France|Heidelberg, BW, Germany|Marburg, HE, Germany|Hamburg, HH, Germany|Hannover, Niedersachsen, Germany|Aachen, NRW, Germany|Koeln, NRW, Germany|Leipzig, Sachsen, Germany|Leipzig, SN, Germany|Heidelberg, VIC, Germany|Berlin, Germany|Lubeck, Germany|Shatin, New Territories, Hong Kong|Bologna, BO, Italy|Milan, MI, Italy|Rozzano, MI, Italy|Palermo, PA, Italy|Chorzow, Poland|Lodz, Poland|Myslowice, Poland|Rzeszow, Poland|Wroclaw, Poland|Alicante, Spain|Barcelona, Spain|Barcelona, Spain|Barcelona, Spain|Madrid, Spain|Portsmouth, Hampshire, United Kingdom|London, United Kingdom|London, United Kingdom|Newcastle, United Kingdom|Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT02217475"
35,"A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GB1211 in Healthy Subjects and in Subjects With Suspected Non-Alcoholic Steato-Hepatitis (NASH) and Liver Fibrosis","Recruiting","No Results Available","Safety and Tolerability","Drug: GB1211|Drug: Placebo","Galecto Biotech AB","Phase 1","87","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","January 14, 2019","January 2020","(For Parts A and B) Covance Clinical Research Unit Ltd, Leeds, United Kingdom","https://ClinicalTrials.gov/show/NCT03809052"
36,"AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH","Recruiting","No Results Available","Nonalcoholic Steatohepatitis","Drug: Cenicriviroc|Drug: Placebo","Tobira Therapeutics, Inc.","Phase 3","2000","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 20, 2017","October 28, 2028","Summit Internal Medicine, Birmingham, Alabama, United States|University of Alabama at Birmingham, Birmingham, Alabama, United States|Cullman Clinical Trials, Cullman, Alabama, United States|Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Objective GI D/B/A North Alabama GI Research Center, Madison, Alabama, United States|The Institute for Liver Health, Chandler, Arizona, United States|East Valley Family Physicians -Synexus, Chandler, Arizona, United States|Synexus-Family Practice Specialists, Phoenix, Arizona, United States|Central Phoenix Medical Clinic, Phoenix, Arizona, United States|Adobe Gastroenterology Research, LLC, Tucson, Arizona, United States|Del Sol Research Management, LLC, Tucson, Arizona, United States|Del Sol Research Management LLC, Tucson, Arizona, United States|ARcare Center for Clinical Research, Augusta, Arkansas, United States|Arkansas Diagnostic Center, Little Rock, Arkansas, United States|Preferred Research Partners, Inc., Little Rock, Arkansas, United States|Anaheim Clinical Trials, Anaheim, California, United States|Franco Felizarta MD, Bakersfield, California, United States|Hope Clinical Research, Inc., Canoga Park, California, United States|GW Research, Chula Vista, California, United States|Precision Research Institute, Chula Vista, California, United States|Southern California Research Center, Coronado, California, United States|Citrus Valley Gastroenterology, Covina, California, United States|University of San Francisco, Fresno Medical Education Program, Fresno, California, United States|Fresno Clinical Research Center (FCRC), Fresno, California, United States|National Research Institute, Huntington Park, California, United States|University of California San Diego, La Jolla, California, United States|University of California San Diego, La Jolla, California, United States|Irvine Center for Clinical Research 067, La Jolla, California, United States|eStudySite, La Mesa, California, United States|Om Research, Lancaster, California, United States|Southern California Kaiser Permanente, Los Angeles Medical Center, Los Angeles, California, United States|Global Research Institute, Los Angeles, California, United States|Ruane Medical and Liver Health Institute, Los Angeles, California, United States|Cedars-Sinai Medical Group, Los Angeles, California, United States|National Research Institute, Los Angeles, California, United States|GastroIntestinal Biosciences, Los Angeles, California, United States|Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States|United Medical Doctors, Murrieta, California, United States|eStudySite, Oceanside, California, United States|Odyssey Clinical Research, LLC, Orange, California, United States|Palmtree Clinical Research Inc., Palm Springs, California, United States|Stanford School of Medicine, Center for Clinical Sciences Research, Palo Alto, California, United States|Asclepes Research Centers, Panorama City, California, United States|National Research Institute, Panorama City, California, United States|Havana Research Institute LLC, Pasadena, California, United States|Pasadena Liver Center, Pasadena, California, United States|Dream Team Clinical Research, Pomona, California, United States|Alliance Clinical Research, Poway, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|UC Davis Medical Center, Sacramento, California, United States|UC Davis, Sacramento, California, United States|TriWest Research Associates, San Diego, California, United States|Precision Research Institute, San Diego, California, United States|Southern California Permanente Medical Group, San Diego, California, United States|Quest Clinical Research, San Francisco, California, United States|UCSF School of Medicine, San Francisco, California, United States|Southern California Permanente Medical Group, San Marcos, California, United States|Care Access Research LLC, San Pablo, California, United States|Upland Clinical Research, Upland, California, United States|Island View GI, Ventura, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Synexus, Colorado Springs, Colorado, United States|South Denver Gastroenterology, PC, Englewood, Colorado, United States|Western States Clinical Research, Inc., Wheat Ridge, Colorado, United States|Gastroenterology Associates of Fairfield County, Bridgeport, Connecticut, United States|Medical Research Center of Connecticut, LLC, Hamden, Connecticut, United States|Yale University - New Haven, New Haven, Connecticut, United States|Naugatuck Valley Gastroenterology, LLC - Gen1 Research, Prospect, Connecticut, United States|Medstar Georgetown University Hospital, Washington, District of Columbia, United States|Innovative Medical Research of South Florida, Inc., Aventura, Florida, United States|Xera Med Research, Boca Raton, Florida, United States|Gastroenterology Consultants of Clearwater, Clearwater, Florida, United States|West Central Gatroenterology, Clearwater, Florida, United States|All Medical Research, LLC, Cooper City, Florida, United States|Hi Tech and Global Research, LLC, Coral Gables, Florida, United States|Top Medical Research, Inc, Cutler Bay, Florida, United States|ICR Sites, Doral, Florida, United States|Qway Research, LLC, Hialeah, Florida, United States|Direct Helpers Research Center, Hialeah, Florida, United States|Palmetto Research, LLC, Hialeah, Florida, United States|Gastroenterology Associates - Crystal River, Inverness, Florida, United States|Mayo Clinic College of Medicine, Jacksonville, Florida, United States|SIH Research LLC, Kissimmee, Florida, United States|Meridien Research, Lakeland, Florida, United States|Florida Digestive Health Specialists, Lakewood Ranch, Florida, United States|ClinCloud, LLC, Maitland, Florida, United States|Meridien Research, Maitland, Florida, United States|Southwest Gastroenterology, Maitland, Florida, United States|San Marcus Research Clinic, Miami Lakes, Florida, United States|Clinical Pharmacology of Miami, LLC, Miami, Florida, United States|Bruce W. Carter Department of Veterans Affairs Medical Center, Miami, Florida, United States|Optimus U Corporation, Miami, Florida, United States|University of Miami Hospital, Miami, Florida, United States|Invictus Clinical Research Group LLC, Miami, Florida, United States|Regenerate Clinical Trials, Miami, Florida, United States|Gastroenterology Associates of Western Colorado, Miami, Florida, United States|Sanchez Clinical Research, Inc, Miami, Florida, United States|Genoma Research Group Inc., Miami, Florida, United States|Medical Professional Clinical Research Center, INC, Miami, Florida, United States|Clinical Research Associates of South Florida, Miami, Florida, United States|ProLive Medical Research, Miami, Florida, United States|Med Research of Florida, LLC, Miami, Florida, United States|Advanced Research Institute, Inc., New Port Richey, Florida, United States|Orlando Immunology Center, Orlando, Florida, United States|Bioclinical Research Alliance, Orlando, Florida, United States|Omega Research Maitland, LLC, Orlando, Florida, United States|Innovation Medical Research Center, Palmetto Bay, Florida, United States|Gastroenterology Associates of Pensacola, Pensacola, Florida, United States|Advanced Medical Research, Port Orange, Florida, United States|Advanced Research Institute, Inc, Saint Petersburg, Florida, United States|Sensible Healthcare, Summerfield, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|AdventHealth Tampa, Tampa, Florida, United States|Guardian Angel Research Center, Tampa, Florida, United States|Gastro Florida, Tampa, Florida, United States|Bioclinica Research, The Villages, Florida, United States|South Florida Center of Gastroenterology, PA, Wellington, Florida, United States|Cleveland Clinic Florida, Weston, Florida, United States|Florida Medical Clinic, Zephyrhills, Florida, United States|Summit Clinical Research, LLC, Athens, Georgia, United States|Consultative Gastroenterology, Atlanta, Georgia, United States|Digestive Healthcare of Georgia - Atlanta, Atlanta, Georgia, United States|Piedmont Healthcare, Atlanta, Georgia, United States|WellStar Health System, Atlanta, Georgia, United States|Gastroenterology Associates of Central Georgia, Macon, Georgia, United States|GI Specialists of Georgia - Marietta Office, Marietta, Georgia, United States|Infinite Clinical Trials, Riverdale, Georgia, United States|Digestive Disease Specialist, Inc., Snellville, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|RxClinicals, Crystal Lake, Illinois, United States|Georgia Clinical Research LLC, New Lenox, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Endoscopy Center of the North Shore LLC, Wilmette, Illinois, United States|Investigators Research Group, LLC, Brownsburg, Indiana, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, United States|Indianapolis Gastroenterology Research Foundation, Indianapolis, Indiana, United States|Aquiant Research, New Albany, Indiana, United States|Digestive Research Alliance of Michiana, South Bend, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Kansas Medical Clinic-Gastroenterology, Topeka, Kansas, United States|University of Louisville Physicians - University Medical Associates (UMA), Louisville, Kentucky, United States|Delta Research Partners, LLC, Bastrop, Louisiana, United States|Gastroenterology Associates of Central Georgia, Bastrop, Louisiana, United States|Avant Research Associates LLC, Crowley, Louisiana, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Tandem Clinical Research, Marrero, Louisiana, United States|New Orleans Research Institute, Metairie, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|Louisiana Research Center, Shreveport, Louisiana, United States|Clinical Trials of America LA LLC, West Monroe, Louisiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Johns Hopkins University, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Digestive Disease Associates, Catonsville, Maryland, United States|Chevy Chase Clinical Research, Chevy Chase, Maryland, United States|Gastro Center of Maryland, Columbia, Maryland, United States|Woodholme Gastroenterology - Severn, Glen Burnie, Maryland, United States|Victory Clinical Research, Greenbelt, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Commonwealth Clinical Studies, Brockton, Massachusetts, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, United States|The Research Institute, Springfield, Massachusetts, United States|Umass Memorial Medical Center, Worcester, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Minnesota Gastroenterology, Maplewood, Minnesota, United States|National Diabetes and Obesity Research Institute, Biloxi, Mississippi, United States|GastroIntestinal Associates, Flowood, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Clinical Research Professionals, Creve Coeur, Missouri, United States|Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, United States|Saint Louis University, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|CHI Health Research, Omaha, Nebraska, United States|Synexus Clinical Research/ Rita Chuang, MD, Henderson, Nevada, United States|Machuca Family Medicine, Las Vegas, Nevada, United States|Jubilee Clinical Research, Inc., Las Vegas, Nevada, United States|Sierra Clinical Research, Las Vegas, Nevada, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, United States|Digestive Disease Specialist, Las Vegas, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Hassman Research Institute, Berlin, New Jersey, United States|Garden State Endocrinology LLC, Brick, New Jersey, United States|AGA Clinical Research Associates, LLC, Egg Harbor Township, New Jersey, United States|Amici Clinical Research, Martinsville, New Jersey, United States|Rutgers University New Jersey Medical School, Newark, New Jersey, United States|Coastal Healthcare, Ocean Township, New Jersey, United States|New York Clinical Trials, Brooklyn, New York, United States|New York Methodist Hospital, Brooklyn, New York, United States|The State University of New York, University at Buffalo, Buffalo, New York, United States|Sing Chan, MD, Flushing, New York, United States|United Health Services Hospitals, Inc, Johnson City, New York, United States|Digestive Disease Specialist, New Hyde Park, New York, United States|Beth Israel Medical Center, New York, New York, United States|Concorde Medical Group, New York, New York, United States|NYU Langone Health - Perlmutter Cancer Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Mount Sinai Medical Center, New York, New York, United States|Tandem Clinical Research, New York, New York, United States|Digestive Disease Associates of Rockland - Gen1 Research, Pomona, New York, United States|New York Medical College, Valhalla, New York, United States|The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Carolinas Medical Center, Charlotte, North Carolina, United States|Northeast GI Research Division, Concord, North Carolina, United States|Duke University, Durham, North Carolina, United States|Cumberland Research Associates, LLC, Fayetteville, North Carolina, United States|Carolina Research, Greenville, North Carolina, United States|High Point Clinical Trials Center, High Point, North Carolina, United States|Wake Research Associates, Raleigh, North Carolina, United States|PMG Research of Winston-Salem, Winston-Salem, North Carolina, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|Endocrinology Research Associates, Columbus, Ohio, United States|The Ohio University - Gastroenterology, Hepatology, Columbus, Ohio, United States|Gastroenterology Research of Lima, Lima, Ohio, United States|Paramount Medical Research & Consulting, LLC, Middleburg Heights, Ohio, United States|IMIC, Inc., Oklahoma City, Oklahoma, United States|Integris Baptist Medical Center, Oklahoma City, Oklahoma, United States|Options Health Research, Tulsa, Oklahoma, United States|Gastroenterology Specialists, Inc., Tulsa, Oklahoma, United States|Adult Gastroenterology Associates-Gen1 Research, Tulsa, Oklahoma, United States|Main Line Gastroenterology Associates, P.C., Bala-Cynwyd, Pennsylvania, United States|Eastern Pennsylvania Gastroenterology and Liver Specialist, Bethlehem, Pennsylvania, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|UPMC -Center for Liver Diseases, Pittsburgh, Pennsylvania, United States|VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States|Care Access Research, Pottsville, Pottsville, Pennsylvania, United States|Digestive Disease Associates, LTD, Wyomissing, Pennsylvania, United States|Partners in Clinical Research, Cumberland, Rhode Island, United States|University Medical Group, North Providence, Rhode Island, United States|University Gastroenterology, Providence, Rhode Island, United States|Care Access Research-Warwick, Warwick, Rhode Island, United States|Rapid City Medical Center, Rapid City, South Dakota, United States|Mount Vernon Clinical Research, Chattanooga, Tennessee, United States|Gastro One, Germantown, Tennessee, United States|Digestive Health Research, Hermitage, Tennessee, United States|East Tennessee Research Institute, Johnson City, Tennessee, United States|GIA Clinical Trials LLC, Knoxville, Tennessee, United States|Digestive Health Research, Lebanon, Tennessee, United States|UT-Memphis, Methodist University Hospital, Memphis, Tennessee, United States|Vanderbilt University, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Avant Research Associates, Austin, Texas, United States|Clinical Trials of Texas Inc, Austin, Texas, United States|Austin Center for Clinical Research, Austin, Texas, United States|Trinity Universal Research Associates, Inc, Carrollton, Texas, United States|Methodist Dallas Medical Center, Dallas, Texas, United States|Dallas Diabetes Research Center, Dallas, Texas, United States|Meritus Center for Clinical Research, Dallas, Texas, United States|Liver Center of Texas, Dallas, Texas, United States|Synexus, Dallas, Texas, United States|Southwest Family Medicine Associates, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|Baylor Scott & White All Saints Medical Center - Ft. Worth, Fort Worth, Texas, United States|Texas Digestive Disease Consultants - Fort Worth, Fort Worth, Texas, United States|Therapeutic Concepts, PA, Houston, Texas, United States|Kelsey Research Foundation, Houston, Texas, United States|Liver Associates of Texas, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Michael E. DeBakey VA Medical Center (MEDVAMC), Houston, Texas, United States|St. Luke's Medical Center, Houston, Texas, United States|Biopharma Informatic, LLC, Houston, Texas, United States|Centex Studies, Houston, Texas, United States|Biopharma Informatic, LLC, Houston, Texas, United States|Amir A. Hassan, MD, PA, Houston, Texas, United States|Pioneer Research Solutions, Inc., Houston, Texas, United States|GI Specialists of Houston, Humble, Texas, United States|Pinnacle Clinical Research, Live Oak, Texas, United States|Rio Grande Gastroenterology, McAllen, Texas, United States|Centex Studies, Inc., McAllen, Texas, United States|LinQ Research, LLC, Pearland, Texas, United States|ClinRx Research LLC, Plano, Texas, United States|Synexus Clinical Research, Plano, Texas, United States|Digestive Health Associates of Texas-Rockwall, Richardson, Texas, United States|American Research Corporation, San Antonio, Texas, United States|Quality Research Inc., San Antonio, Texas, United States|American Research Corporation, San Antonio, Texas, United States|San Antonio Premier Internal Medicine, San Antonio, Texas, United States|Diabetes & Glandular Disease Clinic, P.A. (DGD), San Antonio, Texas, United States|Endeavor Clinical Trials, LLC, San Antonio, Texas, United States|Sagact Pllc, San Antonio, Texas, United States|Synexus, San Antonio, Texas, United States|Anson Medicine, San Antonio, Texas, United States|Texas Digestive Disease Consultants, Southlake, Texas, United States|Gastrointestinal and Liver disease consultants, Sugar Land, Texas, United States|Mount Olympus Medical Research, LLC, Sugar Land, Texas, United States|Texas Digestive Disease Consultants, Webster, Texas, United States|Wichita Falls Gastroenterology, Wichita Falls, Texas, United States|Physician's Research Options, LLC, Draper, Utah, United States|Wasatch Peak Family Practice, Layton, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|Care Access Research, LLC, Ogden, Utah, United States|Advanced Clinical Research - Center for Digestive Health, Riverton, Utah, United States|Care Access Research LLC, Salt Lake City, Utah, United States|University of Utah, Salt Lake City, Utah, United States|University of Virginia Health Systems, Charlottesville, Virginia, United States|Gastroenterology Associates of Northern Virginia, Fairfax, Virginia, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|Liver Institute of Virginia, Newport News, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States|VCU Medical Center, Richmond, Virginia, United States|Digestive Disease Care PC, Roanoke, Virginia, United States|Gastroenterology Consultants of Southwest Virginia, Roanoke, Virginia, United States|Washington Gastroenterology, Bellevue, Washington, United States|Virginia Mason Hospital, Seattle, Washington, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|Marshall University Department of Clinical and Translational Sciences, Huntington, West Virginia, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Froedtert Hospital, Milwaukee, Wisconsin, United States|Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|Centro de Hepatologia S.A., La Plata, Buenos Aires, Argentina|Hospital Universitario Austral, Pilar, Buenos Aires, Argentina|DIM Clinica Privada, Ramos Mejia, Buenos Aires, Argentina|Hospital Provincial del Centenario, Rosario, Santa Fe, Argentina|Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Saint George Hospital, Kogarah, New South Wales, Australia|Gallipoli Medical Research Foundation, Greenslopes, Queensland, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Center, Bedford Park, South Australia, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|Medizinische Universität Graz, Graz, Styria, Austria|Medizinische Universität Innsbruck, Innsbruck, Tyrol, Austria|Klinikum Wels-Grieskirchen, Wels, Upper Austria, Austria|Wilhelminenspital der Stadt Wien, Wien, Vienna, Austria|Universitair Ziekenhuis Antwerpen, Edegem, Antwerpen, Belgium|Algemeen Ziekenhuis Maria Middelares, Gent, Oost-Vlaanderen, Belgium|Universitair Ziekenhuis Gent, Gent, Oost-Vlaanderen, Belgium|Hôpital Erasme, Brussels, Belgium|Cliniques Universitaires Saint-Luc, Brussels, Belgium|Centre Hospitalier Chretien CHC, Liege, Belgium|Hospital Universitário Professor Edgard Santos, Salvador, Bahia, Brazil|Hospital São Rafael-Monte Tabor, Salvador, Bahia, Brazil|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva, Goiânia, Goias, Brazil|Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|Hospital Universitário Gafrée e Guinle, Tijuca, Rio De Janeiro, Brazil|Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital das Clínicas da Faculdade de Medicina da Riberao Preto da Universidade de São Paulo, Ribeirão Preto, Sao Paulo, Brazil|Faculdade de Medicina de São José do Rio Preto Hospital de Base, São José do Rio Preto, Sao Paulo, Brazil|UNIFESP Universidade Federal De São Paulo, São Paulo, Sao Paulo, Brazil|Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil|University of Calgary Liver Unit, Calgary, Alberta, Canada|Bailey Health Clinic, Edmonton, Alberta, Canada|Liver and Intestinal Research Centre, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|GI Research (GIRI), Vancouver, British Columbia, Canada|William Osler Health Centre, Brampton Memorial Hospital Campus, Brampton, Ontario, Canada|London Health Sciences Centre University Hospital, London, Ontario, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Ecogene-21, Chicoutimi, Quebec, Canada|MUHC Royal Victoria Hospital, Montreal, Quebec, Canada|Hospital Universidad Católica de Chile, Santiago, Santiago Metropolitan Region, Chile|Hospital Clinico San Borja Arriaran, Santiago de Chile, Santiago, Chile|Centro de Investigaciones Clínicas Viña del Mar, Viña del Mar, Valparaiso, Chile|CHU de Strasbourg, Strasbourg cedex, Alsace, France|Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, Aubergne, France|Centre Hospitalier Universitaire de Caen - Hôpital Côte de Nacre, Caen, Basse-Normandie, France|Centre HospitalierUniversitaire de Caen - Hopital Cote de Nacre, Caen, Basse-Normandie, France|Hopital Pontchaillou, Rennes, Bretagne, France|Centre Hospitalier Regional et Universitaire de Besançon Hôpital Jean-Minjoz, Besançon cedex, Franche-Comte, France|Hôpital Jean Verdier Bondy, Bondy, Ile-De-France, France|Hôpital Beaujon, Clichy, Ile-De-France, France|Hôpital Beaujon, Clichy, Ile-De-France, France|Centre Hospitalier Universitaire Hopital Henri Mondor, Creteil Cedex, Ile-De-France, France|Hôpital Saint Antoine, Paris Cedex 12, Ile-de-France, France|Groupe Hospitalier - Hôpitaux Universitaires Pitie-Salpetriere - Charles-Foix - Pitie-Salpetriere, Paris Cedex 13, Ile-De-France, France|Centre Médical Odysseum, Montpellier cedex 2, Languedoc-Roussillon, France|CHU de Montpellier, Montpellier cedex 5, Languedoc-Roussillon, France|Hôpital Dupuytren, Limoges, Limousin, France|Centre hospitalier universitaire de Poitiers, Rouen, Normandie, France|Center Hospitalier Universitaire d'Angers, Angers, Pays De La Loire, France|CHU Amiens-Picardie, Amiens Cedex 1, Picardie, France|Centre Hospitalier Universitaire de Nice Hôpital l'Archet, Nice Cedex 3, Provence Alpes Cote D'Azur, France|Centre Hospitalier Universitaire Grenoble, Grenoble Cedex 09, Rhone-Alpes, France|Institut Bergonié, Bordeaux, France|Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France|Hopital Edouart Herriot, Lyon, France|Centre Hospitalier Universitaire de Rouen CHU de Rouen Hopital Charles-Nicolle, Poitiers, France|New Hospitals Ltd, Tbilisi, Georgia|LTD Aversi Clinic, Tbilisi, Georgia|Medizinische Universitätsklinik IV (Krehl Klinik) Abt. Gastroenterologie und Infektionskrankhen, Heidelberg, Baden-Wuerttemberg, Germany|Universitätsmedizin Mannheim, Mannheim, Baden-Wuerttemberg, Germany|Universitätsklinikum Tübingen, Tübingen, Baden-Wuerttemberg, Germany|Synexus Clinical Research GmbH, Prüfzentrum Frankfurt, Frankfurt, Hessen, Germany|Philipps-Universität und Universitätsklinikum Gießen und Marburg GmbH, Marburg, Hessen, Germany|Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|Universität Bonn, Bonn, Nordhein-Westfalen, Germany|Gastroenterologische Gemeinschaftspraxis, Herne, Nordhein-Westfalen, Germany|Uniklinik RWTH Aachen, Aachen, Nordrhein-Westfalen, Germany|Uniklinik Köln, Köln, Nordrhein-westfalen, Germany|Universitätsmedizin der Johannes Gutenberg Universität Mainz, Mainz, Rheinland-Pfalz, Germany|Gemeinschaftspraxis Drs. Denger und Pfitzner, Friedrichsthal, Saarland, Germany|Universitätsklinikum des Saarlandes, Homburg, Saarland, Germany|EUGASTRO GmbH, Leipzig, Sachsen, Germany|Universitätsklinikum Leipzig, Berlin, Germany|Praxis Driesener Strasse, Berlin, Germany|Leberzentrum am Checkpoint -Berlin, Berlin, Germany|Synexus Clinical Research GmbH, Prüfzentrum Berlin, Berlin, Germany|Charité Universitätsmedizin Berlin, Berlin, Germany|Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany|Gastroenterologisch-Hepatologisches Zentrum Kiel, Kiel, Germany|University Hospital of Ioannina, Ioannina, Epirus, Greece|General Hospital of Thessaloniki PAPAGEORGIOU, Thessaloniki, Macedoni, Greece|Hippokratio Hospital, Thessaloniki, Macedoni, Greece|Hippokratio Hospital, Thessaloniki, Macedoni, Greece|University General Hospital of Patras Panagia I Voithia, Patra, Peloponnese, Greece|University General Hospital of Alexandroupolis, Alexandroupoli, Thrace, Greece|Humanity and Health Research Centre, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Prince of Wales Hospital, Dept. of Medicine and Therapeutics, Hong Kong, Hong Kong|Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong|Tuen Mun Hospital, Tuen Mun, Hong Kong|Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár, Somogy, Hungary|SYNEXUS Magyarország Kft. - Budapest DRS, Budapest, Hungary|Egyesitett Szent Istvan es Szent Laszlo Korhaz - Rendelointezet; Szent Laszlo Korhaz, Budapest, Hungary|Synexus Magyarorszag Egeszsegugyi Szolgaltato Kft, Debrecen, Hungary|SYNEXUS Magyarország Kft. - Gyula DRS, Gyula, Hungary|Szabolcs - Szatmár - Bereg Megyei Kórházak és Egyetemi Oktatókórház, Nyiregyhaza, Hungary|Pécsi Tudományegyetem, Klinikai Központ, I.sz.Belgyógyászati Klinika, Pécs, Hungary|Sunshine Hospitals, Secunderabad, Andhra Pradesh, India|Surat Institute of Digestive Sciences, Surat, Gujarat, India|BAPS Pramukh Swami Hospital, Surat, Gujarat, India|Artemis Hospitals, Gurgaon, Haryana, India|Victoria Hospital (Bangalore Medical College), Bangalore, Karnataka, India|KLES Prabhakar Kore Hospital and Medical Research Centre, Belgaum, Karnataka, India|Kasturba Medical College Hospital, Mangalore, Karnataka, India|Global Hospital - Super Speciality and Transplant Centre, Mumbai, Maharashtra, India|B.J. Medical College and Sassoon General Hospital, Pune, Maharashtra, India|Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Punjab, India|Sawai Man Singh Hospital, Jaipur, Rajashthan, India|KRM Hospital and Research Center, Lucknow, Uttar Pradesh, India|Om Research Center, Om Surgical Center and Maternity Home, Varanasi, Uttar Pradesh, India|EMMS MC, Nazareth, Jerusalem, Israel|Rambam Health Care Campus - Rambam Medical Center, Haifa, Israel|Carmel Medical Center, Haifa, Israel|Shaare Zedek Medical Center, Jerusalem, Israel|Hadassah Medical Center, Jerusalem, Israel|Galilee Medical Center, Nahariya, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Sheba Medical Center at Tel Hashomer, Tel-Hashomer, Israel|Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy|Polo Universitario - L'Azienda Ospedaliera Luigi Sacco, Milan, Milano, Italy|Istituto Clinico Humanitas, Rozzano, Milano, Italy|Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy|Ospedali Riuniti di Bergamo, Bergamo, Italy|Azienda Ospedaliera S. Orsola - Malpighi, Bologna, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Italy|Ente Ospedaliero Ospedali Galliera, Genova, Italy|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|Ospedale San Giuseppe, Milano, Italy|Ospedale San Raffaele, Milano, Italy|ASST Santi Paolo e Carlo, Milano, Italy|Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, Italy|Azienda Ospedaliero-Universitaria ""Maggiore della Carità"", Novara, Italy|Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone, Palermo, Italy|Fondazione Policlinico Tor Vergata, Roma, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy|Policlinico Umberto I di Roma, Roma, Italy|Pauls Stradins Clinical University Hospital, Riga, Latvia|Consultorio Médico Dr. Alma Laura Ladron de Guevara, Mexico, Distrito Federal, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, México City, Distrito Federal, Mexico|Consultorio Rosario Arechavaleta, Guadalajara, Jalisco, Mexico|JM Research - Cuernavaca, Cuernavaca, Morelos, Mexico|Investigaciones Medicas Cisneros, Monterrey, Nuevo Leon, Mexico|Consultorio Dra. Maria Sarai Gonzalez Huezo, Metepec, Mexico|Hospital Punta Sur, Queretaro, Mexico|Auckland City Hospital, Grafton, Auckland, New Zealand|Middlemore Clinical Trials, Papatoetoe, Auckland, New Zealand|Bay of Plenty Clinical School, Tauranga, Bay Of Plenty, New Zealand|Christchurch Hospital, Christchurch, New Zealand|Dunedin Hospital, Dunedin, New Zealand|Oslo Universitetssykehus-Ullevål Hospital, Oslo, Norway|Hospital Nacional Arzobispo Loayza, Lima, Lima 01, Peru|Hospital Nacional Guillermo Almenara Irigoyen, La Victoria, Lima, Peru|Clínica Delgado, Miraflores, Lima, Peru|SANNA - Clínica San Borja, San Borja, Lima, Peru|Hospital Nacional Dos de Mayo, Lima, Peru|Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru|Centrum Badan Klinicznych Piotr Napora Lekarze Spólka Partnerska, Wroclaw, Dolnoslaskie, Poland|EMC Instytut Medyczny, Wroclaw, Dolnoslaskie, Poland|VitaMED, Bydgoszcz, Kujawsko-Pomorskie, Poland|Wojewódzki Specjalistyczny Szpital im. dr Wl. Bieganskiego w Lodzi, Lódz, Lodzkie, Poland|Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administracji w Warszawie, Warszawa, Mazowieckie, Poland|Szpital Specjalistyczny Nr 1 w Bytomiu, Bytom, Slaskie, Poland|Specjalistyczna Praktyka Lekarska WAMED Zawiercie, Jaworze, Slaskie, Poland|Niepubliczny Zaklad Opieki Zdrowotnej All-Medicus, Katowice, Slaskie, Poland|Centrum Medycyny i Stomatologii Silesia Med, Katowice, Slaskie, Poland|ID Clinic Arkadiusz Pisula, Myslowice, Slaskie, Poland|Hospital Professor Doutor Fernando Fonseca, Amadora, Lisboa, Portugal|Hospital da Senhora da Oliveira - Guimarães, Guimaraes, Portugal|Centro Hospitalar Lisboa Central - Hospital Capuchos, Lisboa, Portugal|Centro Hospitalar de São João, Porto, Portugal|Hospital de São Bernardo, Setúbal, Portugal|Hospital Santa Luzia de Viana do Castelo, Viana do Castelo, Portugal|Centro Hospitalar de Trás-os-Montes e Alto Douro EPE, Vila Real, Portugal|Clinical Research Puerto Rico, San Juan, Puerto Rico|Fundacion de Investigacion De Diego, San Juan, Puerto Rico|Institutul Regional de Gastroenterologie si Hepatologie Prof. Dr. O Fodor, Cluj-Napoca, Cluj, Romania|Centrul Medical Tuculanu SRL, Timisoara, Timis, Romania|Policlinica Dr. Citu, Timisoara, Timis, Romania|Spitalul Clinic Jude¿ean de Urgen¿a Cluj-Napoca, Cluj, Romania|Clinic of Professor Gorbakov, Krasnogorsk, Moscow, Russian Federation|Infection Center, Koltsovo, Novosibirsk, Russian Federation|FSBI ""Federal Siberian Scientific Clinical Center of FMBA"", Krasnoyarsk, Russian Federation|I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation|Modern Medicine Clinic, Moscow, Russian Federation|Moscow Regional Research and Clinical Institute M.F. Vladimirsky, Moscow, Russian Federation|Sklifosovsky Scientific Research Institution of Emergency Care, Moscow, Russian Federation|Novosibirsk State Regional Clinical Hospital, Novosibirsk, Russian Federation|Stavropol State Medical University, Novosibirsk, Russian Federation|Union Clinic, Saint Petersburg, Russian Federation|ECO Bezopasnost, Saint Petersburg, Russian Federation|LLC ""ArsVitae North-West"", Saint-Petersburg, Russian Federation|Research Institute of Influenza, Saint-Petersburg, Russian Federation|Smolensk City Hospital 1, Department of Infectious Diseases, Smolensk, Russian Federation|Stavropol Regional Clinical Hospital, Stavropol, Russian Federation|Stavropol Regional Clinical Hospital, Stavropol, Russian Federation|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|Khoo Teck Puat Hospital, Singapore, Singapore|Univerzitetni klinicni center Ljubljana (University Clinical Center Ljubljana), Ljubljana, Slovenia|Univerzitetni klinicni center Maribor, Maribor, Slovenia|Splošna bolnišnica Dr. Franca Derganca Nova Gorica, Šempeter pri Gorici, Slovenia|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitario Donostia, San Sebastian, Guipuzcoa, Spain|Complejo Hospitalario Torrecardenas, Almeria, Spain|Hospital Santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitari Vall d'Hebrón, Barcelona, Spain|Hospital General Universitario Gregorio Marañon, Madrid, Spain|Hospital Universitario Ramón Y Cajal, Madrid, Spain|Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain|Complejo Hospitalario de Pontevedra, Pontevedra, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitario Nuestra Senora de Valme, Sevilla, Spain|Consorci Hospital General Universitari de València, Valencia, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain|Kantonspital Sankt Gallen, St. Gallen, Saint Gallen, Switzerland|Inselspital, Bern, Switzerland|Changhua Christian Hospital, Changhua, Changhua City, Taiwan|Chia-Yi Christian Hospital, Chiayi City, Chiayi, Taiwan|Chang Gung Memorial Hospital - Kaohsiung Branch, Kaohsiung, Kaohsiung City, Taiwan|China Medical University Hospital, Taichung, Taichung City, Taiwan|Taichung Veterans General Hospital, Taichung, Taichung City, Taiwan|National Cheng Kung University Hospital, Tainan, Tainan City, Taiwan|National Taiwan University Hospital, Taipei, Taipei City, Taiwan|Taipei Veterans General Hospital, Taipei, Taipei City, Taiwan|Tri-Service General Hospital, Taipei, Taipei City, Taiwan|Kaohsiung Medical University Hospital, Kaohsiung, Taiwan|Cathay General Hospital, Taipei, Taiwan|Chang Gung Medical Foundation-LinKou Branch, Taoyuan, Taiwan|St James's University Hospital, Leeds, West Yorkshire, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|Addenbrookes Hospital, Cambridge, United Kingdom|Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom|Synexus North Teesside Clinical Research Centre, Hardwick, United Kingdom|Synexus Hexham Clinical Research Centre, Hexham, United Kingdom|Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom|Synexus Lancashire Clinical Research Centre, Lancashire, United Kingdom|Synexus Merseyside Clinical Research Centre, Liverpool, United Kingdom|Barts Health NHS Trust The Royal London Hospital, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom|Guy's and Saint Thomas' NHS Foundation Trust, London, United Kingdom|Kings College Hospital NHS Foundation Trust, London, United Kingdom|Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom|Luton and Dunstable Hospital NHS Foundation Trust, Luton, United Kingdom|Synexus Manchester Clinical Research Centre, Manchester, United Kingdom|University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom|Newcastle Upon the Tyne Hospitals, Newcastle, United Kingdom|Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom|Nottingham Digestive Diseases Biomedical Research Unit, Nottingham, United Kingdom|Plymouth Hospitals NHS Trust, Plymouth, United Kingdom|Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom|University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom|Swansea Bay UHB, Swansea, United Kingdom","https://ClinicalTrials.gov/show/NCT03028740"
37,"Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis","Not yet recruiting","No Results Available","Fatty Liver Disease|Fibrosis, Liver|Cirrhosis, Liver|Steatohepatitis, Nonalcoholic","Drug: Align Probiotic Supplement Capsule|Drug: Placebos","William Beaumont Hospitals","Phase 1|Phase 2","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 30, 2020","December 1, 2021","Beaumont Hospital, Farmington Hills, Michigan, United States","https://ClinicalTrials.gov/show/NCT04175392"
38,"A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects","Recruiting","No Results Available","NASH - Nonalcoholic Steatohepatitis|Fibrosis, Liver|NAFLD - Nonalcoholic Fatty Liver Disease","Drug: CRV431|Drug: Placebo","Hepion Pharmaceuticals, Inc.","Phase 2","18","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","June 23, 2020","February 2021","Conquest Clinical Research, Orange, California, United States|Alliance Clinical Research, Poway, California, United States|La Salud Research, Inc., Miami, Florida, United States|Progressive Medical Research, Port Orange, Florida, United States|Covenant Research, LLC., Sarasota, Florida, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Aventiv Research Inc., Columbus, Ohio, United States|Quality Research Inc., San Antonio, Texas, United States|Pinnacle Research Group, San Antonio, Texas, United States|FDI Clinical Research, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT04480710"
39,"Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C","Completed","No Results Available","Hepatitis C, Chronic","Drug: Irbesartan|Drug: placebo","French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|Sanofi","Phase 3","166","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 2006","November 2013","CHU Angers, Service d'hépato-gastroentérologie, Angers, France","https://ClinicalTrials.gov/show/NCT00265642"
40,"Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C","Completed","No Results Available","HIV Infections|Hepatitis C, Chronic","Biological: Peginterferon alpha-2a (Pegasys®)|Drug: Ribavirin|Drug: HIV antiretroviral therapy","French National Agency for Research on AIDS and Viral Hepatitis|Hoffmann-La Roche","Phase 3","52","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","November 2003","March 2009","Service de Maladies Infectieuses et de Réanimation Médicale, Rennes, France","https://ClinicalTrials.gov/show/NCT00122616"
41,"Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis","Completed","Has Results","Chronic Hepatitis C Infection","Drug: Fuzheng Huayu|Drug: Placebo","Tarek Hassanein|Shanghai Sundise Traditional Chinese Medicine Co., Ltd.|SCTI Research Foundation","Phase 2","118","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 2010","August 2013","SCTI Research Foundation, Coronado, California, United States|VA Palo Alto HCS, Palo Alto, California, United States|Huntington Medical Research Institutes, Pasadena, California, United States|UC Davis Health System, Sacramento, California, United States|Southern California Liver Centers, San Clemente, California, United States|Advanced Medical Research Center, Port Orange, Florida, United States|St. Luke's Advanced Liver Therapies, Houston, Texas, United States|University of Utah HSC, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00854087"
42,"An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis","Recruiting","No Results Available","Non-alcoholic Steatohepatitis|Fatty Liver|Fibrosis, Liver|Compensated Cirrhosis","Drug: Nitazoxanide 500mg BID","Pinnacle Clinical Research, PLLC","Phase 2","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","December 15, 2018","October 2020","Pinnacle Clinical Research, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT03656068"
43,"Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)","Recruiting","No Results Available","Nonalcoholic Fatty Liver Disease|Nonalcoholic Steatohepatitis With Liver Fibrosis","Drug: Placebo|Drug: PF-06865571|Drug: PF-05221304","Pfizer","Phase 2","450","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","June 15, 2020","December 1, 2022","Magnolia Surgery Center, El Cajon, California, United States|National Research Institute, Huntington Park, California, United States|ART Vascular, Monterey Park, California, United States|Huntington-Hill Imaging Center, Cordova, Pasadena, California, United States|California Liver Research Institute, Pasadena, California, United States|Huntington Medical Research Institute, Pasadena, California, United States|Huntington-Hill Imaging Center, Fair Oaks, Pasadena, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Clinical Trials Research, Sacramento, California, United States|Wake Research MCCR, San Diego, California, United States|Sharp and Children's MRI Center, LLC, San Diego, California, United States|Orange County Research Center, Tustin, California, United States|Clinical Research of South Florida, an AMR company, Coral Gables, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|San Marcus Research Clinic, Inc., Miami Lakes, Florida, United States|Optimus U Corporation, Miami, Florida, United States|Ivetmar Medical Group LLC, Miami, Florida, United States|Janus Clinical Research, Miami, Florida, United States|Clinical Neuroscience Solutions, Inc, Orlando, Florida, United States|Omega Research Maitland, LLC, Orlando, Florida, United States|GCP, Global Clinical Professionals, Saint Petersburg, Florida, United States|Sarasota Interventional Radiology, Sarasota, Florida, United States|Partners Imaging Center, Sarasota, Florida, United States|Kansas Medical Clinic PA, Topeka, Kansas, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Lake Charles Memorial Hospital, Lake Charles, Louisiana, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|M3-Wake Research, Inc., Raleigh, North Carolina, United States|Gastroenterology Associates of the Piedmont, PA, Winston-Salem, North Carolina, United States|Novant Health Medical Center, Winston-Salem, North Carolina, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, United States|University Gastroenterology, Providence, Rhode Island, United States|Center for Medical Research, LLC, Providence, Rhode Island, United States|Roger Williams Hospital, Providence, Rhode Island, United States|Chattanooga Imaging Center, Chattanooga, Tennessee, United States|WR-Clinsearch, LLC, Chattanooga, Tennessee, United States|Quality Medical Research, PLLC, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Touchstone Imaging (MRI-PDFF), Dallas, Texas, United States|Center for Diagnostic Imaging (Liver Biopsy and Abdominal Ultrasound), DeSoto, Texas, United States|Therapeutic Concepts, PA, Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Biopharma Informatic, LLC, Houston, Texas, United States|Premier Vein and Vascular, Houston, Texas, United States|HCA Houston Healthcare Pearland, Pearland, Texas, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, United States|Reddy Cardiac Wellness, Sugar Land, Texas, United States|Physicians' Research Options, LLC, Draper, Utah, United States|Aggarwal and Associates Limited, Brampton, Ontario, Canada|Resonance Magnetique du Saguenay-Lac-Saint-Jean, Chicoutimi, Quebec, Canada|Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean, Chicoutimi, Quebec, Canada|Ecogene-21, Chicoutimi, Quebec, Canada|Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan|Fukui-Ken Saiseikai Hospital, Fukui, Japan","https://ClinicalTrials.gov/show/NCT04321031"
44,"Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects","Completed","Has Results","Cirrhosis, Liver","Drug: GI262570 0.5 mg|Drug: GI262570 1.0 mg|Drug: Placebo","GlaxoSmithKline","Phase 2","265","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment","November 2, 2005","March 13, 2008","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, North Little Rock, Arkansas, United States|GSK Investigational Site, Bakersfield, California, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Newport Beach, California, United States|GSK Investigational Site, Pasadena, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Clemente, California, United States|GSK Investigational Site, San Francisco, California, United States|GSK Investigational Site, Santa Clara, California, United States|GSK Investigational Site, Englewood, Colorado, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Fort Lauderdale, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Orlando, Florida, United States|GSK Investigational Site, Sarasota, Florida, United States|GSK Investigational Site, Atlanta, Georgia, United States|GSK Investigational Site, Atlanta, Georgia, United States|GSK Investigational Site, Atlanta, Georgia, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Honolulu, Hawaii, United States|GSK Investigational Site, Indianapolis, Indiana, United States|GSK Investigational Site, Iowa City, Iowa, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Lutherville-Timonium, Maryland, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Worcester, Massachusetts, United States|GSK Investigational Site, Ann Arbor, Michigan, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Binghamton, New York, United States|GSK Investigational Site, Manhasset, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, The Bronx, New York, United States|GSK Investigational Site, Chapel Hill, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Cincinnati, Ohio, United States|GSK Investigational Site, Cincinnati, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Lancaster, Pennsylvania, United States|GSK Investigational Site, Dallas, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Fairfax, Virginia, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, Camperdown, Victoria, Australia|GSK Investigational Site, Clayton, Victoria, Australia|GSK Investigational Site, Fitzroy, Melbourne, Victoria, Australia|GSK Investigational Site, Heidelberg, Victoria, Australia|GSK Investigational Site, Melbourne, Victoria, Australia|GSK Investigational Site, Calgary, Alberta, Canada|GSK Investigational Site, Vancouver, British Columbia, Canada|GSK Investigational Site, Victoria, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, London, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Brno - Bohunice, Czechia|GSK Investigational Site, Hradec Kralove, Czechia|GSK Investigational Site, Praha 4, Czechia|GSK Investigational Site, Praha 6, Czechia|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Erlangen, Bayern, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, Germany|GSK Investigational Site, Homburg, Saarland, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Jerusalem, Israel|GSK Investigational Site, Nazareth, Israel|GSK Investigational Site, Petach-Tikva, Israel|GSK Investigational Site, Rehovot, Israel|GSK Investigational Site, Tel-Aviv, Israel|GSK Investigational Site, Daegu, Korea, Republic of|GSK Investigational Site, Pusan, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Bandar Tun Razak, Cheras, Malaysia|GSK Investigational Site, Kepong, Malaysia|GSK Investigational Site, Auckland, New Zealand|GSK Investigational Site, San Juan, Puerto Rico|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Cluj-Napoca, Cluj, Romania|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Saint-Petersburg, Russian Federation|GSK Investigational Site, Singapore, Singapore|GSK Investigational Site, Kaohsiung, Taiwan|GSK Investigational Site, Kaohsiung, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Taoyuan, Taiwan","https://ClinicalTrials.gov/show/NCT00244751"
45,"Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment","Completed","Has Results","Chronic Hepatitis c|Cirrhosis, Liver|Fibrosis, Liver|Hepatic Cirrhosis","Drug: Peginterferon alfa-2a + Ribavirin|Drug: Peginterferon alfa-2a","National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institute of Allergy and Infectious Diseases (NIAID)|National Institute on Minority Health and Health Disparities (NIMHD)|National Cancer Institute (NCI)|Hoffmann-La Roche","Phase 3","1050","NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","June 2000","October 2009","University of California-Irvine/VA Medical Center-Long Beach, Long Beach, California, United States|USC School of Medicine, Los Angeles, California, United States|UCHSC (University of Colorado), Denver, Colorado, United States|University of Connecticut Health Center, Farmington, Connecticut, United States|Lds, Niddk, Nih, Bethesda, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|UMass Memorial HealthCare, University Campus, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Saint Louis University, Saint Louis, Missouri, United States|University of Texas Southwestern - Dallas, Dallas, Texas, United States|Medical College of Virginia, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00006164"
46,"Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer","Terminated","No Results Available","Liver Cancer|Hepatocellular Carcinoma|Cirrhosis|Liver Fibrosis","Drug: Oral Impact®|Drug: Placebo","Rennes University Hospital|Ministry of Health, France|Novartis","Phase 2|Phase 3","35","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 2003","September 2008","Service de Réanimation Chirurgicale - Hôpital Pontchaillou, Rennes, France","https://ClinicalTrials.gov/show/NCT00151671"
47,"Improving Fibrosis Outcomes With Metformin","Withdrawn","No Results Available","HIV Infection|Hepatitis C","Drug: Metformin|Drug: No metformin treatment","Ottawa Hospital Research Institute|CIHR Canadian HIV Trials Network","Phase 2","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","January 2016","April 3, 2018","The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02306070"
48,"THISTLE - The HIV-HCV Silibinin Trial","Completed","No Results Available","HIV|Hepatitis C","Drug: Intravenous Silibinin (iSIL)","University of Zurich","Phase 2","20","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","April 2013","December 2014","Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT01816490"
49,"Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)","Completed","Has Results","Primary Sclerosing Cholangitis (PSC)","Biological: Simtuzumab|Biological: Placebo","Gilead Sciences","Phase 2","235","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 4, 2013","August 24, 2016","Mayo Clinic Hospital, Phoenix, Arizona, United States|University of Arizona Health Sciences Center, Tucson, Arizona, United States|Southern California Liver Center, Chula Vista, California, United States|Southern California Liver Centers, Coronado, California, United States|Scripps Clinic, La Jolla, California, United States|Verterans Adminstration Hospital, Palo Alto, California, United States|UC Davis Medical Center, Sacramento, California, United States|University of San Diego Medical Center, San Diego, California, United States|University of California San Francisco, San Francisco, California, United States|University of Colorado Denver, Aurora, Colorado, United States|University of Miami Center for Liver Diseases, Miami, Florida, United States|Northwestern University, Chicago, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|Indianapolis Gastroenterology Research Foundation, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|University of Louisville, Louisville, Kentucky, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Minnesota Gastroenterology, PA, Saint Paul, Minnesota, United States|St. Louis University, Saint Louis, Missouri, United States|Weill Cornell Medical College, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|Duke Clinical Research Institute, Durham, North Carolina, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|St. Luke Episcopal Hospital, Houston, Texas, United States|Alamo Medical Research, San Antonio, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States|University of Virginia Health Center, Charlottesville, Virginia, United States|Liver Institute of Virginia, Newport News, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Bon Secours Richmond Health System, Richmond, Virginia, United States|Virginia Commonwealth University Health System, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|Hôpital Erasme, Brussels, Belgium|Université Catholique de Louvain, Bruxelles, Belgium|UZ Antwerpen, Edegem, Belgium|UZ Gent, Gent, Belgium|UZ Leuven, Leuven, Belgium|University of Calgary, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|University of Manitoba, Winnepeg, Manitoba, Canada|Dalhousie University, Halifax, Nova Scotia, Canada|London Health Science Center, London, Ontario, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Hvidovre Hospital, Hvidovre, Denmark|Rigshospitalet, Kobenhavn O, Denmark|Århus Universitetshospital, Århus Sygehus, Århus C, Denmark|Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Gastroenterologisch Hepatologisches Zentrum Kiel, Kiel, Germany|EUGASTRO GmbH, Leipzig, Germany|Istituto Clinico Humanitas, Rozzano, Milano, Italy|Azienda Ospedaliera San Camillo Forlanini, Roma, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy|Eramus MC, Rotterdam, Netherlands|Hospital Universitario Vall d'Hebron, Barcelona, Cataluna, Spain|Hospital Universitario Puerta de Hierro, Majadahonda, Spain|Hospital Donostia, San Sebastian, Spain|Avd för invärtesmedicin och klinisk nutrition, Goteborg, Sweden|New Queen Elizabeth Hospital, Birmingham, United Kingdom|John Radcliffe Hospital, Headington, United Kingdom|Imperial College Healthcare NHS Trust- St. Mary's Hospital, London, United Kingdom|University College London, London, United Kingdom|Norfolk and Norwich University Hospital, Norwich, United Kingdom|University of Nottingham, Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT01672853"
50,"Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)","Terminated","Has Results","Hepatitis C, Chronic","Biological: Peginterferon alfa-2b (PegIFN-2b)|Drug: Comparator: Stronger neo minophagen C (SNMC)","Merck Sharp & Dohme Corp.","Phase 3","261","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","December 2006","February 2011",,"https://ClinicalTrials.gov/show/NCT00686881"
51,"BreathID Multi-center HCV Liver Breath Test Study","Terminated","No Results Available","Hepatitis C","Other: MBT and BreathID","Exalenz Bioscience LTD.|Icahn School of Medicine at Mount Sinai|Baylor College of Medicine|Virginia Commonwealth University|Hadassah Medical Organization|US Department of Veterans Affairs","Phase 2","75","Industry|Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","July 2006","February 2007","Mount Sinai School of Medicine, New York, New York, United States|Baylor College of Medicine, Houston, Texas, United States|U.S. Dept. of Veteran Affairs, Hunter Holmes McGuire Medical Center, Richmond, Virginia, United States|Virginia Commonwealth Univeristy, Richmond, Virginia, United States|Hadassah Medical Center, Jerusalem, Israel","https://ClinicalTrials.gov/show/NCT00350714"
52,"Study on PK of Hydronidone in Patients and Special Population","Recruiting","No Results Available","Hepatitis b & Liver Dysfunction","Drug: Hydronidone","Beijing Continent Pharmaceutical Co, Ltd.","Phase 1","8","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","September 3, 2019","June 30, 2020","Medical ethics committee of wuhan infectious disease hospital, Wuhan, Hubei, China","https://ClinicalTrials.gov/show/NCT04123769"
53,"A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver","Completed","No Results Available","Hepatobiliary Disorders|Non-alcoholic Fatty Liver Disease","Drug: Semaglutide|Drug: Placebo","Novo Nordisk A/S","Phase 1","67","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 28, 2017","March 20, 2020","Novo Nordisk Investigational Site, Mainz, Germany|Novo Nordisk Investigational Site, Neuss, Germany","https://ClinicalTrials.gov/show/NCT03357380"
54,"Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis","Completed","No Results Available","Non-Alcoholic Steatohepatitis (NASH)","Drug: GR-MD-02|Drug: Placebo","Galectin Therapeutics Inc.","Phase 1","31","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 2013","February 2015","Brooke Army Medical Ctr., San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT01899859"
55,"Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)","Not yet recruiting","No Results Available","Primary Sclerosing Cholangitis","Drug: PLN-74809|Drug: Placebo","Pliant Therapeutics, Inc.","Phase 2","84","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 10, 2020","March 30, 2022",,"https://ClinicalTrials.gov/show/NCT04480840"
56,"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis","Active, not recruiting","No Results Available","Hepatic Cirrhosis|Liver Fibrosis|Nonalcoholic Fatty Liver Disease (NAFLD)|Nonalcoholic Steatohepatitis","Drug: BMS-986036|Other: Placebo","Bristol-Myers Squibb","Phase 2","152","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 4, 2018","October 27, 2021","North Alabama GI Research Center, Madison, Alabama, United States|Arizona Liver Health, Chandler, Arizona, United States|Saint Josephs Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic - Arizona, Phoenix, Arizona, United States|The Institute for Liver Health - Tuscon, Tucson, Arizona, United States|Southern California Research Center, Coronado, California, United States|Kindred Medical Institute for Clinical Trials, Corona, California, United States|University of California San Diego, La Jolla, California, United States|Ruane Clinical Research Group, Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|GastroIntestinal Biosciences, Los Angeles, California, United States|Catalina Research Institute, Montclair, California, United States|Kaiser Permanente, Oakland, California, United States|Diverse Research Solutions, Oxnard, California, United States|California Liver Research Institute, Pasadena, California, United States|Huntington Medical Research Institutes - HMRI Liver Center, Pasadena, California, United States|Stanford Center for Clinical Research, Redwood City, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Southern California Liver Centers - San Clemente, San Clemente, California, United States|Research and Education-Tuan Nguyen MD, San Diego, California, United States|Medical Associates Research Group, San Diego, California, United States|California Pacific Medical Center, San Francisco, California, United States|Bridgeport Hospital, Bridgeport, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Clinical Research of South Florida - Coral Gables, Coral Gables, Florida, United States|Top Medical Research, Cutler Bay, Florida, United States|Clinical Research of Homestead, Homestead, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|University of Miami Hospital and Clinics, Miami, Florida, United States|A+ Research, Miami, Florida, United States|IMIC Research, Miami, Florida, United States|Sensible Healthcare, Ocoee, Florida, United States|Bioclinica Research - Orlando, Orlando, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Piedmont Hospital, Atlanta, Georgia, United States|GI Specialists of Georgia, Marietta, Georgia, United States|Tandem Clinical Research, Marrero, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|Mercy Medical Center - McAuley Plaza, Baltimore, Maryland, United States|Digestive Disease Associates, Catonsville, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|NECCR PrimaCare Research, Fall River, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Clinical Research Professionals, Chesterfield, Missouri, United States|Saint Lukes Hospital - Kansas City, Kansas City, Missouri, United States|Saint Louis University, Saint Louis, Missouri, United States|University at Buffalo, Buffalo, New York, United States|Northwell Health, Manhasset, New York, United States|Mount Sinai Hospital, New York, New York, United States|New York University, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Carolinas Medical Center - Transplant Center, Charlotte, North Carolina, United States|Northeast GI Research Division, Concord, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center - Center for Liver Disease, Pittsburgh, Pennsylvania, United States|ClinSearch, Chattanooga, Tennessee, United States|Gastro One, Germantown, Tennessee, United States|Associates in Gastroenterology, Hermitage, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States|Liver Center of Texas, Dallas, Texas, United States|Texas Digestive Disease Consultants - Dallas, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Texas Digestive Disease Consultants - Southlake, Fort Worth, Texas, United States|Spring Gastroenterology, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Pinnacle Clinical Research - San Antonio, Rollingwood, Texas, United States|The Texas Liver Institute, San Antonio, Texas, United States|Clinical Trials of Texas, San Antonio, Texas, United States|Pinnacle Clinical Research - San Antonio, San Antonio, Texas, United States|University of Vermont Medical Center, Burlington, Vermont, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Gastroenterology Associates, PC, Manassas, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|The Gastroenterology Group, Reston, Virginia, United States|Bon Secours Liver Institute of Richmond, Richmond, Virginia, United States|Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Local Institution, Kurume, Fukuoka, Japan|Local Institution, Yokohama-shi, Kanagawa, Japan|Local Institution, Kashihara, Nara, Japan|Local Institution, Minato, Tokyo, Japan|Local Institution, Shinjuku-ku, Tokyo, Japan|Local Institution, Fukushima, Japan","https://ClinicalTrials.gov/show/NCT03486912"
57,"A Study of Experimental Medication BMS-986036 Given to Healthy Participants","Completed","No Results Available","Hepatic Cirrhosis|Liver Fibrosis|Nonalcoholic Fatty Liver Disease|Nonalcoholic Steatohepatitis","Drug: BMS-986036","Bristol-Myers Squibb","Phase 1","30","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","February 14, 2018","May 2, 2018","PRA Health Sciences, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT03445208"
58,"The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation","Completed","No Results Available","Hepatitis C Recurrence After Liver Transplant","Drug: EVL arm|Drug: MMF arm","Hospital Vall d'Hebron","Phase 3","18","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","October 2012","August 2016","Department of HPB Surgery and Transplant, Hospital Vall d´Hebron, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT01707849"
59,"Anti-Fibrotic Effects of Losartan In Nash Evaluation Study","Completed","No Results Available","Nonalcoholic Steatohepatitis","Drug: Losartan","Newcastle-upon-Tyne Hospitals NHS Trust|Newcastle University","Phase 3","45","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 2011","December 2014","Plymouth Hospitals NHS Trust, Plymouth, Devon, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|Cambridge University NHS Foundation Trust, Cambridge, United Kingdom|Royal Derby Hospital, Derby, United Kingdom|Royal Liverpool & Broadgreen University Hospital, Liverpool, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Imperial College (St Mary's Site), London, United Kingdom|St George's Hospital, London, United Kingdom|Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom|Queens Medical Centre, Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT01051219"
60,"Study of ORL-1M (D-mannose) in Patients With CDG-Ib","Recruiting","No Results Available","CDG Ib","Drug: ORL-1M - D-mannose","Orpha Labs","Phase 1|Phase 2","5","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","March 31, 2015","June 1, 2019","Orpha Labs, Ankara, Turkey","https://ClinicalTrials.gov/show/NCT03404869"
61,"A Phase 3/4 Clinical Study to Evaluate the Efficacy and Safety of Aramchol Versus Placebo in Subjects With NASH (ARMOR)","Recruiting","No Results Available","Nonalcoholic Steatohepatitis (NASH)","Drug: Aramchol|Drug: Placebo","Galmed Research and Development, Ltd.|Galmed Pharmaceuticals Ltd","Phase 3","2000","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 23, 2019","December 2024","Texas Clinical Research Institute, LLC, Arlington, Texas, United States","https://ClinicalTrials.gov/show/NCT04104321"
62,"Low-Dose Danazol for the Treatment of Telomere Related Diseases","Recruiting","No Results Available","Telomere Disease","Drug: Danazol","National Heart, Lung, and Blood Institute (NHLBI)|National Institutes of Health Clinical Center (CC)","Phase 2","40","NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","February 8, 2018","September 1, 2021","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT03312400"
63,"Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir","Recruiting","No Results Available","HIV","Drug: generic single tablet TAF/FTC/DTG","The HIV Netherlands Australia Thailand Research Collaboration|Faculty of Medical Sciences, Radboud University of Medical Center|Department of Pharmaceutical care, Faculty of Pharmacy, Chiang Mai University|Police General Hospital","Phase 3","190","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","May 1, 2019","December 31, 2021","HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand|Police General Hospital, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT03727152"
64,"Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease","Completed","No Results Available","Liver Cancer","Diagnostic Test: Magnetic Resonance Elastogram|Diagnostic Test: 2-Point Dixon Magnetic Resonance Imaging","M.D. Anderson Cancer Center","Phase 1|Phase 2","44","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","September 2007","January 13, 2020","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00543777"
65,"Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection","Completed","Has Results","Hepatitis C Virus","Drug: Simeprevir 150 mg|Drug: Daclatasvir 60 mg|Drug: Sofosbuvir 400 mg","Janssen Research & Development, LLC","Phase 2","68","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","January 2015","May 2016","Bakersfield, California, United States|Jacksonville, Florida, United States|Lutherville, Maryland, United States|Winston Salem, North Carolina, United States|Knoxville, Tennessee, United States|Arlington, Texas, United States|San Antonio, Texas, United States|Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02349048"
66,"Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis","Completed","No Results Available","Non-alcoholic Steatohepatitis|Fibrosis|Liver Diseases","Drug: Emricasan (5 mg)|Drug: Emricasan (50 mg)|Drug: Placebo","Conatus Pharmaceuticals Inc.","Phase 2","318","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 26, 2016","February 28, 2019","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of Arizona Clinical and Translational Sciences Research Center, Tucson, Arizona, United States|Preferred Research Partners, Inc., Little Rock, Arkansas, United States|Fresno Clinical Research Center, Freestone, California, United States|UCLA The Pfleger Liver Institute, Los Angeles, California, United States|Gastrointestinal Biosciences, Los Angeles, California, United States|Surinder Singh Saini, M.D., Inc., Newport Beach, California, United States|California Liver Research Institute, Pasadena, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|University of California Davis Medical Center, Sacramento, California, United States|University of California San Diego Medical Center, San Diego, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Sibley Memorial Hospital, Washington, District of Columbia, United States|Howard University, Washington, District of Columbia, United States|UF Hepatology Research at CTRB, Gainesville, Florida, United States|Florida Digestive Health Specialist, Lakewood Ranch, Florida, United States|Miami Veterans Administration Healthcare System, Miami, Florida, United States|University of Miami/Schiff Center for Liver Diseases, Miami, Florida, United States|Florida Hospital Orlando Transplant Institute, Orlando, Florida, United States|Tampa General Medical Group, Tampa, Florida, United States|iResearch Atlanta LLC, Decatur, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Aquiant Research, New Albany, Indiana, United States|Iowa Digestive Disease Center, P.C, Clive, Iowa, United States|UnityPoint Clinic Center For Liver Disease, Des Moines, Iowa, United States|University of Louisville, Louisville, Kentucky, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Lahey Clinic Medical Center, Burlington, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Kansas City VA Medical Center, Kansas City, Missouri, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Washington University School of Medicine-Infectious Disease Clinical Research Unit, Saint Louis, Missouri, United States|Doctors Office Center, Newark, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|State University of New York, Buffalo, New York, United States|Northwell Health, Inc., Manhasset, New York, United States|Mount Sinai Beth Israel Medical Center, New York, New York, United States|NYU Langone Medical Center, New York, New York, United States|Columbia University Medical Center (CUMC), New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Asheville Gastroenterology Associates, PA, Asheville, North Carolina, United States|Carolinas Healthcare System, Center for Liver Disease, Charlotte, North Carolina, United States|Duke University Medical Center, Duke South Clinics, Durham, North Carolina, United States|Rex Healthcare, Raleigh, North Carolina, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Options Health Research, LLC, Tulsa, Oklahoma, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|PMG Research at Charleston, Charleston, South Carolina, United States|ClinSearch, LLC, Chattanooga, Tennessee, United States|Gastro One, Germantown, Tennessee, United States|Methodist University Hospital, Memphis, Tennessee, United States|Vanderbilt University Medical Center - Digestive Disease Center, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor All Saints Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Liver Associates of Texas, P.A., Houston, Texas, United States|Research Specialists of Texas, Houston, Texas, United States|Pinnacle Clinical Research, PLLC, Live Oak, Texas, United States|American Research Corporation at the Texas Liver Institue, San Antonio, Texas, United States|Brooke Army Medical Center, San Antonio, Texas, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|University of Vermont, Burlington, Vermont, United States|Bon Secours Richmond Health System, Newport News, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|McGuire VA Medical Center, Richmond, Virginia, United States|University of Washington Harborview Medical Center, Seattle, Washington, United States|Universitätsklinikum der RWTH Aachen, Aachen, North Rhine-Westphalia, Germany|Universitätsklinikum Bonn, Bonning, North Rhine-Westphalia, Germany|Universitätsklinikum Münster, Munster, North Rhine-Westphalia, Germany|Charité - Universitätsmedizin Berlin, Berlin, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Eugastro GmbH, Leipzig, Germany|Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañon, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda, Spain|Hospital Universitario de Donostia, San Sebastian, Spain|Hospital Universitario Marques de Valdecilla, Santander, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Hospital General Universitario de Valencia, Valencia, Spain","https://ClinicalTrials.gov/show/NCT02686762"
67,"Hepatic Impairment, Cholestatic Liver Disease, & NASH With Advanced Fibrosis & Normal Hepatic Function","Not yet recruiting","No Results Available","Hepatic Impairment","Drug: Saroglitazar Magnesium 2 mg|Drug: Saroglitazar Magnesium 4 mg","Zydus Discovery DMCC","Phase 1","100","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","July 2020","April 2021",,"https://ClinicalTrials.gov/show/NCT04469920"
68,"The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes","Completed","No Results Available","Type 2 Diabetes Nonalcoholic Fatty Liver","Dietary Supplement: caffeine and chlorogenic acid|Dietary Supplement: caffeine|Dietary Supplement: chlorogenic acid|Dietary Supplement: placebo","National Nutrition and Food Technology Institute","Phase 2|Phase 3","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 2016","March 2019","NNFTRI clinic, Tehran, Iran, Islamic Republic of","https://ClinicalTrials.gov/show/NCT02929901"
69,"Mesenchymal Stem Cells Treat Liver Cirrhosis","Suspended","No Results Available","Liver Cirrhosis","Drug: Conserved Therapy|Procedure: Hepatic artery infusion or Intravenous infusion","Yufang Shi|Soochow University|Chinese Academy of Sciences","Phase 1|Phase 2","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","October 2009","December 2019","First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China","https://ClinicalTrials.gov/show/NCT01233102"
70,"Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection","Terminated","Has Results","Recurrent Hepatitis C","Drug: CsA-TAC (standard Treatment)|Drug: Everolimus","Novartis Pharmaceuticals|Novartis","Phase 2","43","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","December 2007","January 2010","Novartis Investigative site, Buenos Aires, Argentina","https://ClinicalTrials.gov/show/NCT00582738"
71,"Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis","Completed","No Results Available","Liver Cirrhosis","Drug: conventional plus MSC treatment|Drug: conventional plus placebo treatment","Beijing 302 Hospital","Phase 1|Phase 2","266","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","May 2009","April 2016","Beijing 302 Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT01220492"
72,"Safety Study of Autologous Stem Cell in Liver Cirrhosis","Terminated","No Results Available","Liver Cirrhosis","Procedure: Autologous bone marrow-derived mononuclear cells infusion","Universidade Federal do Rio de Janeiro|Financiadora de Estudos e Projetos","Phase 1|Phase 2","15","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","November 2005","February 2008","Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil","https://ClinicalTrials.gov/show/NCT00382278"
73,"Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis","Completed","No Results Available","Liver Cirrhosis","Other: Autologous bone marrow-derived endothelial progenitor cells","Clinica Universidad de Navarra, Universidad de Navarra|Foundation Ramon Areces|Instituto de Salud Carlos III","Phase 1|Phase 2","14","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","June 2012","March 2015","Clinica Universidad de Navarra, Pamplona, Navarra, Spain","https://ClinicalTrials.gov/show/NCT01333228"
74,"Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells","Terminated","No Results Available","Liver Cirrhosis","Biological: adipose tissue derived stromal cells","Kanazawa University","Phase 1","6","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","February 2009","April 2010","Kanazawa University Hospital, Kanazawa, Ishikawa, Japan","https://ClinicalTrials.gov/show/NCT00913289"
75,"A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis","Not yet recruiting","No Results Available","Nonalcoholic Steatohepatitis (NASH) With Fibrosis","Drug: Placebo|Drug: Dose 1 JKB-122|Drug: Dose 2 JKB-122","TaiwanJ Pharmaceuticals Co., Ltd","Phase 2","300","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 30, 2020","December 31, 2023",,"https://ClinicalTrials.gov/show/NCT04255069"
76,"Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis","Recruiting","No Results Available","Decompensated Liver Cirrhosis","Biological: umbilical cord-derived mesenchymal stem cell|Other: Comprehensive treatment","Beijing 302 Hospital","Phase 2","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","May 20, 2019","December 30, 2023","Beijing 302 Hospital, Beijing, China","https://ClinicalTrials.gov/show/NCT03945487"
77,"Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)","Recruiting","No Results Available","Nonalcoholic Steatohepatitis (NASH) With Fibrosis","Drug: Elafibranor|Drug: Placebo","Genfit","Phase 3","2000","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 2016",,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|The Institute for Liver Health, Chandler, Arizona, United States|The Institute for Liver Health, Glendale, Arizona, United States|Banner University Medical Center Phoenix, Phoenix, Arizona, United States|Dignity Health St. Joseph's Hospital, Phoenix, Arizona, United States|Mayo Clinic Hospital, Phoenix, Arizona, United States|Institute for Liver Health, Tucson, Arizona, United States|Adobe Clinical Research, LLC, Tucson, Arizona, United States|The University of Arizona College of Medicine Liver Research Institute, Tucson, Arizona, United States|Liver Wellness Center, Little Rock, Arkansas, United States|GW Research, Inc., Chula Vista, California, United States|Southern California Research Center, Coronado, California, United States|University of California, San Francisco, Fresno Community Regional Medical Center, Fresno, California, United States|Fresno Clinical Research Center, Fresno, California, United States|University of California, San Francisco, Fresno Community Regional Medical Center, Fresno, California, United States|Scripps Clinic Torrey Pines, La Jolla, California, United States|University of California - San Diego, La Jolla, California, United States|Loma Linda University Medical Center - Transplantation Insitute, Loma Linda, California, United States|VA Long Beach Healthcare System, Long Beach, California, United States|Keck Hospital of USC, Los Angeles, California, United States|Ruane Clinical Research Group Inc., Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Gastrointestinal Biosciences Clinical Trials LLC, Los Angeles, California, United States|Veterans Affaires Greater Los Angeles Healthcare System, West LA VA Medical Center, Los Angeles, California, United States|Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States|Alliance Clinical Research, Oceanside, California, United States|National Research Institute, Panorama City, California, United States|Alliance Clinical Research, Poway, California, United States|University of California, Davis Medical Center, Sacramento, California, United States|University of California, San Diego Airway Research and Clinical Trials Center, San Diego, California, United States|Medical Associates Research Group, Inc., San Diego, California, United States|VA San Diego HealthCare System, San Diego, California, United States|Quest Clinical Research, San Francisco, California, United States|Sutter West Bay Hospitals dba California Pacific Medical Center, San Francisco, California, United States|University of California, San Francisco, Medical Center at Parnassus, San Francisco, California, United States|Ventura Clinical Trials, Ventura, California, United States|South Denver Gastroenterology, Englewood, Colorado, United States|Yale University School of Medicine, Section of Digestive Diseases, New Haven, Connecticut, United States|Georgetown University Hospitals, Washington, District of Columbia, United States|Sibley Memorial Hospital, Washington, District of Columbia, United States|Excel Medical Clinical Trials LLC, Boca Raton, Florida, United States|Integrity Clinical Research LLC, Doral, Florida, United States|University of Florida, Gainesville, Florida, United States|Nature Coast Clinical Research, Inverness, Florida, United States|Mayo Clinic Hospital, Jacksonville, Florida, United States|Florida Digestive Health Specialists, LLP, Lakewood Ranch, Florida, United States|Atlantic Gastroenterology Associates, LLC, Lakewood Ranch, Florida, United States|Miami VA Healthcare System, Miami, Florida, United States|University of Miami - Miller School of Medicine, Miami, Florida, United States|University of Miami - Schiff Center for Liver Diseases, Miami, Florida, United States|South Florida Center of Gastroenterology, PA, Wellington, Florida, United States|Florida Medical Clinic, PA, Zephyrhills, Florida, United States|Summit Clinical Research, Athens, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|Atlanta Medical Center, Inc., Atlanta, Georgia, United States|Gastrointestinal Specialists of Georgia, PC, Marietta, Georgia, United States|The Queen's Medical Center, Honolulu, Hawaii, United States|Northwestern Memorial Hospital - Arkes Family Pavilion, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Loyola University Chicago, Maywood, Illinois, United States|Gastroenterology Associates of Hazard, Hazard, Kentucky, United States|University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States|University of Louisville Medical / Dental Complex, Louisville, Kentucky, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Kaiser Permanente Shady Grove Medical Center, Rockville, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|Henry Ford Health System, Division of Gastroenterology & Hepatology, Detroit, Michigan, United States|Gastrointestinal Associates & Endoscopy Center, Flowood, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|St. Luke's Liver Transplant & Specialist, Kansas City, Missouri, United States|Kansas City VA Medical Center, Kansas City, Missouri, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Saint Louis University School of Medicine, Saint Louis, Missouri, United States|Rutgers, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|Rutgers, New Jersey Medical School, Newark, New Jersey, United States|Southwest Gastroenterology Associates, Albuquerque, New Mexico, United States|Montefiore Medical Center, Bronx, New York, United States|University at Buffalo, Clinical and Translational Research Center, Buffalo, New York, United States|Hofstra Northwell School of Medicine, Manhasset, New York, United States|Concorde Medical Group, New York, New York, United States|New York University Langone Medical Center, New York, New York, United States|Weill Medical College of Cornell University, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|New York-Presbyterian Hospital - Columbia University Medical Center, New York, New York, United States|Beth Israel Medical Center, New York, New York, United States|Premier Medical Group, Poughkeepsie, New York, United States|Asheville Gastroenterology Associates, Asheville, North Carolina, United States|UNC Health Care System, Chapel Hill, North Carolina, United States|Carolinas Medical Center, Charlotte, North Carolina, United States|Duke Gastroenterology, Durham, North Carolina, United States|Cumberland Research Associates, LLC, Fayetteville, North Carolina, United States|Carolinas Center for Liver Disease, Carolinas HealthCare System/Atrium Health, Huntersville, North Carolina, United States|Diabetes & Endocrinology Consultants, Morehead City, North Carolina, United States|Wake Research Associates, Raleigh, North Carolina, United States|Piedmont Healthcare, Statesville, North Carolina, United States|Trial Management Associates, Wilmington, North Carolina, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|Ohio Gastroenterology & Liver Institute, Cincinnati, Ohio, United States|University of Cincinnati Physicians Company , LLC, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Options Health Research, LLC, Tulsa, Oklahoma, United States|Drexel University, College of Medicine, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Temple University Health System, Philadelphia, Pennsylvania, United States|Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States|UPMC Montefiore, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States|Medical University of South Carolina (MUSC), Charleston, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Associates in Gastroenterology, PLC, Hermitage, Tennessee, United States|Methodist University Hospital, Memphis, Tennessee, United States|Quality Medical Research, PLLC, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Methodist Dallas Medical Center, Dallas, Texas, United States|Liver Center of Texas, Dallas, Texas, United States|Baylor All Saints Medical Center - Baylor Research Institute, Fort Worth, Texas, United States|DHAT Research Institute, Garland, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Liver Associates of Texas, P.A., Houston, Texas, United States|Research Specialists of Texas, Houston, Texas, United States|Centex Studies Inc., Houston, Texas, United States|Gulf Coast Research Group LLC, Houston, Texas, United States|Brooke Army Medical Center, Houston, Texas, United States|Gastroenterology Consultants of San Antonio, Live Oak, Texas, United States|Centex Studies Inc, McAllen, Texas, United States|Pinnacle Clinical Research, PLLC, Rollingwood, Texas, United States|The Texas Liver Institute, Inc., San Antonio, Texas, United States|Pinnacle Clinical Research, PLLC, San Antonio, Texas, United States|Texas Digestive Consultants (TDDC), Southlake, Texas, United States|Victoria Gastroenterology, Victoria, Texas, United States|University of Utah School of Medicine, Salt Lake City, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|University of Virginia, Charlottesville, Virginia, United States|Inova Fairfax Medical Campus - Center for Liver Disease, Falls Church, Virginia, United States|Bon Secours Liver Institute of Virginia - Newport News, Newport News, Virginia, United States|Bon Secours Liver Institute of Virginia - Richmond, Richmond, Virginia, United States|Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Kaiser Permanente Springfield Medical Center, Springfield, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Organ Transplant and Liver Center, Seattle, Washington, United States|Sanatorio Güemes, Caba, Buenos Aires, Argentina|Axismed S.R.L, Caba, Buenos Aires, Argentina|Instituto de Investigaciones Clinicas San Nicolas SRL, San Nicolas, Buenos Aires, Argentina|Hospital Alemán, Buenos Aires, Argentina|Centro de Investigación y Prevención Cardiovascular SA (CIPREC), Buenos Aires, Argentina|Fundación Sanatorio Güemes, Buenos Aires, Argentina|Hospital Italiano de Buenos Aires, Buenos Aires, Argentina|Hospital Británico de Buenos Aires, Buenos Aires, Argentina|CCBR Clinical Research, Buenos Aires, Argentina|Centro De Hepatologia Ciudad de La Plata, La Plata, Argentina|Hospital Universitario Austral, Pilar, Argentina|Dim Clinica Privada, Ramos Mejía, Argentina|Hospital Provincial del Centenario, Rosario, Argentina|Instituto Medico Alas, Salta, Argentina|Flinders Medical Centre, Bedford Park, Australia|Box Hill Hospital, Box Hill, Australia|Monash Medical Centre Clayton, Clayton, Australia|Concord Repatriation General Hospital, Concord, Australia|St. Vincent's Hospital Melbourne, Fitzroy, Australia|Austin Hospital, Heidelberg, Australia|Nepean Hospital, Kingswood, Australia|The St George Hospital, Kogarah, Australia|The Alfred Hospital, Melbourne, Australia|Fiona Stanley Hospital, Murdoch, Australia|Sir Charles Gairdner Hospital (SCGH), Nedlands, Australia|Westmead Hospital, Westmead, Australia|Hôpital Erasme, Bruxelles, Belgium|Universitair Ziekenhuis Brussel, Bruxelles, Belgium|Cliniques Universitaires Saint-Luc, Bruxelles, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Universitair Ziekenhuis Leuven, Leuven, Belgium|Centre Hospitalier de Wallonie Picardie (CHWAPI), Tournai, Belgium|LAIR Centre, Vancouver, British Columbia, Canada|Vancouver General Hospital (VGH) - Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Toronto Liver Centre, Toronto, Ontario, Canada|Monteregie Centre de Recherche, Greenfield Park, Quebec, Canada|The Montreal Chest Institute, Montréal, Quebec, Canada|University of Calgary, Cumming School of Medicine, Calgary, AB, Canada|Queen Elizabeth II Health Sciences Centre, Nova Scotia Health Authority, Halifax, Canada|Mc Gill University Health Centre (MUHC), Montreal, Canada|University of Manitoba, Winnipeg, MB, Canada|Hospital de La Serena, La Serena, Chile|Alta Salud, Los Ángeles, Chile|Hospital Clínico UC, Santiago, Chile|Hospital Clínico Universidad de Chile, Santiago, Chile|Centro de Estudios Clinicos Barros Luco SPA (Patients seen, Fibroscan stored and Drug Shipment), Santiago, Chile|Clínica Reñaca, Vina Del Mar, Chile|Solano&Terront Servicios Médicos LTDA - Unidad Integral de Endocrinologia UNIENDO, Bogotá, Bogota D.C, Colombia|Fundación Cardio Infantil - Instituto de Cardiología, Bogotá, Colombia|Fundación Valle del Lili, Cali, Colombia|Centro Medico Imbanaco, Cali, Colombia|Hospital Universitario San Vicente de Paul Fundación, Medellin, Colombia|Hospital Pablo Tobon Uribe, Medellin, Colombia|Fundacion Hospitalaria San Vicente de Paul, Medellín, Colombia|Fakultní Nemocnice Brno, Brno, Czechia|Research Site S.R.O., Plzen, Czechia|Research Site, s.r.o, Plzen, Czechia|KlinMed s.r.o., Praha 2, Czechia|Aarhus University Hospital, Aarhus, Denmark|Helsinki University Central Hospital, Helsinki, Finland|CHU Amiens Picardie, Amiens, France|CHU Angers, Angers, France|Hôpital Antoine-Béclère, Clamart, France|Hôpital Beaujon, Clichy, France|Hôpital Henri Mondor, Créteil, France|CHU Limoges - Hôpital Dupuytren, Limoges, France|Hôpital de la Croix-Rousse, Lyon, France|Hôpital Saint Joseph, Marseille, France|CHRU Montpellier- Hôpital Saint Eloi, Montpellier, France|CHU de Nantes - Hôpital Laennec, Nantes, France|CHU de Nice- Hôpital de l'Archet II, Nice, France|Hôpital Saint-Antoine, Paris, France|Hopital Pitie-Salpetriere, Paris, France|Hôpital Cochin, Paris, France|Hôpital Haut-Lévêque, Pessac, France|CHU Toulouse - Hôpital Purpan, Toulouse, France|CHU Nancy - Hôpital Brabois, Vandoeuvre Les Nancy, France|Hôpital Paul Brousse, Villejuif, France|Universitätsklinikum Köln, Köln, Northwest, Germany|Universitätsklinikum RWTH Aachen, Aachen, Germany|Liver Center, Berlin, Germany|Gastroenterologie am Bayerischen Platz/ Gastro-Studien, Berlin, Germany|Universitätsklinikum Bonn, Bonn, Germany|Universitätsklinikum Essen, Essen, Germany|Universitätsklinikum Frankfurt - Goethe Universität, Frankfurt, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Asklepios Klinik St. Georg, Hamburg, Germany|Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg, Germany|Medizinische Hochschule Hannover (MHH), Hannover, Germany|Universitätsklinikum Heidelberg, Heidelberg, Germany|Universitätsklinikum Köln, Köln, Germany|EUGASTRO GmbH, Leipzig, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|Universitätsklinikum Magdeburg, Magdeburg, Germany|Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany|Universitätsklinikum Würzburg, Würzburg, Germany|Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi, Bologna, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy|Azienda Ospedaliera di Rilievo Nazionale ""A. Cardarelli"", Napoli, Italy|Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Italy|Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Italy|Policlinico Tor Vergata, Roma, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy|Ospedale Casa Sollievo della Sofferenza I.R.C.C.S., San Giovanni Rotondo, Italy|Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino - Ospedale Molinette, Torino, Italy|Hospital Angeles Clinica Londres, Mexico, DIF, Mexico|Centro de Investigación Clínica del Pacífico, S.A de C.V., Acapulco, Mexico|Hospital Maria Auxiliadora, Guadalajara, Mexico|Médica Sur, Mexico City, Mexico|Consultorio Medico, Mexico City, Mexico|Accelerium S de RL de C.V., Monterrey, Mexico|Vrije Universiteit Medical Center, Amsterdam, Netherlands|Academisch Medisch Centrum, Amsterdam, Netherlands|Maastricht UMC+, Maastricht, Netherlands|Radboud UMC, Nijmegen, Netherlands|Centro Hospitalar e Universitário de Coimbra, EPE - Hospitais da Universidade de Coimbra, Coimbra, Portugal|Centro Hospitalar Lisboa Central, EPE - Hospital Santo António dos Capuchos, Lisboa, Portugal|Centro Hospitalar de Lisboa Norte, EPE - Hospital Santa Maria, Lisboa, Portugal|Centro Hospitalar de São João, EPE - Hospital de São João, Porto, Portugal|Centro Hospitalar de São João, Porto, Portugal|Centro Hospita de Tras-os-Montes e Alto Douro, EPE, Vila Real, Portugal|Caparra Internal Medicine Research Center, Rio Grande, Puerto Rico|Klinical Investigations Group, LLC, San Juan, Puerto Rico|Fundacion de Investigacion de Diego, San Juan, Puerto Rico|Fundación de Investigación, San Juan, Puerto Rico|Institutul National de Boli Infectioase ""Prof. Dr. Matei Bals"", Bucharest, Romania|Institutul Clinic Fundeni, Bucharest, Romania|SC Cabinet Particular Policlinic Algomed SRL, Timisoara, Romania|Spitalul Clinic Judetean de Urgenta ""Pius Brinzeu"" Timisoara, Timisoara, Romania|FSBRI ""Federal Research Center of nutrition and biotechnology, Moscow, Russian Federation|I. M. Sechenov - First Moscow State Medical University, Moscow, Russian Federation|M. F. Vladimirsky - Clinical Research Institution of Moscow Region, Moscow, Russian Federation|Military medical academy n. a. S.M. Kirov, Saint Petersburg, Russian Federation|St Petersburg State Budgetary Healthcare Institution City Clinical Hospital N°31, Saint Petersburg, Russian Federation|City Clinical Hospital No. 31, St. Petersburg, Russian Federation|Tiervlei Trial Centre, Cape Town, South Africa|Mediclinic Constantiaberg, Cape Town, South Africa|Phoenix Pharma (Pty) Ltd, Port Elizabeth, South Africa|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Clinic i Provincial, Barcelona, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Puerta de Hierro, Majadahonda, Spain|Hospital Universitario Virgen de la Victoria, Málaga, Spain|Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Spain|Campus Hospital Universitario Virgen del Rocío - Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain|Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden|INSELSPITAL, University Hospital Bern, Bern, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|Kantonsspital St. Gallen, Saint Gallen, Switzerland|UniversitätsSpital Zürich, Zurich, Switzerland|Ankara Üniversitesi Tıp Fakültesi, Ankara, Turkey|Bezmiâlem Vakıf Üniversitesi, Fatih, Turkey|Sağlık Bilimleri Üniversitesi Ümraniye Eğitim ve Araştırma Hastanesi, Istanbul, Turkey|Ege Üniversitesi, Izmir, Turkey|Marmara Üniversitesi Eğitim ve Araştırma Hastanesi, Pendik, Turkey|Istanbul Universitesi Istanbul Tip Fakultesi, Çapa, Turkey|University Hospitals Birmingham NHS foundation Trust, Birmingham, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|Frimley Park Hospital NHS Foundation Trust, Frimley, United Kingdom|Hull and East Yorkshire Hospitals NHS Trust - Hull Royal Infirmary, Hull, United Kingdom|Bart Health NHS Trust- Royal London Hospital, London, United Kingdom|The Royal Free London NHS Foundation Trust - The Royal Free Hospital, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust - St Thomas' Hospital, London, United Kingdom|St George's University Hospitals NHS Foundation Trust - St George's Hospital, London, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital, Newcastle upon Tyne, United Kingdom|Nottingham University Hospitals NHS FoundationTrust - Queen's Medical Centre, Nottingham, United Kingdom|Plymouth Hospitals NHS Trust - Derriford Hospital, Plymouth, United Kingdom|Portsmouth Hospitals NHS Trust - Queen Alexandra Hospital, Portsmouth, United Kingdom","https://ClinicalTrials.gov/show/NCT02704403"
78,"Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis","Completed","Has Results","Liver Cirrhosis","Drug: G-colony stimulating factor|Other: Infusion of the mobilized monocyte cells","Seoul National University Hospital","Phase 1","9","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","January 2012","August 2014",,"https://ClinicalTrials.gov/show/NCT01503749"
79,"GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT","Recruiting","No Results Available","Decompensated Cirrhosis of Liver","Drug: G-CSF|Drug: Placebo","Postgraduate Institute of Medical Education and Research|Society for the Study of Liver Diseases, Chandigarh ( India )","Phase 2|Phase 3","70","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 4, 2019","June 30, 2020","Post Graduate Institute of Medical Education and Research, Chandigarh, India","https://ClinicalTrials.gov/show/NCT03911037"
80,"Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis","Completed","No Results Available","Liver Cirrhosis","Drug: Ng-monomethyl-L-arginine (drug)","Regional Hospital Holstebro","Phase 1","30","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single",,,,"https://ClinicalTrials.gov/show/NCT00344916"
81,"Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy","Recruiting","No Results Available","Cirrhosis, Liver","Drug: Midazolam|Drug: Propofol","Sherief Abd-Elsalam|Tanta University","Phase 3","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","April 1, 2016","December 11, 2022","Sherief Abd-Elsalam, Tanta, Egypt","https://ClinicalTrials.gov/show/NCT03388151"
82,"Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis","Completed","No Results Available","Liver Cirrhosis","Biological: conventional therapy plus low dose hUC-MSCs treatment|Biological: conventional therapy plus medium dose hUC-MSCs treatment|Biological: conventional therapy plus high dose hUC-MSCs treatment","Shenzhen Beike Bio-Technology Co., Ltd.|No.85 Hospital, Changning, Shanghai, China","Phase 1|Phase 2","20","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","October 2010","October 2011","Shanghai Liver Disease Research Center, the Nanjing Military Command (Shanghai 85 Hospital), Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT01342250"
83,"Mesenchymal Stem Cell Therapy for Liver Cirrhosis","Recruiting","No Results Available","Liver Cirrhosis","Biological: Autologous BM MSC","Stem Med Pte. Ltd.|Parkway Cancer Centre|Asian American Liver Centre|Desmond Wai Liver & Gastrointestinal Diseases Centre","Phase 1|Phase 2","20","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","August 18, 2018","October 22, 2020","Asian American Liver Centre - Gleneagles Hospital (Annexe Block), Singapore, Singapore|Parkway Cancer Centre - Gleneagles Hospital, Singapore, Singapore|Desmond Wai Liver & Gastrointestinal Disease Centre - Mount Elizabeth Novena Specialist Centre, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT03626090"
84,"Sorafenib PK in Patients With Advanced HCC and Child-Pugh B","Terminated","No Results Available","BCLC Stage C HCC|CP-B Liver Cirrhosis","Drug: Sorafenib|Other: Midazolam clearance test|Other: CYP cocktail clearance test","Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Erasmus Medical Center","Phase 2","5","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","May 2014","March 2017","Academic Medical Center, Amsterdam, Netherlands","https://ClinicalTrials.gov/show/NCT04051853"
85,"A Study of ADR-001 in Patients With Liver Cirrhosis","Recruiting","No Results Available","Decompensated Liver Cirrhosis","Biological: Mesenchymal stem cell","Rohto Pharmaceutical Co., Ltd.","Phase 1|Phase 2","15","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","July 20, 2017","December 2019","Niigata University Medical & Dental Hospital, Niigata, Japan|Nihon University Itabashi Hospital, Tokyo, Japan","https://ClinicalTrials.gov/show/NCT03254758"
86,"Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development","Recruiting","No Results Available","Liver Cirrhoses","Drug: Simvastatin|Drug: Rifaximin|Drug: Placebo of Simvastatin|Drug: Placebo of Rifaximin","Judit Pich|Institut d'Investigacions Biomèdiques August Pi i Sunyer","Phase 2|Phase 3","240","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","January 3, 2019","December 31, 2021","Beajuon Hospital, Clichy, Paris, France|Universitatsklinikum Frankurt, Frankfurt, Germany|Bologna University Hospital, Bologna, Italy|Padova University Hospital, Padova, Italy|San Giovanni Battista Hospital, Torino, Italy|Academic Medical Centre, Amsterdam, Netherlands|Hospital Clínic de Barcelona, Barcelona, España, Spain|Hospital Universitari Vall d'Hebrón, Barcelona, Spain|Royal Free Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT03780673"
87,"Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3","Completed","Has Results","Non-Alcoholic Steatohepatitis (NASH)","Drug: SEL|Biological: SIM","Gilead Sciences","Phase 2","72","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","June 8, 2015","October 11, 2016","Stanford University Medical Center, Palo Alto, California, United States|University of California San Diego, San Diego, California, United States|University of California San Francisco, San Francisco, California, United States|University of Colorado Denver, Aurora, Colorado, United States|Northwestern University, Chicago, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Duke University Medical Center, Durham, North Carolina, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburg Medical Center, Pittsburgh, Pennsylvania, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Methodist Dallas Medical Center, Dallas, Texas, United States|CHI St. Luke's Health Baylor College of Medicine, Houston, Texas, United States|Brooke Army Medical Center Ft. Sam, Houston, Texas, United States|Digestive Research Center, Live Oak, Texas, United States|American Research Corporation at Texas Liver Institute, San Antonio, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Mary Immaculate Hospital, Newport News, Virginia, United States|St. Mary's Hospital, Richmond, Virginia, United States|Virginia Commonwealth University Health System, Richmond, Virginia, United States|Swedish Medical Center, Seattle, Washington, United States|University of Calgary, Calgary, Alberta, Canada|Toronto Liver Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02466516"
88,"A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis","Recruiting","No Results Available","Liver Cirrhosis","Drug: GXHPC1","Gwo Xi Stem Cell Applied Technology Co., Ltd.","Phase 2","20","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","February 27, 2020","June 30, 2022","HualienTzu Chi Hospital, Hualien City, Taiwan|National Taiwan University Hospital, Taipei county, Taiwan","https://ClinicalTrials.gov/show/NCT04088058"
89,"Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study","Completed","No Results Available","Cirrhosis","Drug: standard medical therapy|Drug: G-CSF|Drug: Growth Hormone","Postgraduate Institute of Medical Education and Research","Phase 2|Phase 3","65","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","May 2015","June 2016","Dept. of Hepatology, PGIMER, Chandigarh, Chandigarh, India|Department of Hepatology,Postgraduate Institute of Medical Education and Research, Chandigarh, India","https://ClinicalTrials.gov/show/NCT02451033"
90,"Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis","Completed","No Results Available","Liver Cirrhosis","Drug: ADSCs","Gwo Xi Stem Cell Applied Technology Co., Ltd.","Phase 1","6","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","July 13, 2015","March 27, 2018","China Medical University Beigang Hospital, Taichung, Beigang, Taiwan|Gwo Xi Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan","https://ClinicalTrials.gov/show/NCT02297867"
91,"A Study of IDN-6556 in Subjects With Liver Cirrhosis","Completed","Has Results","Liver Cirrhosis|Hepatic Cirrhosis","Drug: IDN-6556|Drug: Placebo","Conatus Pharmaceuticals Inc.","Phase 2","87","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 2014","January 2016","University of Alabama at Birmingham, Birmingham, Alabama, United States|Scripps Clinic, La Jolla, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Cedar-Sinai Medical Center, Los Angeles, California, United States|Univeristy of California, San Diego, San Diego, California, United States|California Pacific Medical Center, San Francisco, California, United States|University of Florida, Gainesville, Florida, United States|University of Miami, Miami, Florida, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|University of Chicago, Chicago, Illinois, United States|Loyola University Medical Cente, Maywood, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|University of Louisville, Louisville, Kentucky, United States|Henry Ford Hospital, Detroit, Michigan, United States|Rutgers New Jersey Medical School, Newark, New Jersey, United States|North Shore University Hospital, Manhasset, New York, United States|NYU Medical Center, New York, New York, United States|Mt. Sinai School of Medicine, New York, New York, United States|University of Cincinnati Physicians Company, LLC, Cincinnati, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Einstein Healthcare Network, Philadelphia, Pennsylvania, United States|Baylor All Saints Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|UT Health Science Center at Houston, Houston, Texas, United States|University of Utah Hospital, Salt Lake City, Utah, United States|Bon Secours Mary Immaculate Hospital, Newport News, Virginia, United States|Bon Secours St. Mary's Hospital of Richmond, Inc., Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT02230670"
92,"Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis","Completed","No Results Available","Liver Cirrhosis","Drug: Placebo|Drug: Rifaximin SSD 40 mg IR tablet|Drug: Rifaximin SSD 80 mg IR tablet|Drug: Rifaximin SSD 40 mg SER tablet|Drug: Rifaximin SSD 80 mg SER tablet|Drug: Rifaximin SSD 80mgIR/80mgSER tablet","Bausch Health Americas, Inc.","Phase 2","420","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 2013","July 2015","Salix Investigative Site, Birmingham, Alabama, United States|Salix Investigative Site, Dothan, Alabama, United States|Salix Investigative Site, Mobile, Alabama, United States|Salix Investigative Site, Tucson, Arizona, United States|Salix Investigational Site, Artesia, California, United States|Salix Investigational Site, Bakersfield, California, United States|Salix Investigational Site, Chula Vista, California, United States|Salix Investigational Site, Coronado, California, United States|Salix Investigational Site, Costa Mesa, California, United States|Salix Investigative Site, Fresno, California, United States|Salix Investigational Site, La Jolla, California, United States|Salix Investigative Site, Los Angeles, California, United States|Salix Investigational Site, Monterey, California, United States|Salix Investigational Site, Riverside, California, United States|Salix Investigational Site, San Diego, California, United States|Salix Investigational Site, Ventura, California, United States|Salix Investigational Site, Englewood, Colorado, United States|Salix Investigational Site, Littleton, Colorado, United States|Salix Investigational Site, Bristol, Connecticut, United States|Salix Investigational Site, New Haven, Connecticut, United States|Salix Investigational Site, Waterbury, Connecticut, United States|Salix Investigational Site, Coral Gables, Florida, United States|Salix Investigational Site, Gainesville, Florida, United States|Salix Investigative Site, Hialeah, Florida, United States|Salix Investigational Site, Hialeah, Florida, United States|Salix Investigational Site, Hollywood, Florida, United States|Salix Investigative Site, Inverness, Florida, United States|Salix Investigational Site, Lake Worth, Florida, United States|Salix Investigative Site, Largo, Florida, United States|Salix Investigative Site, Maitland, Florida, United States|Salix Investigational Site, Miami Springs, Florida, United States|Salix Investigational Site, Miami, Florida, United States|Salix Investigational Site, Miami, Florida, United States|Salix Investigational Site, Miami, Florida, United States|Salix Investigational Site, New Port Richey, Florida, United States|Salix Investigative Site, Orlando, Florida, United States|Salix Investigational Site, Pembroke Pines, Florida, United States|Salix Investigational Site, Port Orange, Florida, United States|Salix Investigational Site, Saint Cloud, Florida, United States|Salix Investigational Site, Tamarac, Florida, United States|Salix Investigational Site, Atlanta, Georgia, United States|Salix Investigative Site, Atlanta, Georgia, United States|Salix Investigative Site, Decatur, Georgia, United States|Salix Investigational Site, Macon, Georgia, United States|Salix Investigative Site, Chicago, Illinois, United States|Salix Investigative Site, Maywood, Illinois, United States|Salix Investigational Site, Evansville, Indiana, United States|Salix Investigational Site, Indianapolis, Indiana, United States|Salix Investigative Site, Iowa City, Iowa, United States|Salix Investigational Site, Bowling Green, Kentucky, United States|Salix Investigational Site, Bastrop, Louisiana, United States|Salix Investigational Site, Monroe, Louisiana, United States|Salix Investigational Site, New Orleans, Louisiana, United States|Salix Investigational Site, Shreveport, Louisiana, United States|Salix Investigational Site, Annapolis, Maryland, United States|Salix Investigational Site, Baltimore, Maryland, United States|Salix Investigational Site, Baltimore, Maryland, United States|Salix Investigational Site, Chevy Chase, Maryland, United States|Salix Investigational Site, Hagerstown, Maryland, United States|Salix Investigational Site, Boston, Massachusetts, United States|Salix Investigational Site, Boston, Massachusetts, United States|Salix Investigational Site, Brockton, Massachusetts, United States|Salix Investigational Site, Springfield, Massachusetts, United States|Salix Investigative Site, Chesterfield, Michigan, United States|Salix Investigational Site, Wyoming, Michigan, United States|Salix Investigational Site, Minneapolis, Minnesota, United States|Salix Investigative Site, Tupelo, Mississippi, United States|Salix Investigational Site, Kansas City, Missouri, United States|Salix Investigative Site, Saint Louis, Missouri, United States|Salix Investigational Site, Marlton, New Jersey, United States|Salix Investigational Site, New Brunswick, New Jersey, United States|Salix Investigative Site, Bronx, New York, United States|Salix Investigative Site, Brooklyn, New York, United States|Salix Investigational Site, Flushing, New York, United States|Salix Investigational Site, New York, New York, United States|Salix Investigational Site, New York, New York, United States|Salix Investigational Site, Rochester, New York, United States|Salix Investigational Site, Asheville, North Carolina, United States|Salix Investigational Site, Chapel Hill, North Carolina, United States|Salix Investigative Site, Charlotte, North Carolina, United States|Salix Investigational Site, Charlotte, North Carolina, United States|Salix Investigational Site, Fayetteville, North Carolina, United States|Salix Investigational Site, Wilmington, North Carolina, United States|Salix Investigational Site, Winston-Salem, North Carolina, United States|Salix Investigative Site, Cincinnati, Ohio, United States|Salix Investigational Site, Cincinnati, Ohio, United States|Salix Investigational Site, Cleveland, Ohio, United States|Salix Investigative Site, Dayton, Ohio, United States|Salix Investigational Site, Mentor, Ohio, United States|Salix Investigational Site, Portland, Oregon, United States|Salix Investigative Site, Bristol, Tennessee, United States|Salix Investigational Site, Chattanooga, Tennessee, United States|Salix Investigational Site, Nashville, Tennessee, United States|Salix Investigational Site, Nashville, Tennessee, United States|Salix Investigative Site, Arlington, Texas, United States|Salix Investigational Site, Austin, Texas, United States|Salix Investigational Site, Dallas, Texas, United States|Salix Investigational Site, Dallas, Texas, United States|Salix Investigative Site, Dallas, Texas, United States|Salix Investigational Site, Fort Worth, Texas, United States|Salix Investigational Site, Houston, Texas, United States|Salix Investigational Site, Houston, Texas, United States|Salix Investigational Site, Houston, Texas, United States|Salix Investigational Site, San Antonio, Texas, United States|Salix Investigational Site, San Antonio, Texas, United States|Salix Investigational Site, Bountiful, Utah, United States|Salix Investigative Site, Salt Lake City, Utah, United States|Salix Investigational Site, Charlottesville, Virginia, United States|Salix Investigative Site, Norfolk, Virginia, United States|Salix Investigative Site, Richmond, Virginia, United States|Salix Investigational Site, Richmond, Virginia, United States|Salix Investigative Site, Richland, Washington, United States|Salix Investigative Site, Seattle, Washington, United States|Salix Investigative Site, Krasnogorsk, Russian Federation|Salix Investigative Site, Moscow, Russian Federation|Salix Investigative Site, Novosibirsk, Russian Federation|Salix Investigative Site, Petersburg, Russian Federation|Salix Investigative Site, Samara, Russian Federation|Salix Investigative Site, Smolensk, Russian Federation|Salix Investigative Site, St. Petersburg, Russian Federation|Salix Investigative Site, Stavropol, Russian Federation","https://ClinicalTrials.gov/show/NCT01904409"
93,"A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis","Recruiting","No Results Available","NASH - Nonalcoholic Steatohepatitis","Drug: MGL-3196|Drug: Placebo","Madrigal Pharmaceuticals, Inc.","Phase 3","2000","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 28, 2019","March 2024","East Valley Family Physicians, Chandler, Arizona, United States|The Institute for Liver Health - Chandler, Chandler, Arizona, United States|The Institute for Liver Health - Glendale, Glendale, Arizona, United States|Desert Clinical Research, Mesa, Arizona, United States|Adobe Gastroenterology, Tucson, Arizona, United States|The Institute for Liver Health - Tucson, Tucson, Arizona, United States|Texas Digestive Disease Consultants - San Marcos, North Little Rock, Arkansas, United States|Fresno Clinical Research Center, Fresno, California, United States|National Research Institute - Huntington Park, Huntington Park, California, United States|National Research Institute - Los Angeles, Los Angeles, California, United States|Ruane Clinical Research, Los Angeles, California, United States|National Research Institute - Panorama City, Panorama City, California, United States|Colorado Springs Family Practice, Colorado Springs, Colorado, United States|South Denver Gastroenterology - Swedish Medical Center Office, Englewood, Colorado, United States|Excel Medical Clinical Trials, Boca Raton, Florida, United States|University of Florida Hepatology Research at CTRB, Gainesville, Florida, United States|Bioclinica Research - Orlando, Orlando, Florida, United States|Bioclinica Research - The Villages, The Villages, Florida, United States|GI Specialists of Georgia, Marietta, Georgia, United States|Kansas Medical Clinic - Gastroenterology, Topeka, Kansas, United States|Texas Digestive Disease Consultants - Gastroenterology Associates - Baton Rouge, Baton Rouge, Louisiana, United States|Tandem Clinical Research, Marrero, Louisiana, United States|Gastrointestinal Associates and Endoscopy Center - Madison, Flowood, Mississippi, United States|Southern Therapy and Advanced Research, Jackson, Mississippi, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Saint Louis Univeersity, Saint Louis, Missouri, United States|Clinical Research US - Henderson, Henderson, Nevada, United States|AccumetRx Clinical Trials, Albuquerque, New Mexico, United States|Mt. Sinai Medical Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cumberland Research Associates, Fayetteville, North Carolina, United States|Aventiv Research - Columbus, Columbus, Ohio, United States|Premier Medical Group - Clarksville, Clarksville, Tennessee, United States|Gastro One - Germantown - Centre Oak Way, Germantown, Tennessee, United States|Associates in Gastroenterology, Hermitage, Tennessee, United States|Gastrointestinal Associates - Knoxville, Knoxville, Tennessee, United States|Liver Center of Texas, Dallas, Texas, United States|Texas Digestive Disease Consultants - Dallas, Dallas, Texas, United States|The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States|Texas Digestive Disease Consultants - Fort Worth, Fort Worth, Texas, United States|Liver Associates of Texas, Houston, Texas, United States|Doctor's Hospital at Renaissance, McAllen, Texas, United States|Plano Research Center, Plano, Texas, United States|Pinnacle Clinical Research - Austin, Rollingwood, Texas, United States|Pinnacle Clinical Research, San Antonio, Texas, United States|San Antonio Research Center, San Antonio, Texas, United States|The Texas Liver Institute, San Antonio, Texas, United States|Texas Digestive Disease Consultants - San Marcos, San Marcos, Texas, United States|Texas Digestive Disease Consultants - Bay Area Gastroenterology, Webster, Texas, United States|Wasatch Peak Family Practice, Layton, Utah, United States|Salt Lake City Research Center, Murray, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Royal Adelaide Hospital, Adelaide, Australia|Monash Medical Centre, Clayton, Australia|Austin Health, Heidelberg, Australia|Royal Brisbane and Women's Hospital, Herston, Australia|John Hunter Hospital, New Lambton, Australia|The Royal Melbourne Hospital, Parkville, Australia|Royal Perth Hospital, Perth, Australia|Mater Misericordiae, South Brisbane, Australia|Westmead Hospital, Westmead, Australia|Centre Hospitalier Universitaire Brugmann, Laeken, Belgium|Universitair Ziekenhuis Leuven, Leuven, Belgium|University of Calgary Liver Unit, Calgary, Alberta, Canada|LAIR Centre, Vancouver, British Columbia, Canada|LMC/ Manna Research - Brampton, Brampton, Ontario, Canada|William Osler Health System, Brampton, Ontario, Canada|Toronto Liver Center, Toronto, Ontario, Canada|Hôpital Beaujon, Clichy, France|Hôpital Universitaire Pitié Salpêtrière, Paris Cedex 13, France|Centre Hospitalier Universitaire de Nancy - Hôpital de Brabois, Vandœuvre-lès-Nancy, France|Magyarország Research Center, Budapest, Hungary|Emek Medical Center, Afula, Israel|Soroka University Medical Center, Be'er Sheva, Israel|Rabin Medical Center, Petah Tikva, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|Aintree University Hospitals NHS Foundation Trust, Liverpool, United Kingdom|Saint George's University Hospitals NHS Foundation Trust, London, United Kingdom|Plymouth Hospitals NHS Trust, Plymouth, United Kingdom|Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom","https://ClinicalTrials.gov/show/NCT03900429"
94,"Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis","Terminated","Has Results","Nonalcoholic Steatohepatitis","Drug: SEL|Drug: Placebo to match SEL 6 mg|Drug: Placebo to match SEL 18 mg","Gilead Sciences","Phase 3","808","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","February 13, 2017","June 19, 2019","Institute of Liver Health, Chandler, Arizona, United States|Banner University Medical Center-Phoenix, Phoenix, Arizona, United States|St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic, Phoenix, Arizona, United States|University of Arizona, Tucson, Arizona, United States|Baptist Medical Center, Little Rock, Arkansas, United States|Arkansas Gastroenterology, North Little Rock, Arkansas, United States|eStudySite, Chula Vista, California, United States|Southern California Liver Centers, Coronado, California, United States|United Gastroenterologists, Costa Mesa, California, United States|TriWest Research Associates, LLC, El Cajon, California, United States|Fresno Clinical Research Center, Fresno, California, United States|University of California San Diego (UCSD), La Jolla, California, United States|Ruane Clinical Research Group, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|VA Greater Los Angeles Healthcare System, Los Angeles, California, United States|eStudySite, Oceanside, California, United States|California Liver Institute, Pasadena, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|University of California, Davis Medical Center, Sacramento, California, United States|Medical Associates Research Group, San Diego, California, United States|Kaiser Permanente, San Diego, California, United States|California Pacific Medical Center - Sutter Pacific Medical Foundation San Francisco Center for Liver Disease Dept. of Transplant, San Francisco, California, United States|Mission Gastroenterology and Hepatology, San Francisco, California, United States|University of California San Francisco (UCSF), San Francisco, California, United States|Silicon Valley Research Institute, San Jose, California, United States|University of Colorado, Aurora, Colorado, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Integrity Clinical Research, LLC, Doral, Florida, United States|UF Hepatology Research at CTRB, Gainesville, Florida, United States|UF Health Jacksonville-Gastroenterology Emerson, Jacksonville, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|Sunrise Medical Research, Inc, Lauderdale Lakes, Florida, United States|Sunrise Research Institute, Miami, Florida, United States|Schiff Center for Liver Diseases/University of Miami, Miami, Florida, United States|Genoma Research Group, Inc, Miami, Florida, United States|Advanced Research Institute, New Port Richey, Florida, United States|Avail Clinical Research, LLC, Orange City, Florida, United States|South Florida Center of Gastroenterology, PA, Wellington, Florida, United States|Florida Medical Clinic, PA, Zephyrhills, Florida, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|Piedmont Transplant Institute, Atlanta, Georgia, United States|Gastrointestinal Specialists of Georgia, PC, Marietta, Georgia, United States|Northwestern Memorial Hospital; Clinical Research Unit, Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|NorthShore University Healthsystem, Glenview, Illinois, United States|Indiana University Health - University Hospital, Indianapolis, Indiana, United States|Indianapolis Gastroenterology Research Foundation, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Gastroenterology Associates of Hazard, Hazard, Kentucky, United States|Delta Research Partners, LLC, Bastrop, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Ocshner Medical Center, New Orleans, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, United States|Henry Ford Health System, Detroit, Michigan, United States|Gastroenterology Associates of Western Michigan, P.L.C., Wyoming, Michigan, United States|Huron Gastroenterology Associates/Center for Digestive Care, Ypsilanti, Michigan, United States|University of Minnesota Medical Center - Fairview, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Southern Therapy and Advanced Research LLC (STAR), Ridgeland, Mississippi, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Kansas City Gastroenterology and Hepatology, Kansas City, Missouri, United States|Saint Louis University, Saint Louis, Missouri, United States|eStudySite, Las Vegas, Nevada, United States|Rutgers New Jersey Medical School- Doctors Office Center, Newark, New Jersey, United States|University of Buffalo, Clinical and Translational Research Center, Buffalo, New York, United States|Northwell Health - Sandra Atlas Bass Center for Liver Diseases, Manhasset, New York, United States|Icahn School of Medicine at Mount Sinai Beth Israel, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|University of North Carolina at Chapel Hill / UNC School of Medicine, Chapel Hill, North Carolina, United States|Duke University Medical Center - Duke South Clinics, Durham, North Carolina, United States|Cumberland Research Associates, LLC, Fayetteville, North Carolina, United States|Triad Clinical Trials LLC, Greensboro, North Carolina, United States|Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease, Huntersville, North Carolina, United States|PMG Research of Rocky Mount, LLC, Rocky Mount, North Carolina, United States|Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease, Statesville, North Carolina, United States|Digestive Health Specialists, PA, Winston-Salem, North Carolina, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|UC Health/Holmes Hospital, Cincinnati, Ohio, United States|Northeast Clinical Research Center, LLC, Bethlehem, Pennsylvania, United States|Hospital of the University of Pennsylvania- Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute, Pittsburgh, Pennsylvania, United States|VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States|eStudySite, Pittsburgh, Pennsylvania, United States|Guthrie Medical Group, PC, Sayre, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Greenville Health System - Gastroenterology and Liver Center, Greenville, South Carolina, United States|WR-ClinSearch, LLC, Chattanooga, Tennessee, United States|Gastro One, Germantown, Tennessee, United States|Quality Medical Research PLLC, Nashville, Tennessee, United States|Vanderbilt University Medical Center - Digestive Disease Center, Nashville, Tennessee, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, United States|Pinnacle Clinical Research, PLLC, Austin, Texas, United States|Austin Center for Clinical Research, Austin, Texas, United States|The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States|Texas Digestive Disease Consultants, Dallas, Texas, United States|Baylor Scott & White All Saints Medical Center, Fort Worth, Texas, United States|Kelsey-Seybold Clinic, Houston, Texas, United States|Baylor College of Medicine - Advanced Liver Therapies, Houston, Texas, United States|VAMC & Baylor College, Houston, Texas, United States|Pinnacle Clinical Research, PLLC, Live Oak, Texas, United States|American Research Corporation, The Texas Liver Institute, San Antonio, Texas, United States|Intermountain Liver Disease and Transplant Center, Murray, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|The University of Vermont Medical Center, Burlington, Vermont, United States|University of Virginia Medical Center, Charlottesville, Virginia, United States|Verity Research, Inc., Fairfax, Virginia, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|Emeritas Research Group, Lansdowne Town Center, Virginia, United States|Bon Secours St. Mary's Hospital of Richmond, Inc. d/b/a Bon Secours Liver Institute of Virginia, Newport News, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Bon Secours St. Mary's Hospital of Richmond, Inc. d/b/a Bon Secours Liver Institute of Virginia, Richmond, Virginia, United States|McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Virginia Mason, Seattle, Washington, United States|Swedish Organ Transplant and Liver Center, Seattle, Washington, United States|Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States|Hospital Italiano de Buenos Aires, Buenos Aires, Argentina|Instituto Oulton, Córdoba, Argentina|St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|St. George's Hospital, Kogarah, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Royal Brisbane & Women's Hospital, Herston, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Monash Health, Monash Medical Centre, Clayton, Victoria, Australia|St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Austin Hospital, Heidelberg, Victoria, Australia|The Alfred Hospital, Alfred Health, Melbourne, Victoria, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|Medizinische Universitat Graz, Universitatsklinik fue Innere Medizin, Graz, Austria|Allgemeines Krankenhaus Wien, Vienna, Austria|CUB Hopital Erasme, Brussels, Belgium|UZ Brussel, Brussel, Belgium|Universitaire Ziekenhuizen Leuven, Leuven, Belgium|Hospital das Clínicas da Faculdade de Medicina de Botucatu - FMB/Universidade Estadual Paulista Julio de Mesquita Filho - UNESP, Botucatu, Brazil|Hospital de Clínicas de Porto Alegre - HCPA/UFRGS, Porto Alegre, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, Brazil|Hospital Das Clinicas Da Faculdade De Medicina Da Universidade De Sao Paulo, São Paulo, Brazil|Universidade Federal de São Paulo / Unidade Ambulatorial de Pesquisa Clínica - I (UAPC-I), São Paulo, Brazil|University of Calgary Liver Unit (Heritage Medical Research Clinic), Calgary, Alberta, Canada|University of Alberta Hospital - Walter C. Mackenzie Health Sciences Centre (WMC), Edmonton, Alberta, Canada|LAIR Centre, Vancouver, British Columbia, Canada|Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada|(G.I.R.I.) GI Research Institute, Vancouver, British Columbia, Canada|PerCuro Clinical Research Ltd., Victoria, British Columbia, Canada|South Shore Medical Arts, Bridgewater, Nova Scotia, Canada|William Osler Health System-Brampton Civic Hospital, Brampton, Ontario, Canada|South Shore Medical Arts, London, Ontario, Canada|Toronto Center for Liver Diseases (TCLD), Toronto General Hospital, Toronto, Ontario, Canada|Chronic Viral Illness Service/Royal Victoria Hospital/McGill University Health Centre (MUHC), Montréal, Quebec, Canada|Centre Hospitalier Universitaire d'Angers, Angers, France|Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, France|Hopital Henri Mondor, Créteil, France|CHU de Grenoble- Hopital Michallon, Grenoble, France|Centre Hospitalier Regional Universitaire- Hopital Claude Huriez, Lille, France|CHU de Limoges- Hopital Dupuytren- Federation Hepatologie, Limoges, France|Hopital de la Croix Rousse, Lyon, France|Hôpital Saint Joseph, Marseille, France|Centre Hospitalier Universitaire de Nice- Hopital l'Archet 2, Nice, France|Hopital Cochin, Paris, France|Hopital Beaujon, Pessac, France|Centre Hospitalier Universitaire de Bordeaux, Pessac, France|Centre Hospitalier Universitaire de Strasbourg- Nouvel Hopital Civil, Strasbourg, France|Centre Hospitalier Universitaire de Toulouse- Hopital Purpan, Toulouse, France|Hopital Paul Brousse, Villejuif, France|Uniklinik RWTH Aachen, Medizinische Klinik III, Aachen, Germany|Zentrum fur Infektiologie Berlin Prenzlauer Berg GmbH (zibp), Berlin, Germany|Universitatsklinikum Bonn (AoR), Bonn, Germany|Universitatsklinikum Frankfurt der Goethe-Universitat, Frankfurt, Germany|Medizinische Hochschule Hannover, Hanover, Germany|Uniklinikum des Saarlandes- Klinik fur Innere Medizin II, Homburg, Germany|Gastroenterologisch- Hepatologisches Zentrum Kiel, Kiel, Germany|Eugastro Gmbh, Leipzig, Germany|Johannes Gutenberg-Universitat, Mainz, Germany|Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong|Tuen Mun Hospital, Tuen Mun, Hong Kong|Midas Multispecialty Hospital, Nagpur, Maharashtra, India|Institute of Post Graduate Medical Education and Research / SSKM Hospital, Kolkata, India|Kasturba Medical College (KMC) Hospital, Mangalore, India|Global Hospital-Super Speciality & Transplant Centre (A Unit of Centre for Digestive and Kidney Diseases (India) Pvt. Ltd.), Mumbai, India|Maharaja Agrasen Hospital, New Delhi, India|All India Institute of Medical Sciences, New Delhi, India|Fortis Flt. Lt. Rajan Dhall Hospital, New Delhi, India|Institute of Liver & Biliary Sciences, New Delhi, India|Rambam Health Care Campus, Haifa, Israel|The Lady Davis Carmel Medical Center, Haifa, Israel|Holy Family hospital, Nazaret, Israel|The Chaim Sheba Medical Center, Ramat Gan, Israel|Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|IRCCS Ospedale Casa Sollievo Della Soferrenza, San Giovanni Rotondo, Italy|Chiba University Hospital, Chiba, Japan|Fukui-Ken Saiseikai Hospital, Fukui-shi, Japan|Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan|Hiroshima University Hospital, Hiroshima, Japan|Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan|Juntendo University Shizuoka Hospital, Izunokuni, Japan|Kagoshima University Medical And Dental Hospital, Kagoshima, Japan|Kanazawa University Hospital, Kanagawa, Japan|Nara Medical University Hospital, Kashihara, Japan|Toranomon Hospital Kajigaya, Kawasaki, Japan|Shinkokura Hospital, Kitakyushu, Japan|Kumamoto Shinto General Hospital, Kumamoto, Japan|Kurume University Hospital, Kurume, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan|Shinshu University Hospital, Matsumoto, Japan|Toranomon Hospital, Minato, Japan|Miyazaki Medical Center Hospital, Miyazaki, Japan|Japanese Red Cross Musashino Hospital, Musashino, Japan|Aichi Medical University Hospital, Nagakute, Japan|Heart Life Hospital, Nakagami, Japan|Nara City Hospital, Nara, Japan|Hyogo College of Medicine Hospital, Nishinomiya, Japan|Kawasaki Medical School General Medical Center, Okayama, Japan|Okayama University Hospital, Okayama, Japan|National Hospital Organization Osaka National Hospital, Osaka, Japan|Saga University Hospital, Saga, Japan|Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo, Japan|Tohoku Rosai Hospital, Sendai, Japan|National Center for Global Health and Medicine Hospital, Shinjuku-ku, Japan|Saiseikai Suita Hospital, Suita, Japan|Kagawa Prefectural Central Hospital, Takamatsu, Japan|Mie University Hospital, Tsu, Japan|Ehime University Hospital, Tōno, Japan|Yamagata University Hospital, Yamagata, Japan|Yokohama City University Hospital, Yokohama, Japan|National Hospital Organization Nagasaki Medical Center, Ōmura, Japan|Hirakata Kohsai Hospital, Ōsaka, Japan|Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Korea, Republic of|National Health Insurance Service- Ilsan Hospital, Goyang-si, Korea, Republic of|Hanyang University Seoul Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Chung-Ang University Hospital, Seoul, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wŏnju, Korea, Republic of|Hospital Selayang, Batu Caves, Malaysia|University of Malaya Medical Centre, Kuala Lumpur, Malaysia|Phylasis Clinicas Research S. de RL de CV., Cuautitlán, Mexico|Consultorio Médico, Mexico City, Mexico|Investigaciones Medicas Cisneros SC, Monterrey, Mexico|University Medical Center Utrecht, Utrecht, Netherlands|Auckland City Hospital, Grafton, New Zealand|Szpital Specjalistyczny Nr 1 w Bytomiu, Oddzial Obserwacyjno-Zakazny i Hepatologii, Bytom, Poland|Wojewodzki Specjalistyczny Szpital im. W. Bieganskiego, Łódź, Poland|Centro Hospitalar de Tras-os-Montes e Alto Douro, E.P.E, Vila Real, Portugal|Klinical Investigations Group, LLC, San Juan, Puerto Rico|VA Caribbean Healthcare System, San Juan, Puerto Rico|Fundacion de Investigacion de Diego, San Juan, Puerto Rico|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|Tan Tock Seng Hospital, Singapore, Singapore|Changi General Hospital Pte Ltd., Singapore, Singapore|Khoo Teck Puat Hospital, Singapore, Singapore|Hospital del Mar, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Puerto de Hierro Majadahonda, Majadahonda, Spain|CHOP_Complejo Hospitalrio Universitario de Pontevedra, Pontevedra, Spain|Hospital Universitario Marques de Valdecilla, Santander, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain|Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital, Hepatologie, Bern, Switzerland|Istituto Cantonale di Patologia Locarno, Lugano, Switzerland|Changhua Christian Hospital, Chang-hua, Taiwan|Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|E-DA Hospital, Kaohsiung, Taiwan|Chang Gung Medical Foundation, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan|Taichung Veterans General Hospital, Taichung, Taiwan|National Cheng Kung University Hospitalv, Tainan, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Mackay Memorial Hospital, Taipei, Taiwan|Cathay General Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Chang Gung Medical Foundation, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Derby Teaching Hospitals NHS FT, Derby, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Edgbaston, United Kingdom|King's College Hospital NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom|Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom|Abertawe Bro Morgannwg University Health Board, Swansea, United Kingdom","https://ClinicalTrials.gov/show/NCT03053050"
95,"Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)","Completed","No Results Available","Nonalcoholic Steatohepatitis","Drug: SEL|Drug: Firsocostat|Drug: Cilofexor|Drug: SEL Placebo|Drug: Firsocostat Placebo|Drug: Cilofexor Placebo","Gilead Sciences","Phase 2","395","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 21, 2018","November 19, 2019","The Institute for Liver Health, Chandler, Arizona, United States|Mayo Clinic Arizona, Mayo Clinic Hospital, Phoenix, Arizona, United States|Liver Wellness Center, Little Rock, Arkansas, United States|Arkansas Gastroenterology, North Little Rock, Arkansas, United States|eStudySite, Chula Vista, California, United States|Southern California Liver Center, Coronado, California, United States|Fresno Clinical Research Center, Fresno, California, United States|UCSD NAFLD Clinical Research Center, La Jolla, California, United States|Ruane Clinical Research Group Inc., Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|California Liver Research Institute, Pasadena, California, United States|Huntington Medical Research Institutes Liver Center, Pasadena, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|University of California, Davis Medical Center (study visits), Sacramento, California, United States|Medical Associates Research Group, San Diego, California, United States|South Denver Gastroenterology, PC, Englewood, Colorado, United States|Integrity Clinical Research, Doral, Florida, United States|UF Hepatology Research at CTRB, Gainesville, Florida, United States|Schiff Center for Liver Diseases/University of Miami, Miami, Florida, United States|IMIC Inc, Miami, Florida, United States|Genoma Research Group, Miami, Florida, United States|Florida Research Institute, Tampa, Florida, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|Piedmont Hospital, Atlanta, Georgia, United States|Gastrointestinal Diseases Research, Columbus, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Northwestern University; Feinberg School of Medicine, Chicago, Illinois, United States|Indianapolis Gastroenterology Research Foundation, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, P.C., Clive, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Delta Research Partners, LLC, Bastrop, Louisiana, United States|Tulane University, New Orleans, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Henry Ford Health Systems, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Southern Therapy and Advanced Research (STAR) LLC, Ridgeland, Mississippi, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Saint Louis University, Saint Louis, Missouri, United States|Jubilee Clinical Research, Inc., Las Vegas, Nevada, United States|Rutgers New Jersey Medical School- Doctors Office Center, Newark, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|Sandra Atlas Bass Center for Liver Diseases and Transplantation, Manhasset, New York, United States|Icahn School of Medicine at Mount Sinai Beth Israel, New York, New York, United States|Concorde Medical Group, PLLC, New York, New York, United States|NYU Langone Health, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Carolinas Healthcare System Center for Liver Disease and Transplant, Charlotte, North Carolina, United States|Duke University Medical Center, Duke South Clinics, Durham, North Carolina, United States|Cumberland Research Associates, LLC, Fayetteville, North Carolina, United States|Consultants for Clinical Research wed, Cincinnati, Ohio, United States|Hospital of the University of Pennsylvania- Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute, Pittsburgh, Pennsylvania, United States|VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|Medical University of South Carolina (Liver Biopsy), Charleston, South Carolina, United States|GHS Gastroenterology and Liver Center, Greenville, South Carolina, United States|Gastro One, Germantown, Tennessee, United States|Quality Medical Research, PLLC, Nashville, Tennessee, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, United States|Pinnacle Clinical Research, PLLC, Austin, Texas, United States|Austin Center for Clinical Research, Austin, Texas, United States|The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States|University of Texas Southwestern Medical Center Internal Medicine Digestive and Liver Diseases Clinical Trials, Dallas, Texas, United States|Baylor College of Medicine - Advanced Liver Therapies, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Pinnacle Clinical Research, Live Oak, Texas, United States|American Research Corporation at Texas Liver Institute, San Antonio, Texas, United States|Intermountain Liver Disease and Transplant Center, Murray, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|University of Virginia Medical Center, Charlottesville, Virginia, United States|California Pacific Medical Center - Sutter Pacific Medical Foundation San Francisco Center for Liver Disease Dept. of Transplant, Falls Church, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Bon Secours Richmond Community Hospital, Inc. d/b/a Bon Secours Liver Institute of Richmond, Richmond, Virginia, United States|McGuire DVAMC, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish Organ Transplant and Liver Center, Seattle, Washington, United States|Royal Brisbane & Women's Hospital, Herston, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Monash Health, Monash Medical Centre, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|Royal Prince Alfred Hospital, Camperdown, Australia|St Vincent's Hospital Sydney, Darlinghurst, Australia|Austin Health, Heidelberg, Australia|The Alfred Hospital, Alfred Health, Melbourne, Australia|Westmead Hospital, Westmead, Australia|William Osler Health System-Brampton Civic Hospital, Brampton, Canada|University of Calgary Liver Unit (Heritage Medical Research Clinic), Calgary, Canada|Chronic Viral Illness Service McGill University Health Centre (MUHC)/ Royal Victoria Hospital, Montreal, Canada|Toronto General Hospital, Toronto, Canada|Toronto Liver Centre, Toronto, Canada|Prince of Wales Hospital, Shatin, Hong Kong|Auckland City Hospital, Auckland, New Zealand|Fundacion de Investigacion de Diego, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT03449446"
96,"Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis","Completed","No Results Available","Cirrhosis, Liver","Drug: Rifaximin 550 mg twice a day and Norfloxacin 400 mg once a day","Postgraduate Institute of Medical Education and Research","Phase 3","142","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","January 1, 2016","June 30, 2017",,"https://ClinicalTrials.gov/show/NCT03695705"
97,"Simvastatin Plus Rifaximin in Decompensated Cirrhosis","Completed","No Results Available","Cirrhoses, Liver","Drug: Simvastatin 20 mg|Drug: Simvastatin 40mg|Drug: Rifaximin 400 mg|Other: Placebo of Simvastatin|Other: Placebo of Rifaximin","Judit Pich|Institut d'Investigacions Biomèdiques August Pi i Sunyer","Phase 2","44","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 26, 2017","March 12, 2018","Beajuon Hospital, Clichy, Paris, France|Universitatsklinikum Bonn, Bonn, Germany|Bologna University Hospital, Bologna, Italy|Padova University Hospital, Padova, Italy|San Giovanni Battista Hospital, Torino, Italy|Academic Medical Centre, Amsterdam, Netherlands|Hospital Universitari Vall d'Hebrón, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Royal Free Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT03150459"
98,"Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)","Completed","No Results Available","Inflammation|Fibrosis|Insulin Resistance","Dietary Supplement: Vitamin treatment (alpha tocopherol plus ascorbic acid)|Dietary Supplement: Placebo","Bambino Gesù Hospital and Research Institute","Phase 2|Phase 3","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 2003","October 2006","Dept. Of HepatoGastoEnterology and Nutrition, Liver Unit, Rome, Italy","https://ClinicalTrials.gov/show/NCT00655018"
99,"Trial of Faecal Microbiota Transplantation in Cirrhosis","Recruiting","No Results Available","Cirrhosis of the Liver","Biological: Faecal microbiota transplantation|Biological: Placebo","King's College London|King's College Hospital NHS Trust","Phase 3","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other","March 27, 2018","August 2020","King's College Hospital NHS Foundation Trust, London, United Kingdom","https://ClinicalTrials.gov/show/NCT02862249"
100,"Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone","Terminated","No Results Available","Liver Cirrhosis","Drug: Dexamethasone|Drug: Placebo","University Hospital Inselspital, Berne|University Hospital, Geneva|University of Lausanne Hospitals","Phase 3","2","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","February 2011","November 2011","University Hospital Lausanne, Lausanne, Vaud, Switzerland|University Hospital Inselspital, Bern, Switzerland|University Hospital Geneva, Geneva, Switzerland","https://ClinicalTrials.gov/show/NCT01311167"
101,"Efficacy of Baclofen in the Treatment of Alcohol Addiction","Completed","No Results Available","Liver Cirrhosis, Alcoholic","Drug: Baclofen|Drug: placebo","Catholic University of the Sacred Heart","Phase 1|Phase 2","86","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 2003","November 2006",,"https://ClinicalTrials.gov/show/NCT00525252"
102,"A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients","Completed","Has Results","Liver Cirrhosis","Drug: conivaptan|Drug: Placebo","Cumberland Pharmaceuticals","Phase 2","20","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 2007","November 2008","Barcelona, Spain","https://ClinicalTrials.gov/show/NCT00592475"
103,"Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.","Not yet recruiting","No Results Available","Cirrhosis, Liver|Ascites Hepatic","Drug: Ularitide|Drug: Placebo","University of Aarhus|Aarhus University Hospital|ADS AIPHIA Development Services AG","Phase 2","38","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","August 1, 2020","August 31, 2023","Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Central Denmark Region, Denmark","https://ClinicalTrials.gov/show/NCT04311489"
104,"Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure","Withdrawn","No Results Available","Fibrosis|Renal Failure|Hepatorenal Syndrome","Drug: Albumin|Drug: Midodrine|Drug: Octreotide","Anna Cruceta|Fundacion Clinic per a la Recerca Biomédica","Phase 2","0","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","July 2016","August 2017","Hospital Clinic i Provincial de Barcelona, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT01587222"
105,"Safety and Efficacy of SHED for Decompensated Liver Cirrhosis","Not yet recruiting","No Results Available","Liver Cirrhosis","Biological: SHED group","Changhai Hospital|Eastern Hepatobiliary Surgery Hospital|CAR-T (Shanghai) Biotechnology Co., Ltd.","Early Phase 1","40","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","December 2, 2019","December 31, 2021","Changhai Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT03957655"
106,"Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury","Completed","No Results Available","Cirrhosis, Liver|AKI","Drug: Dextran 40","Ramathibodi Hospital","Phase 2|Phase 3","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","July 1, 2015","June 30, 2016",,"https://ClinicalTrials.gov/show/NCT03070353"
107,"Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis","Recruiting","No Results Available","Cirrhosis","Other: Laboratory Biomarker Analysis|Other: Placebo Administration|Other: Questionnaire Administration|Drug: Simvastatin","National Cancer Institute (NCI)","Phase 2","80","NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","June 21, 2017","April 14, 2021","Cedars Sinai Medical Center, Los Angeles, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Northwestern University, Chicago, Illinois, United States|University of Puerto Rico, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT02968810"
108,"Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment","Active, not recruiting","No Results Available","Non Alcoholic Steatohepatitis (NASH)","Drug: Obeticholic Acid|Drug: Placebo","Intercept Pharmaceuticals","Phase 3","2480","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 2015","October 2022","The University of Alabama at Birmingham, Birmingham, Alabama, United States|Digestive Health Specialists of the Southeast, Dothan, Alabama, United States|Institute for Liver Health, Chandler, Arizona, United States|Banner Advanced Liver Disease and Transplant Institute, Phoenix, Arizona, United States|St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic Arizona, Phoenix, Arizona, United States|Liver Wellness Center, Little Rock, Arkansas, United States|Arkansas Gastroenterology, North Little Rock, Arkansas, United States|GW Research Inc., Chula Vista, California, United States|Precision Research Institute, Chula Vista, California, United States|eStudy Site, Chula Vista, California, United States|Southern California Research Center, Coronado, California, United States|Citrus Valley Gastroenterology, Covina, California, United States|TriWest Research Associates, LLC, El Cajon, California, United States|UCSF Fresno, Clinical Research Center, Fresno, California, United States|Fresno Clinical Research Center, Fresno, California, United States|Scripps Clinic, La Jolla, California, United States|University of California, San Diego, La Jolla, California, United States|Keck Medical Center of USC, Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|National Research Institute, Wilshire, Los Angeles, California, United States|Gastrointestinal Biosciences, Los Angeles, California, United States|Veteran Affairs Great Los Angeles Healthcare System, Los Angeles, California, United States|Stanford University, Palo Alto, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|University of California Davis Medical Center, Sacramento, California, United States|Medical Associates Research Group, San Diego, California, United States|Kaiser Permanente, San Diego, California, United States|California Pacific Medical Center (CPMC), San Francisco, California, United States|University of California San Francisco (UCSF) / San Francisco General Hospital, San Francisco, California, United States|Quest Clinical Research, San Francisco, California, United States|University of California, San Francisco, San Francisco, California, United States|Silicon Valley Research Institute, San Jose, California, United States|University of Colorado Denver and Hospital, Aurora, Colorado, United States|South Denver Gastroenterology, PC, Englewood, Colorado, United States|Western States Clinical Research, Inc., Wheat Ridge, Colorado, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Integrity Clinical Research, LLC, Doral, Florida, United States|UF Hepatology Research at CTRB, Gainesville, Florida, United States|Nature Coast Clinical Research, Inverness, Florida, United States|UF Health Jacksonville-Gastroenterology Emerson, Jacksonville, Florida, United States|Mayo Clinic, Jacksonville, Florida, United States|Florida Digestive Health Specialist Research Institute, Lakewood Ranch, Florida, United States|Sunrise Medical Research, Inc., Lauderdale Lakes, Florida, United States|Meridien Research, Maitland, Florida, United States|Bruce W. Carter Miami VA Medical Center, Miami, Florida, United States|Schiff Center for Liver Diseases, Miami, Florida, United States|ProLive Medical Research, Miami, Florida, United States|Janus Clinical Research, Inc., Miami, Florida, United States|Sensible Healthcare, LLC, Ocoee, Florida, United States|Florida Hospital Transplant Institute, Orlando, Florida, United States|South Florida Center of Gastroenterology, P.A., Wellington, Florida, United States|Florida Medical Clinic, P.A., Zephyrhills, Florida, United States|Summit Clinical Research, LLC, Athens, Georgia, United States|Digestive Healthcare of Georgia, Atlanta, Georgia, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|The Emory Clinic (TEC), Atlanta, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|The Queen's Medical Center - Liver Center, Honolulu, Hawaii, United States|Grand Teton Research Group, Idaho Falls, Idaho, United States|Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Indiana University Health University Hospital, Indianapolis, Indiana, United States|Indianapolis Gastroenterology & Hepatology, Indianapolis, Indiana, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|The Medical Center of Bowling Green, Bowling Green, Kentucky, United States|University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States|University of Louisville Medical, Clinical Trials Unit, Louisville, Kentucky, United States|Tulane Medical Center, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Louisiana Research Center, LLC, Shreveport, Louisiana, United States|Investigative Clinical Research, Annapolis, Maryland, United States|Mercy Medical Center, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Gastroenterology Associates of Western Michigan, d.b.a West Michigan Clinical Research, Wyoming, Michigan, United States|Huron Gastroenterology Associates/Center for Digestive Care, Ypsilanti, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Minnesota Gastroenterology, Saint Paul, Minnesota, United States|Southern Therapy and Advanced Research, LLC, Jackson, Mississippi, United States|Kansas City VA Medical Center, Kansas City, Missouri, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Saint Louis University Gastroenterology & Hepatology, Saint Louis, Missouri, United States|Washington University School of Medicine - Gastroenterology, Saint Louis, Missouri, United States|CHI Health Alegent Creighton Clinic Gastroenterology, Omaha, Nebraska, United States|AGA Clinical Research Associates, LLC, Egg Harbor Township, New Jersey, United States|Amici Clinical Research, Martinsville, New Jersey, United States|Amici GI - LLC, Martinsville, New Jersey, United States|Rutgers University New Jersey Medical School, Newark, New Jersey, United States|AccumetRx Clinical Research, Albuquerque, New Mexico, United States|Montefiore Medical Center, Bronx, New York, United States|University at Buffalo, Clinical and Translational Research Center, Buffalo, New York, United States|Mount Sinai Beth Israel, New York, New York, United States|Concorde Medical Group PLLC, New York, New York, United States|New York University (NYU) Langone Medical Center, New York, New York, United States|Icahn School of Medicine at Mt. Sinai, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Asheville Gastroenterology Associates, PA, Asheville, North Carolina, United States|University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States|Center for Liver Disease, Charlotte, North Carolina, United States|Charlotte Gastroenterology & Hepatology, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Cumberland Research Associates, LLC, Fayetteville, North Carolina, United States|Carolinas Center for Liver Disease/Carolinas HeatlhCare System, Huntersville, North Carolina, United States|Digestive Health Specialists, PA, Winston-Salem, North Carolina, United States|Consultants for Clinical Research, Cincinnati, Ohio, United States|University of Cincinnati, Cincinnati, Ohio, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Clinical Research Solutions, Middleburg Heights, Ohio, United States|INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma, United States|Doylestown Health Gastroenterology, Doylestown, Pennsylvania, United States|Hillmont GI, pc, Flourtown, Pennsylvania, United States|The Pennsylvania State University and The Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Drexel University, Philadelphia, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Einstein Healthcare Network, Philadelphia, Pennsylvania, United States|UPMC, Pittsburgh, Pennsylvania, United States|University Gastroenterology, Providence, Rhode Island, United States|Greenville Health System, Gastroenterology and Liver Center, Greenville, South Carolina, United States|Rapid City Medical Center, Rapid City, South Dakota, United States|WR-ClinSearch, LLC, Chattanooga, Tennessee, United States|Gastro One, Germantown, Tennessee, United States|Associates in Gastroenterology, PLC, Hermitage, Tennessee, United States|Clinical Research Solutions, Jackson, Tennessee, United States|East Tennesse Research Institute, Johnson City, Tennessee, United States|Methodist Healthcare, University Hospital, Memphis, Tennessee, United States|Nashville Gastrointestinal Specialists, Nashville, Tennessee, United States|Quality Medical Research, PLLC, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States|Liver Center of Texas, Dallas, Texas, United States|Texas Digestive Disease Consultants, Dallas, Texas, United States|UT Southwestern Medical Center, Dallas, Texas, United States|MedResearch, Inc., El Paso, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|Baylor Scott & White All Saints Medical Center, Fort Worth, Texas, United States|Texas Digestive Disease Consultants, Fort Worth, Texas, United States|Baylor College of Medicine Ben Taub General Hospital, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Liver Associates of Texas, P.A., Houston, Texas, United States|The University of Texas Health Science Center at Houston-Medical School IM-Division of Gastroenterology, Hepatology & Nutrition, Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Centex Studies, Inc., McAllen, Texas, United States|American Research Corporation at the Texas Liver Institute, San Antonio, Texas, United States|Gastroenterology Consultants of San Antonio, San Antonio, Texas, United States|Texas Digestive Disease Consultants - San Marcos, San Marcos, Texas, United States|University of Utah Hospital, Salt Lake City, Utah, United States|The University of Vermont Medical Center - Smith 2, Burlington, Vermont, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Bon Secours St. Mary's Hospital, Richmond, Virginia, United States|McGuire DVAMC GI, Richmond, Virginia, United States|Virginia Commonwealth University Clinical Research Services Unit (CRSU), Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish Organ Transplant and Liver Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|University of Wisconsin Hospital & Clinics, Madison, Wisconsin, United States|Royal Adelaide Hospital Gastroenterology and Hepatology Dept., Adelaide, Australia|Flinders Medical Centre, Bedford Park, Australia|Royal Brisbane and Women's Hospital, Brisbane, Australia|Gallipoli Medical Research Foundation, Brisbane, Australia|AW Morrow Gastroenterology and Liver Centre Royal Prince Alfred Hospital, Camperdown, Australia|Monash Health - Monash Medical Centre, Clayton, Australia|Austin Hospital, Heidelberg, Australia|Nepean Hospital, Kingswood, Australia|The Alfred Hospital, Department of Gastroenterology, Melbourne, Australia|Fiona Stanley Hospital, Murdoch, Australia|The Royal Melbourne Hospital, Parkville, Australia|Westmead Hospital, Westmead, Australia|Medizinische Universität Innsbruck Universitätsklinik für Innere Medizin I Gastroenterologie und Hepatologie, Innsbruck, Austria|Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria|Ordensklinikum Linz GmbH, Linz, Austria|Uniklinikum Salzburg, Salzburg, Austria|Medizinische Universität Wien, Wien, Austria|UZ Antwerpen, Edegem, Antwerp, Belgium|ULB Hȏpital Erasme - Gastroenterology, Brussels, Brabant, Belgium|UZ Leuven Campus Gathuisberg Hepatology Department, Leuven, Vlaams-Brabant, Belgium|AZ Sint-Jan Brugge Oostende, Brugge, Belgium|UCL Saint-Luc - Hepatology Department, Brussels, Belgium|Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium|UZ Gent Gastroenterology Department, Ghent, Belgium|AZ Nikolaas, Sint-Niklaas, Belgium|University of Alberta, Edmonton, Alberta, Canada|University of Calgary Liver Unit, Calgary, Canada|GI Research, Edmonton, Canada|London Health Sciences Centre University Hospital, London, Canada|Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Canada|The Research Institute of the McGill University Health Centre, Montreal, Canada|Toronto Center for Liver Disease, Toronto, Canada|Toronto Liver Centre, Toronto, Canada|Gordon and Leslie Diamond Health Care Centre, Vancouver, Canada|GIRI - GI Research Institute, Vancouver, Canada|PerCuro Clinical Research, Victoria, Canada|John Buhler Research Centre, Winnipeg, Canada|Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital Medicinsk Hepatogastroenterologisk Afdeling, Aarhus, Denmark|Copenhagen University Hospital Hvidovre, Hvidovre, Denmark|Odense University Hospital, Odense, Denmark|Helsinki University Hospital, Helsinki, Finland|Turku University Hospital, Turku, Finland|CHU Amiens Picardie, Amiens, France|CHU Angers-Service d'Hepato-Gastroenterologie, Angers, France|Centre hospitalier Pierre Oudot, Bourgoin-Jallieu, France|CHU Beaujon-Service d'Hépatologie, Clichy, France|Hôpital Henri Mondor - Service d'hépatologie, Creteil, France|CHU Grenoble, Grenoble, France|CHRU Hôpital Claude Huriez, Lille, France|Hôpital de la Croix Rousse, Lyon, France|Hôpital Saint Joseph, Marseille, France|Hôpital de l'Archet II-CHU Nice, Nice, France|Service d'Hepato-Gastroenterologie CHR Orleans - La Source, Orléans, France|Hospital Saint Antoine Department of Hepatology, Paris, France|Hôpital Cochin, Paris, France|Hôpital de la Pitié Salpétrère, Paris, France|Hopital Haut-Lévêque-Hépatogastroentérologie-Bât USN, Pessac, France|CHU de Rouen, Rouen, France|CHU Toulouse - Hopital de Purpan, Toulouse, France|CHU de Nancy - Hôpital de Brabois adultes, Vandoeuvre-Lès-Nancy, France|Hopital Paul Brousse, Villejuif, France|Universitätsklinikum Heidelberg Medizinischen Klinik IV Gastroenterologie und Hepatologie, Heidelberg, Baden-Wurttemberg, Germany|Friedrich-Alexander-Universität Erlangen Medizinische Klinik 1, Erlangen, Bavaria, Germany|Universitätsmedizin Mainz, I. Med. Klinik und Poliklinik, Mainz, Rhineland-Palatinate, Germany|Universitätsklinikum Leipzig Klinik für Gastroenterologie und Rheumatologie-Sektion Hepatologie, Leipzig, Saxony, Germany|Universitatsklinikum Aachen, RWTH Aachen, Medizinische Klinik III, Aachen, Germany|Charite Universitätsmedizin Campus Virchow, Berlin, Germany|St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany|Universtiy Hosptial Cologne Clinics for Gastroenterology and Hepatology, Cologne, Germany|Katholische Kliniken Ruhrhalbinsel GmbH, Essen, Germany|University Hospital Essen, Essen, Germany|Universitätsklinikum Hamburg- Eppendorf, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Gastroenterologische Gemeinschaftspraxis, Herne, Germany|Hepato-Gastroenterology Center Kiel, Kiel, Germany|EUGASTRO GmbH, Leipzig, Germany|Krankenhaus Barmherzige Bruder Innere Medizin I - Gastroenterologie, Munich, Germany|Universitätsklinikum Würzburg, Würzburg, Germany|Egyesitett Szent Istvan és Szent Laszlo, Budapest, Hungary|Kenezy Gyula Korhaz es Rendelointezet, Debrecen, Hungary|Pecsi Tudomanyegyetem Klinikai Kozpont, I. sz, Pécs, Hungary|Soroka Medical Center Division of Internal Medicine, Be'er Sheva, Israel|Carmel Medical Center, Haifa, Israel|Rambam Medical Center Center for Liver diseases, Haifa, Israel|Shaarei Zedek Medical Center, Jerusalem, Israel|Hadassah Ein Kerem MC, Jerusalem, Israel|West Galilee Hospital, Nahariya, Israel|Holy Family Medical Center, Nazareth, Israel|Rabin Medical Center, Liver Institute, Petach Tikva, Israel|Sheba Medical Center, Ramat Gan, Israel|Sourasky Tel-Aviv Medical Center, Tel Aviv, Israel|AOU Policlinico Sant'Orsola Malpighi, Bologna, Italy|University di Bologna - Dipartimento di Scienze Mediche e Chirurgiche — DIMEC, Bologna, Italy|Fondazione IRCCS Ca Granda Ospedale, Milano, Italy|Azienda Socio-Sanitaria Territoriale (ASST) Santi Paolo e Carlo, Milano, Italy|Fondazione IRCCS Ca' Grande Ospedale, Milano, Italy|Ospedale san Giuseppe - Multimedica, Milan, Italy|AOU di Modena Ospedale Civile, Modena, Italy|Azienda Ospedaliero Universitaria Policlinico, Naples, Italy|Policlinico Paolo Giaccone di Palermo, Palermo, Italy|University of Tor Vergata (Roma), Roma, Italy|Policlinico University Campus Biomedico, Rome, Italy|Istituto Clinico Humanitas, Rozzano, Italy|A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy|Vrije Universiteit Medisch centrum, Amsterdam, Netherlands|University of Amsterdam, Amsterdam, Netherlands|Radboud University Nijmegen Medical Center, Nijmegen, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|NZ Liver Transplant Unit, Grafton, Auckland, New Zealand|Middlemore Hospital, Auckland, New Zealand|Centrum Badan Klinicznych PI-House Sp. z o.o., Gdansk, Poland|Uniwersyteckie Centrum Kliniczne im. Prof K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowicach, Katowice, Poland|Wojewodzki Specjalistyczny Szpital im. Dr WI. Bieganskiego, Lodz, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 1, Lublin, Poland|Centrum Badan Klinicznych Piotr Napora, Wroclaw, Poland|Centro Hospitalar do Baixo Vouga, EPE, Aveiro, Portugal|Hospital da Senhora da Oliveira - Guimarães, Guimarães, Portugal|Centro Hospitalar de Lisboa Norte, EPE - Hosp. de Santa Maria, Lisboa, Portugal|Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal|Klinical Investigations Group, LLC, San Juan, Puerto Rico|Ave Ponce De Leon #715, San Juan, Puerto Rico|Fundacion de Investigacion, San Juan, Puerto Rico|Clinical Center of Serbia, Belgrade, Serbia|University Medical Centar Zvezdara, Belgrade, Serbia|Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia|Clinical Center Nis, Nis, Serbia|Hospital Universitari Son Espases, Palma de Mallorca, Baleares, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Fundación Alcorcon, Alcorcón, Spain|Hospital General y Universitario de Alicante, Alicante, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Clinic(o) de Barcelona, Barcelona, Spain|Complejo Asistencial Universitario de Leon, Leon, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital (Universitario) Virgen de la Victoria, Malaga, Spain|Hospital Universitario Donostia, San Sebastian, Spain|Hospital (Universitario) Marqués de Valdecilla, Santander, Spain|Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Consorcio Hospital General Universitario, Valencia, Spain|Hospital Universitario La Fe., Valencia, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Sahlgrenska University Hospital, Gothenburg, Sweden|Universitetsjukhuset Linkoping, Linkoping, Sweden|Karolinska University Hospital, Stockholm, Sweden|UVCM Hepatologie, Bern, Switzerland|Epatocentro Ticino, Lugano, Switzerland|Hospital of St. Gallen, St.Gallen, Switzerland|University Clinic of Gastroenterology & Hepatology, Zürich, Switzerland|Royal Cornwall Hospital, Truro, Cornwall, United Kingdom|Royal Bournemouth Hospital, Bournemouth, Dorset, United Kingdom|Queen Alexandra Hospital, Portsmouth, Hampshire, United Kingdom|Norfolk and Norwich University Hospitals, Norwich, Norfolk, United Kingdom|John Radcliffe Hospital, Headington, Oxford, United Kingdom|Royal Surrey County Hospital NHS Trust, Guildford, Surrey, United Kingdom|Institute of Biomedical Research, Birmingham, United Kingdom|Bradford Royal Infirmary, Bradford, United Kingdom|University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom|Cambridge University Hospital, Cambridge, United Kingdom|University Hospitals Coventry & Warwickshire, Coventry, United Kingdom|Glasgow Royal Infirmary, NHS Greater, Glasgow, United Kingdom|Gastroenterology Department Hull Royal Infirmary, Hull, United Kingdom|University Hospital Aintree, Liverpool, United Kingdom|Royal London Hospital, London, United Kingdom|Institute for Liver and Digestive Health, London, United Kingdom|Guy's and St. Thomas NHS Foundation Trust, London, United Kingdom|St. Mary's Hospital, London, United Kingdom|Central Manchester University Hospital NHS Foundation Trust Manchester Royal Infirmary, Manchester, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom|Nottingham Digestive Diseases and Biomedical Research Unit, Nottingham, United Kingdom|Derriford Hospital, Plymouth, United Kingdom","https://ClinicalTrials.gov/show/NCT02548351"
109,"Human Fetal Liver Cell Transplantation in Chronic Liver Failure","Completed","Has Results","Liver Cirrhosis","Other: Human Fetal Liver Cell Transplantation","The Mediterranean Institute for Transplantation and Advanced Specialized Therapies|University of Pittsburgh","Phase 1|Phase 2","25","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","February 2007","July 2011","ISMETT, Palermo, Italy","https://ClinicalTrials.gov/show/NCT01013194"
110,"A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)","Recruiting","No Results Available","Non-Alcoholic Steatohepatitis (NASH)|Type2 Diabetes Mellitus","Biological: Oral Insulin","Oramed, Ltd.|Hadassah Medical Organization","Phase 2","30","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","September 20, 2018","April 2020","Hadassah Medical Center, Jerusalem, Israel","https://ClinicalTrials.gov/show/NCT02653300"
111,"Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis","Completed","No Results Available","Alcoholic Liver Cirrhosis","Biological: Allogeneic Mesenchymal Stem Cells","Stempeutics Research Pvt Ltd","Phase 2","40","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","June 2012","April 2016","Centre for Liver Research & Diagnostics, Hyderabad, Andhra Pradesh, India|Mediciti Hospital, Hyderabad, Andhra Pradesh, India|Manipal Hospital, Bangalore, Karnataka, India|KMC Hospital, Mangalore, Karnataka, India|Institute of liver disease, HPB surgery and transplant Global Hospitals, Mumbai, Maharashtra, India|Bombay Hospital & Medical Research Center, Mumbai, Maharashtra, India|Ruby Hall clinic, Pune, Maharashtra, India|Sahyadri Speciality Hospital, Pune, Maharashtra, India|SMS Medical college and Hospital, Jaipur, Rajasthan, India|SGPGI Lucknow, Lucknow, Uttar Pradesh, India","https://ClinicalTrials.gov/show/NCT01591200"
112,"Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)","Completed","No Results Available","Ascites|Liver Cirrhosis","Drug: Satavaptan|Drug: placebo","Sanofi","Phase 3","463","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 2006","December 2008","Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States|Sanofi-Aventis Administrative Office, Buenos Aires, Argentina|Sanofi-Aventis Administrative Office, Cove, New South Wales, Australia|Sanofi-Aventis Administrative Office, Diegem, Belgium|Sanofi-Aventis Administrative Office, Sao Paulo, Brazil|Sanofi-Aventis Administrative Office, Laval, Quebec, Canada|Sanofi-Aventis Administrative Office, Santiago, Chile|Sanofi-Aventis Administrative Office, Zagreb, Croatia|Sanofi-Aventis Administrative Office, Horsholm, Denmark|Sanofi-Aventis Administrative Office, Paris, France|Sanofi-Aventis Administrative Office, Budapest, Hungary|Sanofi-Aventis Administrative Office, Natanya, Israel|Sanofi-Aventis Administrative Office, Milano, Italy|Sanofi-Aventis Administrative Office, Gouda, Netherlands|Sanofi-Aventis Administrative Office, Warszawa, Poland|Sanofi-Aventis Administrative Office, Porto Salvo, Portugal|Sanofi-Aventis Administrative Office, Bucuresti, Romania|Sanofi-Aventis Administrative Office, Moscow, Russian Federation|Sanofi-Aventis Administrative Office, Madrid, Spain|Sanofi-Aventis Administrative Office, Bromma, Sweden|Sanofi-Aventis Administrative Office, Guildford, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT00358878"
113,"REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)","Completed","No Results Available","Alcoholic Liver Cirrhosis","Biological: Livercellgram","Pharmicell Co., Ltd.","Phase 2","72","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","November 2012","March 2016","Pharmicell Co., Ltd., Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT01875081"
114,"Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial","Completed","No Results Available","Liver Failure|Cirrhosis","Procedure: injection of progenitor of hepatocyte drived from Mesenchymal stem cell","Shahid Beheshti University of Medical Sciences|Tarbiat Modarres University","Phase 1|Phase 2","30","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single|Primary Purpose: Treatment","February 2006","June 2009","Research Center for Gastroenterology and Liver Diseases, Tehran, Iran, Islamic Republic of|Research center of Gastroenterology and Liver Disease, Tehran, Iran, Islamic Republic of","https://ClinicalTrials.gov/show/NCT00420134"
115,"Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC","Recruiting","No Results Available","Alcoholic Liver Cirrhosis","Biological: Cellgram™ (Bone marrow-derived MSCs)","Pharmicell Co., Ltd.","Phase 1","10","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","June 20, 2019","June 2021","University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT03838250"
116,"Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis","Completed","Has Results","Cirrhosis","Device: BreathID (Methacetin breath test)","Virginia Commonwealth University|Exalenz Bioscience LTD.","Phase 3","165","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","March 2010","July 2012","Henry Ford Health System, Detroit, Michigan, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Virginia Commonwealth University Medical Center, Richmond, Virginia, United States|Hadassah Medical Center, Jerusalem, Israel","https://ClinicalTrials.gov/show/NCT01157845"
117,"Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects","Withdrawn","No Results Available","Ascites|Cirrhosis","Drug: Eplerenone","Emma Nilsson|Göteborg University|Uppsala University Hospital|Karolinska University Hospital|University Hospital, Linkoeping|University Hospital, Umeå|Region Örebro County|Region Skane","Phase 2","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","February 2013","October 2015","University Hospital of Skane, Lund, Skane, Sweden","https://ClinicalTrials.gov/show/NCT01801228"
118,"Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure","Terminated","No Results Available","Cirrhosis","Drug: Norfloxacin|Drug: Placebo","Assistance Publique - Hôpitaux de Paris","Phase 3","291","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 2010","November 2015","Assisatnce publique Hoptitaux de Paris, Clichy, France","https://ClinicalTrials.gov/show/NCT01037959"
119,"Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis","Completed","Has Results","Hepatitis C|Liver Cirrhosis","Drug: BI 201335","Boehringer Ingelheim","Phase 1","2","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","June 2008","October 2008","1220.15.49006 Boehringer Ingelheim Investigational Site, Mainz, Germany","https://ClinicalTrials.gov/show/NCT01909778"
120,"Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis","Terminated","No Results Available","Liver Cirrhosis|Peptic Ulcer","Drug: Proton-pump inhibitor|Drug: Propranolol+Proton-pump inhibitor","Taipei Veterans General Hospital, Taiwan","Phase 2|Phase 3","10","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","December 26, 2016","December 31, 2019","Taipei Veterans General Hospital, Taiwan, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT04140591"
121,"Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension","Completed","No Results Available","Liver Cirrhosis|Portal Hypertension","Drug: sapropterin","Fundacion Clinic per a la Recerca Biomédica","Phase 2|Phase 3","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","October 2011","October 2013","Hospital Ramón y Cajal, Madrid, Madrid Community, Spain|Hospital Clínic de Barcelona, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT01456286"
122,"A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients","Not yet recruiting","No Results Available","Non-alcoholic Steatohepatitis (NASH)","Drug: AZD2693|Other: Placebo","AstraZeneca|Parexel","Phase 1","60","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 24, 2020","August 30, 2021","Research Site, Anaheim, California, United States|Research Site, La Mesa, California, United States|Research Site, San Diego, California, United States|Research Site, Hialeah, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Morehead City, North Carolina, United States|Research Site, Columbus, Ohio, United States|Research Site, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT04483947"
123,"Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver","Terminated","No Results Available","Hepatocellular Carcinoma|Liver Cirrhosis","Device: Sirsphere trans-arterial radioembolization","Jules Bordet Institute","Phase 2","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","September 2012","January 2015","Institut Jules Bordet, Brussels, Belgium|Erasme Hosptial, Brussels, Belgium","https://ClinicalTrials.gov/show/NCT01686880"
124,"Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis","Terminated","No Results Available","Hepatopulmonary Syndrome|Liver Cirrhosis","Drug: bosentan|Drug: Placebo","Medical University of Vienna","Phase 2","6","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 2011",,"Medical University Vienna, Dpt. of Internal Medicine 3, Div. of Gastroenterology and Hepatology, Vienna, Austria","https://ClinicalTrials.gov/show/NCT01518595"
125,"Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction","Recruiting","No Results Available","Cirrhosis|Liver Failure","Drug: Human derived Transfer factor|Drug: Aqua pro injectione 4ml ampules for subcutaneous injection","Martin Janičko|F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica|Pavol Jozef Safarik University","Phase 2|Phase 3","124","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","July 2016","July 2020","F.D.Roosevelt Teaching Hospital with policlinic Banska Bystrica, Banska Bystrica, Slovakia","https://ClinicalTrials.gov/show/NCT02837939"
126,"Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis","Completed","No Results Available","Serum Levels of ALAT Transaminases|Serum Markers for Fibrosis and Hepatic Inflammation","Drug: Ursodesoxycholic acid","Axcan Pharma","Phase 2","98","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment","October 2005","November 2008","La Pitié Salpétrière Hospital, Paris, France","https://ClinicalTrials.gov/show/NCT00470171"
127,"Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis","Recruiting","No Results Available","Cirrhosis","Drug: Defined Green Tea Catechin Extract|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Other: Questionnaire Administration","National Cancer Institute (NCI)","Phase 1","48","NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","August 9, 2018","January 15, 2021","MedStar Georgetown University Hospital, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT03278925"
128,"Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis","Completed","No Results Available","Liver Cirrhosis, Biliary","Drug: methotrexate|Drug: ursodiol","National Center for Research Resources (NCRR)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Texas|Office of Rare Diseases (ORD)","Phase 3","315","NIH|Other","Interventional","Allocation: Randomized|Masking: Double|Primary Purpose: Treatment","January 1994",,,"https://ClinicalTrials.gov/show/NCT00004784"
129,"Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)","Recruiting","No Results Available","NASH - Nonalcoholic Steatohepatitis","Biological: NGM282|Other: Placebo","NGM Biopharmaceuticals, Inc","Phase 2","152","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2019","December 2020","NGM Clinical Study Site, Chandler, Arizona, United States|NGM Clinical Study Site, Tucson, Arizona, United States|NGM Clinical Study Site, Tucson, Arizona, United States|NGM Clinical Study Site, North Little Rock, Arkansas, United States|NGM Clinical Study Site, Fresno, California, United States|NGM Clinical Study Site, La Jolla, California, United States|NGM Clinical Study Site, Los Angeles, California, United States|NGM Clinical Study Site, Los Angeles, California, United States|NGM Clinical Study Site, Poway, California, United States|NGM Clinical Study Site, Rialto, California, United States|NGM Clinical Study Site, Boca Raton, Florida, United States|NGM Clinical Study Site, Lakewood Ranch, Florida, United States|NGM Clinical Study Site, Port Orange, Florida, United States|NGM Clinical Study Site, Sarasota, Florida, United States|NGM Clinical Study Site, The Villages, Florida, United States|NGM Clinical Study Site, Chicago, Illinois, United States|NGM Clinical Study Site, Baton Rouge, Louisiana, United States|NGM Clinical Study Site, Baltimore, Maryland, United States|NGM Clinical Study Site, Ann Arbor, Michigan, United States|NGM Clinical Study Site, Flowood, Mississippi, United States|NGM Clinical Study Site, Jackson, Mississippi, United States|NGM Clinical Study Site, Kansas City, Missouri, United States|NGM Clinical Study Site, Saint Louis, Missouri, United States|NGM Clinical Study Site, New York, New York, United States|NGM Clinical Study Site, Durham, North Carolina, United States|NGM Clinical Study Site, Fayetteville, North Carolina, United States|NGM Clinical Study Site, Germantown, Tennessee, United States|NGM Clinical Study Site, Hermitage, Tennessee, United States|NGM Clinical Study Site, Austin, Texas, United States|NGM Clinical Study Site, Edinburg, Texas, United States|NGM Clinical Study Site, Edinburg, Texas, United States|NGM Clinical Study Site, Houston, Texas, United States|NGM Clinical Study Site, San Antonio, Texas, United States|NGM Clinical Study Site, San Antonio, Texas, United States|NGM Clinical Study Site, Richmond, Virginia, United States|NGm Clinical Study Site, Richmond, Virginia, United States|NGM Clinical Study Site, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT03912532"
130,"Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B","Recruiting","No Results Available","Liver Cirrhoses","Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell","PT. Prodia Stem Cell Indonesia","Phase 1|Phase 2","12","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","May 17, 2018","December 20, 2020","Cipto Mangunkusumo hospital, Jakarta, DKI Jakarta, Indonesia","https://ClinicalTrials.gov/show/NCT04357600"
131,"Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)","Completed","Has Results","Liver Cirrhosis, Biliary","Drug: INT-747|Drug: Ursodeoxycholic Acid (URSO)|Drug: Placebo","Intercept Pharmaceuticals","Phase 2","165","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 2007","December 2010","U Florida Hepatology, Gainesville, Florida, United States|University of Miami - Center for Liver Diseases, Miami, Florida, United States|Tufts Medical Center, Boston, Massachusetts, United States|Henry Ford Health Center Columbus, Novi, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Saint Louis University, St. Louis, Missouri, United States|Beth Israel Medical Center, New York, New York, United States|Mt. Sinai School of Medicine, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|McGuire DVAMC, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Karls-Franzens University, Graz, Austria|University of Calgary, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|University of Toronto Western Hospital, Toronto, Ontario, Canada|Centre de Recherche du CHUM / University of Montreal, Montreal, Quebec, Canada|Hopital de l'Hotel Dieu, Lyon, France|Johann Wolfgang Goethe University, Frankfurt, Germany|University Medical Centre Hamburg-Eppendorf, Hamburg, Germany|Medical School of Hannover, Hannover, Germany|University of Munich, Munich, Germany|AMC University of Amsterdam, Amsterdam, Netherlands|Erasmus Medical Centre, Rotterdam, Netherlands|Hospital Clinic i Provincial, Barcelona, Spain|Queen Elizabeth Medical Center, Edgbaston, Birmingham, United Kingdom|Royal Free Hospital, Hampstead, London, United Kingdom|John Radcliffe Hospital, Headington, Oxford, United Kingdom|Royal Infirmary, Edinburgh, United Kingdom|University Upon Tyne/Newcastle, Newcastle Upon Tyne, United Kingdom","https://ClinicalTrials.gov/show/NCT00550862"
132,"Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)","Not yet recruiting","No Results Available","Hyponatremia With Excess Extracellular Fluid Volume|Cirrhosis, Liver","Drug: Albumin treatment","Fundacion Clinic per a la Recerca Biomédica","Phase 2","52","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","July 2020","November 2022","Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain|Hospital Moises Broggi, Barcelona, Catalunya, Spain|Hospital Parc Taulí, Sabadell, Catalunya, Spain","https://ClinicalTrials.gov/show/NCT03941405"
133,"Treatment of Muscle Cramps in Patients With Liver Cirrhosis","Completed","No Results Available","Liver Cirrhosis|Muscle Cramps","Drug: Hydroxychloroquine","Mayo Clinic","Early Phase 1","3","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","December 2011","April 2015","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01495403"
134,"Development of a Breath Test for Monitoring Patients With Liver Disease","Completed","No Results Available","Fatty Liver|Cirrhosis","Drug: 13C-Methacetin|Device: Breath ID Machine","Virginia Commonwealth University|Oridion","Phase 3","120","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","September 2005","April 2007","Virginia Commonwealth University, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00244569"
135,"Erlotinib for Hepatocellular Carcinoma Chemoprevention","Not yet recruiting","No Results Available","Cirrhosis, Liver","Drug: Erlotinib Hydrochloride","University of Texas Southwestern Medical Center","Phase 2","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","July 2020","June 2025",,"https://ClinicalTrials.gov/show/NCT04172779"
136,"Clinical Trial of Pentoxifylline in Patient With Cirrhosis","Completed","No Results Available","Cirrhosis|Liver Failure","Drug: pentoxifylline|Drug: PLACEBO","Assistance Publique - Hôpitaux de Paris","Phase 3","342","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 2004","December 2007","Hôpital Beaujon, Clichy, France","https://ClinicalTrials.gov/show/NCT00162552"
137,"Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis","Not yet recruiting","No Results Available","Liver Cirrhosis","Drug: Gabapentin|Drug: Calcium Carbonate","Tanta University","Phase 3","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","December 2018","December 2022","Tanta university - faculty of medicine, Tanta, Elgharbia, Egypt","https://ClinicalTrials.gov/show/NCT02642484"
138,"Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis","Recruiting","No Results Available","Cirrhosis","Procedure: Contrast-Enhanced Ultrasound|Drug: Sulfur Hexafluoride Lipid Microspheres|Procedure: Ultrasound","M.D. Anderson Cancer Center|National Cancer Institute (NCI)","Early Phase 1","150","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening","January 12, 2018","September 30, 2021","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03407001"
139,"SAMe to Treat Biliary Cirrhosis Symptoms","Terminated","No Results Available","Liver Cirrhosis, Biliary","Drug: S-adenosyl-methionine (SAMe) capsules","National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institutes of Health Clinical Center (CC)","Phase 2","50","NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double|Primary Purpose: Treatment","July 25, 2005","July 2, 2008","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00125281"
140,"Ursodiol-Methotrexate for Primary Biliary Cirrhosis","Completed","No Results Available","Liver Cirrhosis, Biliary","Drug: Methotrexate","National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","Phase 3",,"NIH","Interventional","Allocation: Randomized|Masking: Double|Primary Purpose: Treatment","January 1994","March 2004","Keck School of Medicine at U.S.C., Los Angeles, California, United States|U California Medical Center, San Francisco, California, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Emory University School of Medicine, Atlanta, Georgia, United States|Saint Louis University, St. Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Cleveland Clinic, Cleveland, Ohio, United States|Oregon Health Sciences University, Portland, Oregon, United States|Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States|UT Southwestern Medical Center at Dallas, Dallas, Texas, United States|Medical College of Virginia, Richmond, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00006168"
141,"A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH","Recruiting","No Results Available","NASH - Nonalcoholic Steatohepatitis","Drug: VK2809|Drug: Placebos","Viking Therapeutics, Inc.","Phase 2","337","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 15, 2019","November 2021","Viking Clinical Site 105, Madison, Alabama, United States|Viking Clinical Site 212, Chandler, Arizona, United States|Viking Clinical Site 216, Glendale, Arizona, United States|Viking Clinical Site 214, North Little Rock, Arkansas, United States|Viking Clinical Site 208, Fresno, California, United States|Viking Clinical Site 204, Los Angeles, California, United States|Viking Clinical Site 134, Montclair, California, United States|Viking Clinical Site 205, Panorama City, California, United States|Viking Clinical Site 125, Pasadena, California, United States|Viking Clinical Site 110, Rialto, California, United States|Viking Clinical Site 316, San Francisco, California, United States|Viking Clinical Site 103, San Francisco, California, United States|Viking Clinical Site 202, Englewood, Colorado, United States|Viking Clinical Site 106, Miami, Florida, United States|Viking Clinical Site 301, Miami, Florida, United States|Viking Clinical Site 131, Pensacola, Florida, United States|Viking Clinical Site 215, Port Orange, Florida, United States|Viking Clinical Site 218, Sarasota, Florida, United States|Viking Clinical Site 139, Zephyrhills, Florida, United States|Viking Clinical Site 144, Atlanta, Georgia, United States|Viking Clinical Site 306, Atlanta, Georgia, United States|Viking Clinical Site 111, Marietta, Georgia, United States|Viking Clinical Site 129, Chicago, Illinois, United States|Viking Clinical Site 120, Indianapolis, Indiana, United States|Viking Clinical Site 130, South Bend, Indiana, United States|Viking Clinical Site 211, West Des Moines, Iowa, United States|Viking Clinical Site 145, Topeka, Kansas, United States|Viking Clinical Site 146, Marrero, Louisiana, United States|Viking Clinical Site 109, Baltimore, Maryland, United States|Viking Clinical Site 107, Greenbelt, Maryland, United States|Viking Clinical Site 133, Detroit, Michigan, United States|Viking Clinical Site 213, Jackson, Mississippi, United States|Viking Clinical Site 112, Kansas City, Missouri, United States|Viking Clinical Site 217, Kansas City, Missouri, United States|Viking Clinical Site 128, Rochester, New York, United States|Viking Clinical Site 141, Charlotte, North Carolina, United States|Viking Clinical Site 126, Concord, North Carolina, United States|Viking Clinical Site 137, Cincinnati, Ohio, United States|Viking Clinical Site 108, Cleveland, Ohio, United States|Viking Clinical Site 311, Pittsburgh, Pennsylvania, United States|Viking Clinical Site 127, Greenville, South Carolina, United States|Viking Clinical Site 118, Hermitage, Tennessee, United States|Viking Clinical Site 115, Arlington, Texas, United States|Viking Clinical Site 113, Dallas, Texas, United States|Viking Clinical Site 104, Houston, Texas, United States|Viking Clinical Site 102, San Antonio, Texas, United States|Viking Clinical Site 101, San Antonio, Texas, United States|Viking Clinical Site 143, San Antonio, Texas, United States|Viking Clinical Site 201, San Antonio, Texas, United States|Viking Clinical Site 304, Newport News, Virginia, United States|Viking Clinical Site 209, Richmond, Virginia, United States|Viking Clinical Site 219, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT04173065"
142,"Study of INT-747 as Monotherapy in Patients With PBC","Completed","Has Results","Liver Cirrhosis, Biliary","Drug: Placebo|Drug: INT-747","Intercept Pharmaceuticals","Phase 2","59","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 2007","September 2010","Henry Ford, Novi, Michigan, United States|Baylor College of Medicine, Houston, Texas, United States|McGuire DVAMC, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Karls-Franzens University, Graz, Austria|University of Alberta, Edmonton, Alberta, Canada|University of Toronto, Toronto, Ontario, Canada|Centre de Recherche du CHUM / University of Montreal, Montreal, Quebec, Canada|Hopital de l'Hotel Dieu, Lyon, France|Hopital Saint-Antoine, Paris, France|Johann Wolfgang Goethe University, Frankfurt, Germany|University Medical Centre Hamburg-Eppendorf, Hamburg, Germany|Medical School of Hannover, Hannover, Germany|University of Munich, Munich, Germany|Hospital Clinic i Provincial, Barcelona, Spain|Queen Elizabeth Medical Center, Edgbaston, Birmingham, United Kingdom|Royal Free Hospital, Hampstead, London, United Kingdom|John Radcliffe Hospital, Headington, Oxford, United Kingdom|Royal Infirmary, Edinburgh, United Kingdom|University Upon Tyne/Newcastle, Newcastle Upon Tyne, United Kingdom","https://ClinicalTrials.gov/show/NCT00570765"
143,"Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis","Completed","No Results Available","Liver Cirrhosis, Biliary","Drug: tigecycline","Wyeth is now a wholly owned subsidiary of Pfizer","Phase 1","8","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)","December 2006","March 2009","Pfizer Investigational Site, St. Paul, Minnesota, United States|Pfizer Investigational Site, Durham, North Carolina, United States|Pfizer Investigational Site, Santurce, Puerto Rico","https://ClinicalTrials.gov/show/NCT00406237"
144,"BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis","Completed","Has Results","Chronic Liver Disease","Device: c13 methacetin solution with breath analyzer","Exalenz Bioscience LTD.","Phase 3","414","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Investigator)|Primary Purpose: Diagnostic","August 2008","September 2009","Cedars Sinai Medical Center, Los Angeles, California, United States|Henry Ford Health Sytem, Detroit, Michigan, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|St Luke's Episcopal Hospital, Baylor College of Medicine, Houston, Texas, United States|Inova Helath System, Falls Church, Virginia, United States|Virginia Commonwealth University Medical Center, Richmond, Virginia, United States|Soroka Medical Center, Beer Sheba, Israel|Carmel Medical Center, Haifa, Israel|Hadassah Medical Center, Jerusalem, Israel","https://ClinicalTrials.gov/show/NCT00736840"
145,"Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers","Completed","No Results Available","Hepatic Cirrhosis","Drug: NRL972","Norgine","Phase 1","72","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","March 2006",,"UMHAPT St Ivan Rilski's University Hospital, Sofia, Bulgaria","https://ClinicalTrials.gov/show/NCT00856713"
146,"Administration of Rifaximin to Improve Liver Regeneration and Outcome Following Major Liver Resection","Recruiting","No Results Available","Malignant Liver Disease|Major Liver Resection","Drug: XIFAXAN® (Rifaximin)","RWTH Aachen University","Phase 2","96","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","February 2016","March 2021","RWTH Aachen University, Aachen, Germany","https://ClinicalTrials.gov/show/NCT02555293"
147,"Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis","Completed","No Results Available","Liver Cirrhosis, Experimental","Drug: peginterferon and ribavirin","Casa Sollievo della Sofferenza IRCCS","Phase 2|Phase 3",,"Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)","January 2002","December 2005","Department of Hepatogastroenterology, CSS, San Giovanni Rotondo, Foggia, Italy","https://ClinicalTrials.gov/show/NCT00301509"
148,"Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver","Terminated","No Results Available","Ascites|Liver Cirrhosis","Drug: Satavaptan|Drug: placebo","Sanofi","Phase 3","241","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 2006","December 2008","Sanofi-Aventis Administrative Office, Malvern, Pennsylvania, United States|Sanofi-Aventis Administrative Office, San Isidro, Argentina|Sanofi-Aventis Administrative Office, Macquarie Park, Australia|Sanofi-Aventis Administrative Office, Diegem, Belgium|Sanofi-Aventis Administrative Office, Sarajevo, Bosnia and Herzegovina|Sanofi-Aventis Administrative Office, Sao Paulo, Brazil|Sanofi-Aventis Administrative Office, Sofia, Bulgaria|Sanofi-Aventis Administrative Office, Laval, Canada|Sanofi-Aventis Administrative Office, Santiago, Chile|Sanofi-Aventis Administrative Office, Praha, Czech Republic|Sanofi-Aventis Administrative Office, Paris, France|Sanofi-Aventis Administrative Office, Berlin, Germany|Sanofi-Aventis Administrative Office, Kuala Lumpur, Malaysia|Sanofi-Aventis Administrative Office, Mexico, Mexico|Sanofi-Aventis Administrative Office, Warszawa, Poland|Sanofi-Aventis Administrative Office, Bucuresti, Romania|Sanofi-Aventis Administrative Office, Moscow, Russian Federation|Sanofi-Aventis Administrative Office, Belgrade, Serbia|Sanofi-Aventis Administrative Office, Singapore, Singapore|Sanofi-Aventis Administrative Office, Barcelona, Spain|Sanofi-Aventis Administrative Office, Istanbul, Turkey","https://ClinicalTrials.gov/show/NCT00366795"
149,"Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver","Terminated","No Results Available","Ascites|Liver Cirrhosis","Drug: Satavaptan|Drug: placebo","Sanofi","Phase 3","501","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 2006","October 2008","Sanofi-Aventis Administrative Office, Malvern, Pennsylvania, United States|Sanofi-Aventis Administrative Office, San Isidro, Argentina|Sanofi-Aventis Administrative Office, Macquarie Park, Australia|Sanofi-Aventis Administrative Office, Diegem, Belgium|Sanofi-Aventis Administrative Office, Sarajevo, Bosnia and Herzegovina|Sanofi-Aventis Administrative Office, Sofia, Bulgaria|Sanofi-Aventis Administrative Office, Laval, Canada|Sanofi-Aventis Administrative Office, Zagreb, Croatia|Sanofi-Aventis Administrative Office, Praha, Czech Republic|Sanofi-Aventis Administrative Office, Paris, France|Sanofi-Aventis Administrative Office, Berlin, Germany|Sanofi-Aventis Administrative Office, Budapest, Hungary|Sanofi-Aventis Administrative Office, Natanya, Israel|Sanofi-Aventis Administrative Office, Milano, Italy|Sanofi-Aventis Administrative Office, Seoul, Korea, Republic of|Sanofi-Aventis Administrative Office, Kuala Lumpur, Malaysia|Sanofi-Aventis Administrative Office, Porto Salvo, Portugal|Sanofi-Aventis Administrative Office, Bucuresti, Romania|Sanofi-Aventis Administrative Office, Belgrade, Serbia|Sanofi-Aventis Administrative Office, Singapore, Singapore|Sanofi-Aventis Administrative Office, Midrand, South Africa|Sanofi-Aventis Administrative Office, Barcelona, Spain|Sanofi-Aventis Administrative Office, Taipei, Taiwan|Sanofi-Aventis Administrative Office, Guildford Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT00359437"
150,"Decompression Intervention of Variceal Rebleeding Trial (DIVERT)","Completed","No Results Available","Esophageal and Gastric Varices|Liver Cirrhosis","Procedure: Transjugular Intrahepatic Portosystemic Shunt (TIPS)|Procedure: Distal Splenorenal Shunt","National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","Phase 3","140","NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment","December 1996","December 2003","University of Miami School of Medicine, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|University of Wisconsin, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00006161"
151,"Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation","Completed","No Results Available","HCV Infection|Liver Cirrhosis, Experimental","Drug: Boceprevir|Biological: Peg-Interferon α-2b or Peg-Interferon α-2a|Drug: Ribavirin","French National Agency for Research on AIDS and Viral Hepatitis|Merck Sharp & Dohme Corp.|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)","Phase 2","58","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","January 6, 2012","January 22, 2015","Haut-Lévêque Hospital, Bordeaux, France|Beaujon Hospital, Clichy, France|Henri Mondor Hospital, Creteil, France|A Michallon Hospital, Grenoble, France|Claude Huriez hospital, Lille, France|La Croix-Rousse, Lyon, France|La Conception Hospital, Marseille, France|Saint-Eloi Hospital, Montpellier, France|Archet Hospital, Nice, France|La Pitié Salpétrière Hospital, Paris, France|Cochin Hospital, Paris, France|Staint Antoine Hospital, Paris, France|Pontchaillou Hospital, Rennes, France|Civil Hospital, Strasbourg, France|Purpan Hospital Médecine interne, Toulouse, France|Purpan Hospital, Toulouse, France|Trousseau Hospital, Tours, France|Nancy Hospital, Vandoeuvre Les Nancy, France|Paul Brousse Hospital, Villejuif, France","https://ClinicalTrials.gov/show/NCT01463956"
152,"Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis","Completed","No Results Available","Liver Cirrhosis, Biliary","Drug: colchicine|Drug: methotrexate|Drug: ursodiol","National Center for Research Resources (NCRR)|Tufts Medical Center|Office of Rare Diseases (ORD)","Phase 3","90","NIH|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment","November 1989",,,"https://ClinicalTrials.gov/show/NCT00004748"
153,"Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis","Active, not recruiting","No Results Available","Decompensated Cirrhosis","Drug: Emricasan (25 mg)|Drug: Emricasan (5 mg)|Drug: Placebo","Conatus Pharmaceuticals Inc.","Phase 2","210","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 28, 2017","August 2019","The Institute for Liver Health, Chandler, Arizona, United States|St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States|Mayo Clinic Arizona, Phoenix, Arizona, United States|University of Arizona Liver Research Institute, Tucson, Arizona, United States|University of California, San Francisco-Fresno, Fresno, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|UCLA Pfleger Liver Institute, Los Angeles, California, United States|California Liver Research Institute, Pasadena, California, United States|Stanford University, Redwood City, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|UC Davis GI/Hepatology Clinical Trials Unit, Sacramento, California, United States|Scripps Clinic - Torrey Pines, San Diego, California, United States|California Pacific Medical Center, San Francisco, California, United States|University of California San Francisco, San Francisco, California, United States|University of Colorado Denver, Aurora, Colorado, United States|Peak Enterology Associates, Colorado Springs, Colorado, United States|West Haven VA Medical Center, West Haven, Connecticut, United States|UF Hepatology Research at CTRB, Gainesville, Florida, United States|Mayo Clinic, Jacksonville, Florida, United States|Florida Research Institute, Lakewood Ranch, Florida, United States|Schiff Center for Liver Disease/University of Miami, Miami, Florida, United States|Florida Hospital Transplant Institute, Orlando, Florida, United States|IMIC Inc., Palmetto Bay, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Piedmont Transplant Institute, Atlanta, Georgia, United States|Gastrointestinal Specialists of Georgia, Marietta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Aquiant Research, Albany, Indiana, United States|Indiana University, Indianapolis, Indiana, United States|University of Iowa Hospitals and Clinics/ Internal Medicine, Iowa City, Iowa, United States|Delta Research Partners, Bastrop, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Mercy Medical Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center (WRNMMC), Bethesda, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|University of Mississippi Medical Center, Division of Digestive Diseases, Jackson, Mississippi, United States|Kansas City Research Institute, Kansas City, Missouri, United States|Rutgers New Jersey Medical School, Newark, New Jersey, United States|Northwell Health Inc., Sandra Atlas Bass Center for Liver Diseases., Manhasset, New York, United States|NYU Medical Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Columbia University Medical Center - Center for Liver Disease and Transplantation, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Carolinas Healthcare System, Center for Liver Disease, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Diabetes & Endocrinology Consultants, PC, Morehead City, North Carolina, United States|UC Health/ UCPC LLC, Cincinnati, Ohio, United States|Options Health Research, LLC, Tulsa, Oklahoma, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|GHS Gastroenterology and Liver Center, Greenville, South Carolina, United States|ClinSearch, LLC, Chattanooga, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Clinical Research Institute, Arlington, Texas, United States|Methodist Health System Clinical Research Institute, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor Scott & White Research Institute, Fort Worth, Texas, United States|Baylor College of Medicine - Advanced Liver Therapies, Houston, Texas, United States|Liver Associates of Texas, P.A., Houston, Texas, United States|American Research Corporation at the Texas Liver Institue, San Antonio, Texas, United States|Methodist Specialty & Transplant Hospital, San Antonio, Texas, United States|San Antonio Military Medical Center, San Antonio, Texas, United States|University of Utah, Salt Lake City, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|Emeritas Research Group LLC, Leesburg, Virginia, United States|Banner University Medical Center - Phoenix Transplant Institute, Newport News, Virginia, United States|Bon Secours Liver Institute of Virginia, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Swedish Organ Transplant and Liver Center, Seattle, Washington, United States|University of Washington Harborview Medical Center, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03205345"
154,"PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)","Completed","Has Results","Hepatitis|Hepatitis C, Chronic|Fibrosis|Liver Cirrhosis","Biological: PegIntron (peginterferon alfa-2b; SCH 54031)|Drug: REBETOL (ribavirin; SCH 18908)","Merck Sharp & Dohme Corp.","Phase 3","2333","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","May 2002","September 2007",,"https://ClinicalTrials.gov/show/NCT00039871"
155,"A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis","Completed","No Results Available","Muscle Cramp|Liver Cirrhosis","Drug: Pregabalin|Drug: Placebo","Seoul National University Boramae Hospital|Pfizer","Phase 3","60","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","July 2011","March 2018","Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT01271660"
